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ABSTRACT
Background: Short bowel syndrome remains a condition with high morbidity and 
mortality. The intestine exhibits pronounced diurnal rhythms in glucose absorption, 
mediated by rhythmicity in expression of the sodium glucose co-transporter SGLT1 and 
facilitated by rhythms in enterocyte proliferation. Understanding the mechanisms 
driving these rhythms may facilitate the development of new treatments for short 
bowel syndrome.
Aims: The work in this thesis aims to decipher the molecular pathways behind the 
rhythms in intestinal glucose absorption by examining the role of clock genes, 
implicated in the regulation of other diurnal intestinal transporters, in the regulation of 
SGLT1 rhythmicity and exploring the role of microRNAs, known to regulate proliferation 
in other experimental models, in the regulation of rhythmicity in intestinal proliferation.
Methods: Rhythmicity of Sgltl and clock gene expression was investigated in the 
jejunum of ad libitum and restricted-fed rats. SGLT1 and clock gene expression was 
measured in Caco-2 enterocytes bearing knockdown vectors for PERI. The effects of 
PERI and E-box sequences on the SGLT1 promoter were determined in CHO cells. 
Rhythmicity of microRNA expression in diurnally harvested rat jejunum was analyzed by 
microarrays and validated by qPCR. Temporal expression of the diurnally rhythmic 
microRNA mir-16 was further quantified in intestinal crypts, villi and smooth muscle 
using laser capture microdissection and qPCR. Morphological rhythms in rat jejunum 
were assessed by histology and proliferation by immunostaining for 
bromodeoxyuridine. In IEC-6 cells stably overexpressing mir-16, proliferation was 
assessed by cell counting and MTS assay, cell cycle progression and apoptosis by flow 
cytometry and cell cycle gene expression by qPCR and immunoblotting.
Results: 24-hour periodicity was noted in the expressions of clock genes and Sgltl in ad 
libitum fed rats. The Sgltl rhythm phase shifted in parallel with Perl upon light- 
restricted feeding. PERI suppressed SGLT1 in vitro via E-box independent sites on the 
SGLT1 promoter. Diurnal rhythmicity was noted for mir-16, mir-20a and mir-141 in rat 
jejunum. Diurnal changes in mir-16 were restricted to the crypt fraction and peaked in 
antiphase to crypt depth and villus height. Overexpression of mir-16 suppressed specific 
Gl/S regulators and produced G1 arrest. Protein expression of these genes exhibited 
diurnal rhythmicity in rat jejunum, peaking in antiphase to mir-16.
Conclusions: These findings highlight luminal nutrients as a key Zeitgeber in the 
intestine, capable of simultaneously shifting the phases of transporter and clock gene 
expression and suggest a role for clock genes, specifically PERI, in regulating Sgltl and 
therefore glucose uptake. These data further identify diurnal rhythmicity of specific 
microRNAs in rat jejunum; highlighting mir-16 as an important regulator of rhythmicity 
of proliferation in jejunal crypts. Together these findings suggest that rhythmicity in 
intestinal absorption may be mediated by at least two molecular pathways, circadian 
clock genes and microRNAs, thereby matching proliferation and absorptive capacity 
with nutrient availability. These new insights may allow the development of new 
therapies for short bowel syndrome.
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Chapter 1: Introduction
1.1. Overview of short bowel syndrome
The major role of the intestine is the absorption of nutrients from the luminal surface 
into the bloodstream[l] and intestinal physiology and anatomy have evolved to meet 
this function. Intestinal absorption of nutrients, fluid and electrolytes is proportional to 
intestinal length[l]. Loss of intestinal length, most often caused by massive small bowel 
resection, significantly compromises intestinal function and results in failure of the 
intestine to meet nutritional needs, a phenomenon known as short bowel syndrome[2]. 
The lack of a suitable therapeutic option for the management of short bowel syndrome 
merits the search for new alternatives. Current management options are limited and 
bear many associated side-effects[2]. The identification of new treatments requires a 
greater understanding of intestinal absorption and may be realised by improved insights 
into the physiological regulation of intestinal absorption.
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1.2.The role of the intestine in absorption
1.2.1. Anatomy and physiology of the human intestinal tract
The intra-abdominal digestive tract begins at the stomach, which receives food boluses 
travelling down from the oesophagus]!]. The stomach acts as a reservoir which controls 
the rate of entry of nutrients into the first part of the small intestine known as the 
duodenum]!]. The duodenum measures 25 cm, becoming the jejunum at the Ligament 
of Treitz, a band-iike ligament which attaches the duodenal-jejunal flexure to the 
posterior abdominal wall[3] (Figure 1.1). The jejunum and ileum are the predominant 
sites of absorption in the intestine, particularly the jejunum and together measure 
between 4 to 6 m in length]!, 3] (Figure 1.1). The ileocaecal valve, at the end of the 
ileum, is the site of connection between the small intestine and the colon, specifically 
the region of the colon known as the caecum with the attached appendix]!] (Figure 1.1).
The intestinal epithelium proliferates rapidly via the division of progenitor or stem cells 
residing in the intestinal Crypts of Lieberkuhn and is countered by cell shedding at the 
tips of the villi[4]. Cells hence migrate upwards from the crypt towards the tip of a villus, 
differentiating from progenitor cells to one of 3 cell types in the process - enterocytes 
(responsible for intestinal absorption), enteroendocrine cells (which secrete hormones 
such as glucagon-like peptide 1 and cholecystokinin) and goblet cells (which secrete 
mucous)[4, 5] (Figure 1.2). Progenitor cells may also remain in the crypt and 
differentiate into Paneth cells[4, 5] (Figure 1.2).
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Figure 1.1: A schematic showing the anatomy of the human gastrointestinal tract, with 
the small intestine magnified. Modified from Medline Plus, freely accessible at 
www.nlm.nih.gov.
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Paneth
cell
Figure 1.2: Diagram of the small intestinal crypt-villus axis and differentiated cell types. 
Adapted and modified from Barker et al, Genes Dev 2008 Jul 15;22(14):1856-64.
1.2.2. Intestinal absorption of nutrients
The absorptive function of the intestine has been the subject of much research dating 
back to the late 1800s, when it was discovered that the absorption of substrates from 
the intestine was not dependent on the hydrostatic pressure within the lumen, or the 
osmotic pressure of the luminal contents[6-8]. Indeed it was further demonstrated that 
two solutions of similar osmotic pressure might be absorbed at varying rates, leading 
the researchers of the time to conclude that the intestine "is a membrane of varying 
permeability depending on the nature of the substances presented to it"[6-8]. Although 
these early reports preceded the discovery of specific nutrient and non-nutrient
transporters in the intestine, it was already noted in these studies that the absorption of
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hexose sugars from the intestine could not be explained by mere diffusion or osmosis 
and that sodium appeared to play a role in the regulation of absorption of glucose from 
the intestine[9], heralding the subsequent discovery of active transport mechanisms in 
the intestine.
Understanding the regulation of intestinal absorption is likely to be a key factor in 
developing new treatments for short bowel syndrome. Glucose is one of the most 
important absorbed nutrients and adequate glucose absorption is essential in meeting 
the nutritional demands of the individual^, 3]. The sodium glucose co-transporter 
SGLT1 is responsible for all active glucose uptake in the intestine; subsequent 
movement of glucose across the basolateral membrane occurs down a diffusion 
gradient[10, 11]. Absorption of glucose by SGLT1 is therefore the most important 
component of intestinal glucose absorption and SGLT1 is hence the main transporter of 
interest in understanding the regulation of glucose absorption in the intestine.
Subsequent studies have identified the existence of rhythmicity in intestinal glucose
absorption in rats, with peak absorption occurring at the time of maximal nutrient
delivery[12, 13]. The mechanisms underlying this have yet to be fully characterized.
Circadian clock genes have been shown to regulate rhythms of other intestinal
transporters[14-16], however their role in the regulation of the rhythmicity of glucose
absorption has yet to be identified. microRNAs are a class of non-coding ribonucleic
acids (RNAs) that have been found to regulate rhythmicity in hepatic gene
expression[17] and are known to regulate proliferation in other tissues[18-24], however
their expression in the intestine has yet to be profiled and their role in rhythmicity of
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intestinal absorption remains unknown. These molecular pathways may be responsible
for regulating the rhythmicity of intestinal absorption and understanding the regulatory 
networks behind this phenomenon may allow the development of new therapies for 
short bowel syndrome.
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1.3. Intestinal glucose transport
1.3.1. Background
The first insights into the physiology of glucose absorption by the intestine were 
published in 1955[25], when Fisher showed that no water absorption occurred in the 
intestine of rats in the absence of luminal glucose and that the absorption of water and 
glucose was entirely an active process. Newey et ai[26] subsequently demonstrated the 
ability of the flavonoid phloridzin to inhibit the mucosal absorption of glucose; leading 
to the discovery of specific glucose transporters sensitive to phloridzin. The first 
description of active sodium glucose co-transport was initiated by Crane et al[10], who 
demonstrated, using the Na+K+ ATPase inhibitor ouabain in hamster intestine, that a 
sodium gradient was required for glucose transport.
1.3.2. SGLT1
1.3.2.1. SGLTl-mediated glucose transport
SGLT1 is a 73kDa protein which reacts with 2 Na+ molecules for every glucose
molecule[27]. SGLTl-mediated glucose uptake from the intestine is a form of active
transport, inhibited by phloridzin and facilitated by the Na+K+ATPase on the basolateral
membrane[28] which maintains the sodium gradient (Figure 1.3). During active glucose
transport, two Na+ ions bind to SGLT1 on the luminal side of the brush border
membrane (BBM), producing a conformational change that permits sugar binding[27].
This is followed by a further conformational change which allows the substrates (either
glucose or galactose) to enter the enterocyte[27]. The low affinity of the cytosolic sites
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for sugar and Na+, as well as the low intracellular concentration of Na\ results in 
dissociation of these molecules from SGLT1[27]. The ability of SGLT1 to transport water 
as well as glucose (249 water molecules are transported with every glucose 
molecule)[29] facilitated the development of oral rehydration therapy and saved 
millions of lives by treatment of diarrhoeal dehydration in the developing world[29, 30].
GLUCOSE LUMEN
SGLT1 l
GLUT2 Na+K+ATPase BLOOD
Figure 1.3: Schematic showing the distribution of the glucose transporters on 
enterocytes. SGLT1 (red circle) is situated on the apical border of the enterocyte while 
GLUT2 (purple circle) is on the basolateral membrane. The Na+K+ ATPase (green circle) 
facilitates active transport by SGLT1 and is also situated on the basolateral membrane.
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1.3.2.2. Regulation of SGLT1
SGLT1 has been shown to be regulated at a transcriptional level by intestinal 
transcription factors such as hepatocyte nuclear factor 1 (HNF1) and Spl[31], which are 
also known to regulate transcription of other intestinal genes such as sucrase- 
isomaltase[32] and lactase[33]. These transcription factors are able to bind to GC 
elements on the 5GLT1 promoter and synergistically activate Sgltl transcription[31]. 
Despite this however, no symptoms of glucose-galactose malabsorption were noted in 
HNFla or (3 knockout mice[34, 35]. This is corroborated by the fact that humans with 
deficiencies of either HNFla or (3 do not exhibit diarrhoea or glucose malabsorption, 
suggesting that HNF1 may not be essential for maintaining basal expression of 
SGLT1[36]. SGLT1 activity can be modified by the expression levels of an intracellular 
regulatory protein, regulatory subunit 1 (RSI), via modulation of dynamin-dependent 
5GLT1 trafficking[37]. RSI-/- mice developed obesity associated with post- 
transcriptional increased intestinal expression of SGLT1 and upregulated glucose 
transport[38]. Transforming growth factor (3 {TGF-(3) is another protein that has also 
been shown to increase glucose uptake, but through as yet undefined mechanisms, 
possibly approximating hsp70 (heat shock protein 70, a member of the heat shock 
protein family), thereby stabilising membrane SGLT1[39]. Apical localization of SGLT1 is 
a feature essential for SGLT1 function: mice deficient in the small guanosine 
triphosphate (GTP) -binding protein Rab8, which is essential for the apical localization of 
SGLT1, showed reduced levels of a-methyl-d-glycopyranoside (a-MDG) absorption 
compared to their wild-type counterparts[40].
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1.3.2.3. Mutations of SGLT1 cause glucose-galactose malabsorption
Glucose-galactose malabsorption is a rare autosomal recessive disorder causing a failure 
of SGLT1 protein trafficking to the BBM[41], resulting in severe life-threatening 
diarrhoea which begins at birth and continues until glucose, galactose and lactose are all 
removed from the diet[41, 42]. Over 300 cases have been diagnosed worldwide, the 
majority in females and often as a product of consanguineous relationships[41]. The 
varied and unique mutations in each case of glucose-galactose malabsorption make 
prenatal diagnosis by genetic screening difficult. This condition is diagnosed by the lack 
of response to an oral glucose challenge and treated by abstinence from all glucose, 
galactose and lactose in the dietfll].
1.3.2.4. History of cloning and characterization of SGLT1
These studies laid the groundwork for further research into active intestinal glucose 
transport, however it was not until the 1980s[43] that the first eukaryotic transporter 
was characterized and cloned. This was the sodium glucose co-transporter SGLT1[11, 
43], found to reside on the brush border membrane of enterocytes. SGLT1 was found to 
belong to the solute carrier family 5 {SLC5) group of proteins, containing over 200 
eukaryotic and prokaryotic members and contains 14 transmembrane cc-helices, an 
extracellular N and C terminus, a glycosylation site and two phosphorylation sites[43]. 
SGLT1 (also known as SLC5A1) is expressed in the brush border of enterocytes as well as 
in small quantities in renal proximal tubular cells and the heart and is able to transport 
both glucose and galactose[42, 43].
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1.3.3. Other intestinal glucose transporters
Two other intestinal transporters cooperate with SGLT1 in the intestinal absorption of 
glucose - GLUT2 and GLUT5[44-46]. While SGLT1 transports glucose from the lumen 
into the cytoplasm of the enterocyte, the high-capacity low-affinity transporter GLUT2 
resides on the basolateral membrane of enterocytes and transports glucose, fructose, 
galactose and mannose out of the cell[44, 45]. The facilitated glucose transporter GLUTS 
is responsible for the uptake of fructose at the brush border membrane of the 
intestine[46]. Fructose is then transported out of the enterocyte by GLUT2 at the 
basolateral membrane[46].
1.3.4. Transport of other nutrients
The transporter PEPT1 is the only oligopeptide transporter at the intestinal brush- 
border, responsible for the transport of 400 dipeptides and 8000 tripeptides as well as a 
wide range of peptide-like drugs, such as p-lactam antibiotics and angiotensin­
converting enzyme inhibitors[47]. PEPT1 is a H+-peptide cotransporter that relies on a 
proton gradient for the uphill transport of peptides, which are subsequently transported 
across the basolateral membrane by the facilitative basolateral peptide transporter[48]. 
Targeted disruption of PEPT1 in mice significantly reduced uptake of dipeptides from 
the intestine, suggesting an essential role for PEPT1 in intestinal peptide absorption[49]. 
Lipids are digested in the intestine into free fatty acids and glycerol[50]. Fatty acids are 
absorbed by FAT/CD36 and FATP4[50], Cholesterol influx into enterocytes is regulated
by Niemann-Pick Cl like 1(NPC1L1) and efflux regulated by ATP-binding cassette (ABC)
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proteins ABCG5 and ABCG8[50]. The route of glycerol absorption on the other hand is 
still a topic of much research; paracellular passive diffusion has been assumed to be the 
main route of glycerol absorption, however more recent studies suggest a potential 
carrier-mediated route of absorption[51].
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1.4.Circadian rhythmicity in intestinal absorption
1.4.1. Overview of circadian rhythmicity
Circadian rhythmicity reflects the innate ability of all organisms to detect and adapt to 
external stimuli, evidenced by the adaptation to the 24-hour cyclic pattern of light and 
the daily and seasonal patterns of food availability and temperature[52]. The 
phenomenon of circadian rhythmicity has been discovered in unicellular organisms to 
complex organisms such as plants and humans[52]. One of the earliest forms of 
circadian behavior was the tendency for early metazoans to migrate to deep ocean 
waters during the daylight for protection from ultraviolet (UV) radiation[52]. The first 
descriptions of circadian rhythmicity were written centuries ago; one of the most 
famous descriptions of this was by Christoph Wilhelm Hufeland, who wrote in 1797 the 
text "Die Kunst das menschliche Leben zu verlangern" "Due to the regular rotation of 
our planet there is a 24-hour period transmitted to all inhabitants on earth.. .and in all 
kinds of diseases this regular period can be found again and this 24-hour period 
determines the wonderful timing of all our bodily functions. This period can be called 
the unit of the chronology of nature"[53, 54], Physiological and pathological examples of 
circadian rhythms in visceral function include circadian rhythms in heart rate[55], blood 
pressure[56], nocturnal worsening of asthma [57] and gout[54, 58]. Circadian rhythms 
share similar characteristics common to many species, including flies, mice and humans; 
synchronization by environmental stimuli (zeitgebers - "time-givers")[59], the most 
important of which is light, as almost all rhythms synchronize to the daymight cycle and
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persistence in the absence of cycling zeitgebers, i.e. under constant conditions, such as
constant darkness[60j.
1.4.2. Circadian rhythmicity in feeding across species
Humans and rodents exhibit similarities in their patterns of food consumption. Both 
species engage in specific bouts of eating (meals), which occur across the day at 
differing time intervals[61, 62]. In both cases the longest interval between meals is often 
the inactive rest period, such as during the night in humans and during the day in the 
nocturnal rodent[61, 62]. The existence of these specific feeding patterns may allow 
animals to adapt to their unique environmental conditions, e.g. the availability of food 
and may therefore act as a survival advantage on an evolutionary level[61]. As 
mentioned above, rats in the wild are nocturnal feeders that feed at intervals spaced 
across the dark period and rest during the day. Despite many generations of inbreeding, 
laboratory rats continue to maintain similar feeding patterns[61]. Although mice are 
also nocturnal animals, they have not been observed to exhibit such clear feeding 
patterns as rats and tend to graze during the day (personal communication from David B 
Rhoads). The rhythmicity observed in SGLT1 expression in rats has also been 
documented in non-human primates[63], with a 12 hour difference in the time of peak 
expression consistent with the nocturnal rat versus the diurnal Rhesus monkey. This 
highlights the relevance of circadian rhythmicity across species and suggests that the 
circadian rhythmicity noted in the rat can be extrapolated to primates.
Page 14 of 272
1.4.3. Rhythmicity of intestinal absorption
1.4.3.1. Overview of the rhythmicity of intestinal absorption
Furuya and Yugari first demonstrated in 1974 that intestinal absorption exhibits a 
diurnal rhythm in nocturnal feeding rat, with a peak in histidine absorption during the 
nocturnal feeding period[64, 65]. This work was further developed by Fisher and 
Gardner in 1976, who confirmed peak absorption of glucose during the nocturnal 
period, but also demonstrated that this rhythm in absorption was related to nutrients, 
as restricting the feeding period to the daytime only resulted in peak levels of 
absorption during the day[12]. These findings preceded the discovery and 
characterization of specific glucose transporters, hence these experiments measured 
total glucose uptake using isolated segments of intestine at diurnal timepoints. The 
authors hypothesized that these rhythms were likely to be mediated at least in part by 
the known rhythmicity in intestinal proliferation[66].
Other groups have also demonstrated rhythmicity in intestinal function besides rhythms
in absorption. Saito demonstrated diurnal rhythms in the activities of maltase and
leucylnaphthylamidase, with peak activity occurring during feeding periods[67].
Subsequently circadian rhythmicity in intestinal absorption was confirmed and further
developed in a series of experiments by Stevenson et al, who demonstrated circadian
rhythmicity in the activity of sucrase, lactase, trehalase, y-glutamyltransferase and as
previously shown, maltase and leucylnaphthylamidase[68].
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1.4.3.2. Rhythmicity in absorption of individual nutrients
I.4.3.2.I. Rhythmicity in SGLTl-mediated glucose uptake
The initial findings of diurnal rhythmicity in intestinal glucose absorption preceded the 
characterization of specific intestinal transporters. As described previously, the sodium 
glucose co-transporter SGLT1 was the first transporter to be characterized[43]. Sgltl 
was found to exhibit diurnal rhythmicity with peak mRNA expression in the afternoon 
and evening, in anticipation of and during the time of peak nutrient uptake[13, 63, 69]. 
These studies used phloridzin as an SGLTl-specific inhibitor and identified complete loss 
of rhythmicity following SGLT1 inhibition, indicating that SGLTl-mediated glucose 
uptake was entirely responsible for the diurnal rhythmicity of glucose absorption[13, 
69].
I.4.3.2.2. Rhythmicity of other transporters
Circadian rhythmicity has also been noted for a number of other intestinal 
transporters[70, 71]. The H+-coupled peptide transporter is responsible for active uptake 
of peptides at the brush border of the intestine[47]. Peptide absorption has been shown 
to display diurnal rhythmicity with peak in absorption of L-histidine occurring during the 
dark phase in nocturnal animals[64], coincident with higher levels of PEPT1 protein 
expression during the dark phase than the light phase[70].
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Recent studies have shown that certain drug transporters also exhibit rhythmicity of
expression in the intestine|71]. These transporters act as efflux proteins in the intestine 
to facilitate the excretion of the metabolic products of many drugs including digoxin[72] 
and methotrexate[73]. Five drug transporters {Mdrl, Mctl, Mrp2, Bcrp and the peptide 
transporter Peptl, which also transports 3-lactam drugs[74]) are diurnally rhythmic in 
the intestine at a transcriptional leve![71]. A 2-5 fold change in expression was observed 
between peak and trough times and peak expression varied from morning to late 
afternoon [71].
1.4.4. Tissue-specific circadian rhythmicity
it is of interest to note that the same transporters that exhibit circadian rhythmicity in 
the intestine do not necessarily show a similar rhythmicity in other organ systems. 
SGLT1 and PEPT1 are two such examples, displaying profound rhythmicity in the 
intestine, but lacking diurnal rhythmicity in either mRNA or protein expression in the 
kidney[70]. This has implications for the regulatory mechanisms driving this rhythmicity 
and suggests that tissue-specific regulatory factors may be responsible for this 
differential pattern of expression across tissues.
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1.4.5. The rationale for using rats in diurnal rhythm experiments
The vast majority of experimental research on circadian rhythms in feeding has been 
performed in rats. Although mice may be better suited for genetic manipulation to 
decipher the molecular pathways regulating circadian anticipatory rhythms, mice are 
not as adaptable to restricted patterns of food availability[75j. Rats are nocturnal 
opportunistic feeders, which adapt well to "stuff-and-starve" schedules based on food 
availability, making them an ideal species for investigation of the regulatory pathways 
behind circadian rhythmicity[75]. While non-human primates may ideally represent the 
closest genetic species to humans, the use of this species as an animal model is limited 
by cost and the need for dedicated primate research facilities.
1.4.6. Cues regulating feeding rhythms
I.4.6.I. Nutrient availability and light cycle
The majority of research performed on circadian rhythmicity in nutrient absorption has 
been performed in rats. The association of nutrient consumption with the dark phase in 
the rat[13] has necessitated further experiments to isolate the period of nutrient 
availability from light cycle. The first experiments on this were performed by Fisher and 
Gardner[12], who demonstrated that restricting feeding to only a few hours during the 
daytime resulted in an initial reduction in food consumption and weight loss, but this
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normalized within one week. Rates of absorption were similar toward the end of the 
feeding period regardless of whether animals were fed during the lights on or lights off 
period[12]. Pan et al[76] corroborated the findings of Fisher et al[12] by showing that 
peak SGLT1 mRNA and protein expression was shifted forwards by 8 hours in rats fed for 
a few hours during the day compared to those fed at night[76], suggesting that the 
effect of restricted feeding on shifting glucose absorption may be mediated by a phase 
shift in SGLT1 expression.
I.4.6.2. Effects of food deprivation and intravenous nutrition
The necessity for luminal nutrient exposure for the maintenance of diurnal rhythmicity 
has been investigated in animals subjected to food deprivation followed by a period of 
refeeding[76]. Food deprivation decreased overall levels of SGLT1 mRNA and protein at 
all timepoints compared to fed rats[76]. In addition rhythmicity in SGLT1 protein 
expression was abolished after as little as two days of food deprivation despite 
persistent rhythmicity in expression of Sgltl, suggesting that nutrient exposure may 
regulate rhythmicity at a post-transcriptionai level, but was not essential for 
transcriptional rhythmicity[76].
Circadian rhythmicity in glucose absorption was lost after 9 days of continuous 
intravenous feeding[77] however rats administered discontinuous periods of
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intravenous infusion showed persistent rhythmicity with discontinuous intravenous 
infusion, suggesting that the episodic nature of nutrient availability is a more important 
cue than local nutrient exposure.
1.4.7. Physiological mediators of rhythmicity
I.4.7.I. Circadian hormones
Several hormones are known to exhibit circadian rhythmicity and also have a role in 
regulating baseline glucose absorption[78-80]. These hormones may therefore 
represent candidate mediators of the rhythmicity in glucose absorption; however at 
present few studies have investigated this. Glucocorticoids are secreted by the adrenal 
gland[l] with a circadian rhythm[81], reaching a peak around or just before the onset of 
activity in both diurnal and nocturnal mammals and have been implicated in the 
regulation of circadian function as the rhythmicity in their expression is able to rapidly 
adapt to alterations in activity or feeding schedule[82j. Administration of 
glucocorticoids was able to synchronize asynchronous fibroblasts in vitro to a common 
circadian phase[83, 84] and transiently induce the expression of mPerl in the mouse 
liver in vivo[85]. The effects of glucocorticoids are dependent on a functional 
glucocorticoid receptor, which is absent in the suprachiasmatic nucleus (SCN)[85, 86], 
hence glucocorticoid administration was unable to shift SCN clock gene expression. 
Glucocorticoids are also known to affect glucose absorption in rats by stimulating
transcription of glucose transporters[78j. The effects of glucocorticoids on peripheral
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tissues will be described further later in this chapter. The specific role of glucocorticoids 
in the regulation of the circadian rhythm of intestinal glucose absorption has not been 
studied.
Leptin is another circadian hormone released by adipose tissues, with levels reaching a 
peak after a meal and declining until the next meal[79]. Leptin has also been shown to 
inhibit glucose absorption via SGLT1 and has therefore been implicated in the circadian 
regulation of glucose absorption[80]. Other circadian hormones such as ghrelin have 
been implicated in regulation of nutrient intake, but are as yet not known to have a 
direct role in nutrient absorption[87].
1.4.7.2. Neural mediation of circadian rhythmicity
The nerve supply of the small intestine consists of the afferent and efferent limbs of the 
vagus and the intrinsic enteric nervous plexuses[l]. Rhythmicity of SGLT1 protein 
expression was lost following total vagotomy (ablation of both the afferent and efferent 
vagal limbs) despite persistence of transcriptional rhythmicity[88]. These findings were 
reproduced with selective ablation of only the afferent limb of the vagus[89], suggesting 
a role for the afferent limb of the vagus in post-transcriptional regulation of SGLT1 
rhythmicity.
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Less is known on the exact role of the intrinsic or intramural neural network in
regulation of intestinal function. A recent study examining the effects of disruption of 
the intrinsic nervous system by transection and reanastomosis of the intestine revealed 
no effect on basal levels of hexose transporter expression or glucose uptake[90], 
suggesting that baseline or non-diurnal intestinal absorptive function is independent of 
the intrinsic neural network. This does not exclude a role for the intrinsic nervous 
system in the diurnal regulation of intestinal absorption, which has yet to be studied.
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1.5.Circadian rhythmicity of intestinal proliferation
1.5.1. Apoptosis and proliferation in the intestine
The proliferative capacity of the intestine is uniquely tailored to meet the absorptive 
needs of the organism. Intestinal proliferation is confined to the crypt fractional], and 
driven by the division of intestinal stem ceils situated at position +4 relative to the crypt 
bottom[92]. Cell division in the crypt is mediated by the transcription factor c-myc[93] 
and facilitated by cell cycle proteins which mediate the progression of cells through the 
successive stages of the cell cycle[94] which are detailed further in section 1.5.4. Crypt 
cells are able to differentiate into secretory cells, namely Paneth cells, goblet cells, and 
enteroendocrine cells or absorptive enterocytes, as described in section 1.2.1 and 
shown in Figure 1.2. Lineage specification in the intestine is mediated by the Wnt[95] 
and Notch[96] signaling pathways, which direct differentiation into the secretory and 
absorptive lineages respectively.
Proliferation in the intestine is countered by a low rate of apoptosis, which serves to 
regulate the number of crypt cells entering the crypt villus axis and is also thought to 
occur as part of the cell shedding process on the villus tip[97]. The tumour suppressor 
p53 has been shown to play a vital role in mediating the induction of apoptosis in many 
tissues[98]. Nuclear p53 binds to Mdm2 [99]; cellular stress induces translocation of p53 
into the cytoplasm, allowing sequestration of p53 by anti-apoptotic Bcl-2 family 
members such as Bcl-XL and Bcl2[100]. The interaction of p53 with anti-apoptotic 
proteins is disrupted by one of its targets, PUMA, which liberates p53 to associate with
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pro-apoptotic proteins such as Bax or Bak[101, 102]. This is turn activates caspases.
cysteine proteases which cleave target proteins to bring about the characteristic nuclear 
changes of apoptosis[103-105].
Studies using transgenic mice have attempted to better characterize the proteins 
mediating apoptosis in the small intestine. In particulary these experiments have shown 
an insignificant role for pSSflOG, 107] Bax[108, 109] and Bcl2[110, 111] in small 
intestinal apoptosis - mice deficient in either of these proteins have similar rates of 
apoptosis to their wildtype counterparts. These findings indicate that the specific 
proteins and perhaps also the regulatory cues mediating the apoptotic process in the 
small intestine are distinct from that in other tissues.
1.5.2. Overview of rhythmicity in intestinal proliferation and apoptosis
The first description of circadian rhythmicity in proliferation in the intestine was by
Sigdestad et al, in 1969[66], who identified a circadian rhythm in both the mitotic index
as well as deoxyribonucleic acid (DNA) synthesis in mouse duodenum. This was
subsequently corroborated by Scheving et al in 1972[112], who showed that although
the amplitude of change in DNA synthesis was low, varying from 30 to 60% depending
on the site, there was nonetheless a consistent rhythm across circadian timepoints. In
animals acclimatized to a 12:12 light dark cycle, DNA synthesis peaked at the transition
from dark to light and reached a trough at the transition from light to dark[66]. In
addition, although the amplitude of the rhythms of proliferation varied significantly
depending on the site within the gastrointestinal (Gl) tract (rhythms exhibited greatest
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amplitude in the mouth and anus, the most proximal and distal ends of the 
gastrointestinal tract respectively), the time of peak DNA synthesis was relatively 
consistent along the length of the Gl tract. For example, DNA synthesis in mouse 
jejunum demonstrated peak 3H-thymidine uptake during daylight hours, with rhythms of 
amplitude between 40 to 51%, a similar peak to that demonstrated in the oesophagus, 
duodenum and colon [112].
Circadian rhythmicity of intestinal apoptosis has similarly been studied, however the 
assessment of circadian rhythmicity of spontaneous apoptosis in the small intestine is 
difficult due to the low levels of spontaneous apoptosis[113j. Radiation-induced 
apoptosis has proved a well-characterized model, facilitating the measurement of 
circadian rhythms in apoptosis. Using this model several groups have identified higher 
rates of apoptosis in mouse duodenum and colon during the fasting lights-on period 
compared to the nocturnal feeding period[114-116j.
1.5.3. The role of nutrients in the regulation of rhythmicity in intestinal 
proliferation and apoptosis
DNA synthesis in the rodent gastrointestinal tract begins to increase following the light-
dark transition, in phase with feeding behaviour and motor activity, reaching a peak at
or after the dark-light transition[112]. Rhythmicity of cell proliferation in the intestine is
synchronized to the light cycle in animals fed ad libitum, however restricted feeding
shifts the peak in DNA synthesis - suggesting a role for nutrients in the regulation of the
rhythm in intestinal proliferation[112]. Circadian rhythmicity in proliferation persisted
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for up to 34 hours in the stomach, foregut and hindgut of animals fasted for a period of 
8 hours[117]. Other studies have shown rhythmicity of tongue epithelium to persist for 
even longer periods of fasting of up to 72 hours[118].
Ablation of the SCN did not abolish rhythmicity in the digestive tract, but instead caused 
a phase advance in the rhythms of proliferation in the tongue, esophagus, stomach and 
colon and had a variable effect on the amplitude of rhythmicity depending on the site 
along the Gl tract[112]. Overall these findings suggested that the SCN was not essential 
for maintenance of rhythmicity in Gl proliferation, which might instead have a greater 
reliance on molecular pathways triggered by food availability.
Nutrient exposure is also likely to play a role in the regulation of circadian rhythmicity of 
apoptosis. In contrast to the nocturnal feeding mice, the diurnal Mongolian gerbil did 
not demonstrate circadian rhythmicity in intestinal apoptosis[119]. Fasting increased 
the rates of apoptosis in the intestine of these gerbils, while refeeding decreased the 
rate of apoptosis. A similar increase in the rate of apoptosis was demonstrated in fasted 
rats compared to fed rats[120]. Together these findings highlight a role for luminal 
nutrient exposure in the regulation of circadian rhythms in apoptosis.
1.5.4. Molecular pathways regulating circadian rhythmicity in intestinal 
proliferation
To date the molecular pathways underlying circadian rhythmicity in cellular proliferation
in the intestine remain unclear. A recent microarray-based study on circadian gene
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expression in mouse colon revealed that a large percentage of rhythmically-expressed 
genes (26%) were involved in cell proliferation, cell cycle and DNA replication[121]. Of 
greater interest, not all oscillating transcripts in this study displayed corroboratory 
rhythms in protein expression, highlighting the importance of both transcriptional and 
translational regulation in maintenance of cell proliferation rhythms in the Gl tract[121]. 
Despite this, only one study to date has attempted to identify specific proteins that may 
regulate this rhythmicity in enterocyte proliferation[122]. Cell cycle proteins are known 
regulators of cell division and facilitate the transition between quiescence, DNA 
replication and mitosis[123-125]. Cyclin D/ CDK4/6 and cyclin E/CDK2 complexes, largely 
restricted to the crypts, facilitate the Gl/S transition of crypt cells, promoting 
enterocyte proliferation^]. These cell cycle proteins have been shown to exhibit 
diurnal rhythmicity in expression in human intestinal tissue - colonic biopsies taken at 6 
hourly intervals over a diurnal period revealed rhythmicity in the expression of Gl/S 
regulators cyclins D1 and E, with peak expression in the evening at 18:00 and the trough 
in expression at 00:00[122]. Conversely in the same study pl6 and p21, proteins which 
inhibit the activity of cyclin-dependent kinases, exhibited circadian rhythmicity in 
antiphase to cyclins D1 and E, with lowest expression at 12:00 and 18:00. The 
rhythmicity in cell cycle proteins and CDK inhibitors corroborates the hypothesis of a 
potential role for these proteins in the circadian regulation of enterocyte proliferation.
Rhythmicity in indices of intestinal cellular proliferation has also been described; human 
rectal mucosa exhibits circadian rhythmicity in DNA synthesis (S-phase) in both fasting 
and fed conditions as measured with 3H-thymidine incorporation, with a peak at
07:00[126, 127]. This is in keeping with rodent data, although the timing of peak DNA
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synthesis is in antiphase in rats[112] versus humans[126, 127] (early activity in humans 
vs. late activity in rodents), consistent with the nocturnal feeding behaviour of rats 
versus diurnal humans.
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1.6. Clock genes
1.6.1. Overview of clock genes
The circadian clockwork is regulated by a set of genes, referred to as clock genes, 
involved in the regulation of circadian rhythms such as hormone secretion and 
autonomic functions including body temperature and blood pressure[128, 129]. Clock 
genes have been shown to regulate other intestinal transporters[14-16] and are hence a 
potential candidate for mediating transcriptional rhythmicity in the main intestinal 
glucose transporter, SGLT1. In mammals, the master clock resides in the SCN and 
maintains a 24-h periodicity entrained by light[130] and regulated via opposing positive 
and negative molecular feedback loops. Rhythmicity of the SCN is cell autonomous , as 
rhythms can persist in cultured conditions for weeks in the absence of external 
entraining stimuli[131].
1.6.2. Description of the discovery of clock genes
The molecular pathways and genes regulating circadian rhythms were first investigated 
in the suprachiasmatic nuclei (SCN), considered the master circadian clock and 
responsible for generating circadian rhythms[132-134]. The SCN are small paired 
structures situated in the anterior hypothalamus, just above the optic chiasm and
strategically positioned for receiving visual input for light-dark entrainment via the
Page 29 of 272
retina[135]. Although the first and most complete description of the molecular control 
of the circadian clock was accomplished in the fruit fly, Drosophila melanogaster; the 
core clock mechanisms of Drosophila and mammals are highly similar, in both cases 
consisting of interlocking positive and negative transcriptional-/translational-feedback 
loops[134]. Minor differences exist in the clock control pathways between the two 
species and will be discussed further later in this chapter. For a thorough review of the 
clock gene molecular feedback loops in Drosophila, readers are recommended to 
consult the following articles[136-138].
1.6.3. Clock genes in Drosophila
1.6.3.1. Circadian rhythmicity in Drosophila
Initial studies on circadian rhythmicity in Drosophila used two major rhythmic 
behavioral outputs—eclosion and locomotor activity[139, 140]. Eclosion - the hatching 
of adult files from their pupal cases, occurs predominantly at dawn and was used to 
examine the role of clock genes in the circadian rhythm of metamorphosis[139]. This 
evolved from the original habitat of fruit flies in sub-Saharan Africa, when the morning 
hours were optimal for pumping of haemolymph into their wings to allow them to fly 
(hence the name Drosophila - "dew-lover" in Greek)[136]. Locomotor activity also 
shows circadian rhythmicity in Drosophila, with a bimodal distribution of activity 
confined largely to daylight hours when kept under light:dark cycles[140]. The circadian
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nature of this activity is confirmed by the observation that under free-running 
conditions such as constant darkness, the bimodai peak in activity usually disappears 
and activity occurs throughout the subjective day[137]. More recently circadian 
rhythmicity has been noted in other processes such as olfactory responses, visual 
pigment and sensitivity and egg-laying [141-143].
I.6.3.2. Clock genes and feedback loops in Drosophila
The clock molecular pathways and the feedback loops mediating circadian rhythmicity in 
Drosophila are weli-characterized[136, 144, 145], Clock proteins CLK (clock) and CYC 
(cycle, the homoiogue of mammalian BMAL1) dimerize and activate transcriptional 
induction of period (per) and timeless (tim, the analogue of mammalian Cry) at ~ZT12 via 
E-box elements[146]. As per and tim RNA levels rise, phosphorylation by DBT (double­
time,] prevents PER from accumulating and renders it unstable in the absence of 
TIM[147-149]. TIM is a light-labile protein, hence at nightfall levels of TIM rise, 
protecting PER from degradation and allowing stable TIM:PER heterodimers to form and 
translocate into the nucleus[150-152]. PER binds to dCLK via a small conserved dCLK 
binding domain (CBD) thereby inhibiting the transactivation potential of dCLK-CYC[153]. 
TIM in turn stabilises PER in the cytoplasm by attenuating the degradation of PER by 
DOUBLETIME (DBT, the Drosophila homoiogue of CKle/6. Although TIM has no 
repressional activity of its own[146,154,155], it is able to act as a scaffold to bridge the
association of PER and CLK, thereby mediating the transcriptional repression of
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PER[153]. The onset of daylight destabilises TIM and with reducing TIM levels, PER is no 
longer protected from degradation[150, 151]. Levels of PER and TIM are therefore 
sufficiently low by next dawn to disinhibit CLK:CYC activity, stimulating the next cycle of 
transcription of per and tim and a new round of synthesis[138]. Readers are 
recommended the following references for a thorough review of clock genes in 
Drosophila[136,144, 145].
1.6.4. The molecular feedback loops of clock genes in mammals
The molecular clockwork within the SCN consists of interacting positive and negative 
feedback loops[134, 135]. The negative-feedback loop involves the rhythmic induction 
of three Period genes (designated Perl-3) and two Cryptochrome genes (Cryl and Cry2) 
by heterodimerization of the transcription factors CLOCK and BMAL1 (Figure 1.4)[156- 
159]. CLOCK and BMAL1 contain the functionally important basic helix-loop-helix 
(bHLH)-PER-ARNT-SIM (PAS) protein dimerization domain[160,161], which binds to and 
activates E-boxes (sequences of CAnnTG) on the promoters of the Per and Cry 
genes[161, 162], PER and CRY subsequently form multimers that translocate to the 
nucleus, where they directly interact with CLOCK and/or BMAL1 to inhibit 
transcription[156, 158]. This is turn induces rhythmicity in the transcription of Small, 
with a phase opposite that of Per or Cry, resulting in a positive-feedback loop[158,163].
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Clock
Figure 1.4: Schematic showing the molecular feedback loops of circadian clock genes. 
Black pointed arrows indicate stimulation of one clock gene component by another, 
while the truncated arrows indicate repression.
More recently three further genes have been identified - Retinoic acid-receptor-related 
orphan receptor (ROR) -a and Rev-erbA and Rev-erbB[164]. These orphan nuclear 
receptors have been identified as key regulators linking the positive and negative limbs 
of the circadian oscillator, with Reverb and ROR-a transcription driven by BMAL1/CLOCK 
and in turn suppressing and activating Bmall expression respectively, acting as an 
accessory loop to improve the amplitude and stability of the core clock regulatory 
loops[164, 165].
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Clock genes subsequently regulate downstream events via rhythmically expressed clock- 
controlled genes (CCGs) that are regulated (directly or indirectly) by the core feedback 
loops[166, 167]. Examples of CCGs directly regulated via CLOCK:BMALl heterodimers 
acting on E-box enhancers include arginine vasopressin (AVP)[166] and albumin D- 
element-binding protein (DBP)[166, 167]. Both these genes express robust rhythmicity 
in the SCN which is blunted in Clock mutant mice[135].
Clock gene expression in the SCN is cued by the detection of light by the retina, which is 
transmitted to the SCN by several convergent pathways, the most important of which is 
the retinohypothalamic tract (RHT)[168-170] which arises from the retinal ganglion cells 
and transmits the light signal to the SCN using the neurotransmitter glutamate[171]. 
Indirect pathways such as the geniculohypothalamic tract also play a role, as do 
neurohumoral signals such as the pineal hormone melatonin[135]. Previous studies 
suggest that Perl is the most likely candidate clock gene for resetting the circadian clock 
via photic stimulation[172, 173]. mPerl was the only gene altered by exposure to light 
at night in mice; this was blunted by the introduction of antisense oligonucleotides to 
mPerl[n2, 173]. mPerl is directly stimulated by phosphorylation of cAMP response 
element-binding protein (CREB) acting via a cAMP response element (CRE) in the 5'- 
flanking region of the mPerl gene[174]. mPERl in turn stabilizes mCRYl, extending the 
duration of negative feedback on the clock[172].
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1.6.5. Peripheral circadian oscillators
Circadian rhythmicity exists in many tissues besides the SCN[175-179] and may be 
mediated by rhythmically expressed clock genes in these tissues. These peripheral 
oscillators may exist to provide increased flexibility to allow the organism to adapt to a 
greater variety of stimuli. Although cued by the SCN, the ability of peripheral oscillators 
to be entrained by other external stimuli such as nutrients[180-182] allows the organism 
to optimally adapt to match environmental challenges, for example to alter liver 
function to match the timing of delivery of nutrients and metabolites[180,181].
Circadian rhythmicity had been noted in other tissues outside the SCN long before the 
cloning of clock genes[175-179]. The retinae of hamsters was found to exhibit circadian 
rhythmicity of melatonin production in vitro, entrainable by light[175]. Subsequent 
cloning of clock genes revealed that this rhythmicity in function corresponded with 
rhythmicity of mPerl-3 in the mouse eye, with a 3-6h delay relative to the SCN[183]. 
Peripheral oscillators now been characterized in a number of other tissues, including the 
heart, lung, kidney, peripheral blood cells and liver, with a 3-9h phase delay in 
oscillatory rhythms relative to the SCN [176-179].
A number of observations suggest that the molecular machinery driving rhythmicity of 
the circadian clock in peripheral tissues may bear a number of significant differences to
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that in the SCN. Firstly, rhythms of clock genes exhibit a phase delay in peripheral tissues
relative to that in the SCN[180, 181]. Secondly Bmall levels are elevated in the 
peripheral tissues of Clock-/- mutants, but blunted and expressed at reduced levels in 
the SCN of these mice[184], suggesting that negative autoregulation by CLOCK/BMAL1 
heterodimers affects Bmall transcription in the periphery but not in the SCN. Thirdly, 
unlike in vitro cultures of SCN cells, which maintain their rhythms indefinitely[131], 
cultures derived from peripheral tissues exhibit circadian rhythms which dampen after 
2-7 cycles[185]. These findings suggest that peripheral oscillators may involve a 
population of asynchronous cells requiring intermittent synchronizing stimuli, either 
from the SCN or external entraining cues as occurs in vivo. This is further corroborated 
by the ability of a serum shock consisting of 50% serum to induce rhythmicity in clock 
gene transcription in cell lines including fibroblast derived cell lines in vitro[BA].
Peripheral clocks are primarily cued by the SCN master clock - destruction of the SCN 
flattens oscillatory rhythms in peripheral tissues such as the liver[186]. Circadian 
transcripts continued to oscillate following liver-specific deletion of Clock in mice in the 
presence of an intact SCN clock[187, 188], possibly as a result of persistent rhythmicity 
in feeding behaviour.
Although light (which is the predominant Zeitgeber ("time-giver" or circadian cue) for 
the SCN) may indirectly initiate rhythmicity of peripheral tissues, a number of other 
stimuli are able to regulate peripheral oscillators and dissociate rhythms of the 
peripheral clock from that of the SCN[85, 180, 181, 186, 189-191], These include
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adrenergic stimulation[186], glucocorticoid exposure[85, 189-191] and one of the 
strongest cues - nutrient availability[180, 181], Nutrient availability in contrast is a 
powerful Zeitgeber - restricted feeding was able to reinstate circadian rhythmicity of 
hundreds of genes which had been blunted in Cryl-/-Cry2-/~ mice and in otherwise 
arrhythmic SCN-lesioned mice[192]. Restricted feeding also reset the peripheral clocks 
in the liver, kidney, heart and pancreas within one week with no change in the phase of 
the SCN clock[180, 181, 193]. Glucocorticoid signalling has been postulated as a 
potential regulator of peripheral clocks, specifically as mediators of the effects of 
nutrient-induced phase shifts in clock gene expression[85, 189-191]. However recent 
studies have demonstrated that the phase shifts in rat liver seen in restricted feeding 
could not be induced by daily corticosterone injections to simulate the endogenous 
peak of these hormones in animals subjected to restricted feeding[180]. Le Minh et al 
developed these findings further by showing that rather than facilitating phase shift, 
glucocorticoids act to inhibit phase shifts of peripheral oscillators to daytime feeding 
and may in fact exist to prevent a rapid uncoupling of peripheral oscillators from the 
SCN[82].
Other studies have identified a role for intracellular kinases such as protein kinase A, 
protein kinase C and mitrogen-activaged protein kinase (MARK) in the synchronization 
of the peripheral clock acting through cAMP response elements (CRE sequences) of Per 
genes[194-197]. The oscillation of clock genes in vascular smooth muscle can be 
initiated by angiotensin II and reset by retinoic acid[198, 199], while in the pituitary
gland rhythmicity of Per expression is maintained by an interaction between melatonin
Page 37 of 272
secretion and adenosine[200]. Together these studies suggest that the synchronization 
of peripheral clocks may be regulated by a number of endorine and paracrine cues in a 
tissue-specific manner[201].
Light cycle alone is not a strong cue for clock genes in peripheral tissues; mice held in 
constant darkness continued to exhibit rhythmic feeding and examination of liver 
transcripts in these mice revealed that 15% of transcripts continued to exhibit circadian 
rhythmicity despite a 24-hour dark-dark cycle[202].
1.6.6. Clock genes as rhythmic transcriptional regulators
Clock genes are clearly important transcriptional regulators[14-16]. Several intestinal 
proteins have been found to be regulated by clock and clock-controlled genes; for 
instance CLOCK/BMAL1 heterodimers bind directly to the promoter of the Na+/H+ 
exchanger Nhe3 in the kidney to induce circadian rhythmicity of Nhe3 mRNA in the 
rat[14]. The clock-controlled output gene, DBF has been noted to bind to and activate 
the promoter of the oligopeptide transporter Peptl [16], while similarly clock-controlled 
output genes hepatic leukemia factor (HLF) and E4 promoter binding protein-4 (E4BP4) 
regulated transcription of the multidrug resistance 1 {Mdrla} gene via a reciprocating 
mechanism involving competition for the same Mdrla promoter DNA binding site[15].
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To date no studies have examined the role of clock genes in the regulation of SGLT1
rhythmicity and thereby the rhythmicity of glucose uptake in the intestine.
While clock genes may be candidates for the regulation of individual genes involved in 
intestinal absorption such as SGLT1, a newly discovered class of molecules known as 
microRNAs has been shown to regulate cellular properties such as proliferation[18-24] 
and circadian rhythmicity[17, 203] in non-intestinal tissues, making these genes 
potential regulators of the rhythmicity of intestinal proliferation.
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1.7.microRNAs
1.7.1. Overview of microRNAs
microRNAs are a class of endogenous gene silencers, capable of simultaneously 
regulating multiple genes and implicated in the control of many cellular processes 
including proliferation[18-24]. Recent studies have suggested that microRNAs are able 
to regulate the phenotype of tissues [204, 205] facilitated by the ability of a single 
microRNA to simultaneously silence the expression of multiple genes[20, 206-209], 
thereby targeting many proteins within the molecular pathway[207-209]. By this 
method, microRNAs might exert a greater degree of control over each cellular process 
than by controlling individual genes; as the degree of control over individual genes 
identified in most studies is often modest[207-209]. One example of this is the ability of 
miR-16, to not only downregulate the anti-apoptotic gene Bcl2-like 2[18], but to also 
independently causes cell cycle arrest by downregulation of cell cycle components cyclin 
Dl, cyclin D3, cyclin El and CDK6 in hepatocytes[20], simultaneously inducing an 
accumulation of cells in G0/G1 as well as an increase in apoptosis.
Other studies have demonstrated the importance of "clusters" of microRNAs. Analysis
of tumour samples compared to normal samples has revealed the presence of a
microRNA "signature" - a group of similarly overexpressed or underexpressed
microRNAs associated with a particular type of malignancy[210-213]. These expression
profiles correlated with lineage and stage of differentiation of tumours better than
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transcriptional profiling using mRNAs[214]. Overexpression of clusters of microRNAs,
often genomically adjacent, results in phenotypic changes in vivo such as increased 
proliferation and an undifferentiated phenotype[215].
1.7.2. Functions of microRNAs
microRNAs have been shown to exhibit varied functions in a number of tissues[210, 211, 
214, 216-220]. microRNAs are able to regulate development and differentiation at a 
global level or at a tissue-specific level[221-224]. Knockout of Dicer, a key enzyme in 
microRNA biogenesis, produced embryonic lethality and morphological abnormalities in 
mice[221]. Dicer-null mouse embryonic stem cells similarly exhibited severe defects in 
growth and differentiation and exhibited prolonged GO and G1 and failed to express key 
differentiation markers[222, 223]. microRNAs also play a role in adult stem cells; for 
instance miR-221, miR-222 and miR-223 regulate terminal haematopoietic
differentiation pathways[224].
The ability of microRNAs to simultaneously regulate multiple genes has made this class 
of molecules a particular topic of interest in cancer research. Several studies have 
identified differences in the profile of microRNAs in cancerous and non-cancerous 
tissues[210, 211, 214, 218]. microRNAs have also been shown to mediate changes in 
visceral function, such as cardiac failure[216, 217], diabetic nephropathy[219] and
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hypertension[220]. For a review of the role of microRNAs in differentiation, cancer and
visceral function, readers are recommended the following review articles[225-228].
microRNAs are already known to exhibit circadian rhythmicity in the SCN[229] as well as 
some peripheral tissues[17, 203] and hence rhythmicity in microRNA expression in the 
intestine may represent a potential mechanism governing the rhythmicity in intestinal 
function.
1.7.3. Background of microRNA discovery
microRNAs were first discovered when Ambros and colleagues, in 1993, found that lin-4, 
a gene known to regulate Celegans larval development, was not translated into a 
protein, but instead was transcribed into a 22nt RNA[230]. Ruvkun et al subsequently 
identified translational repression of UN-14 by lin-4 following binding of lin-4 to 3'UTR 
binding sites in the lin-14 gene[230, 231]. lin-4 is now recognized as the first member of 
a new class of regulatory RNAs now termed microRNAs[232-234]. Further work since 
this discovery has further characterized the biogenesis and function of microRNAs. 
These single stranded RNA molecules are able to suppress protein translation of 
multiple targets, thereby simultaneously regulating the expression of hundreds of 
genes[232-234].
Page 42 of 272
1.7.4. Biogenesis of microRNAs
microRNAs are transcribed via the action of pol II RNA polymerases, often from regions 
within introns of protein-coding genes (Figure 1.5), to yield the primary microRNA 
transcript, known as the pri-miRNA[235]. Nuclear cleavage by the microprocessor 
protein complex (containing DROSHA, an Rnase III endonuclease and DiGeorge 
syndrome critical region gene 8 (DGCR8 or PASHA)) at the base of the pri-miRNA 
releases a 60-70nt stem-loop microRNA precursor, or pre-miRNA[235, 236]. The pre- 
miRNA is transported into the cytoplasm via Ran-GTP and the export receptor Exportin- 
5 [237, 238], where the RNase III endonuclease, DICER, removes the terminal base pairs 
and loop of the pre-miRNA leaving an imperfect duplex with a 5' phosphate and 2 nt 3' 
overhang[239, 240]. This duplex is unwound to release 2 strands of RNA, the mature 
microRNA sequence and the microRNA* sequence. The mature microRNA is 
incorporated as a single-stranded RNA molecule into the RNA-induced silencing 
complex, or the RISC complex, which also mediates siRNA activity on its target sequence 
[241-243]. The microRNA* sequence is typically found in much lower concentrations in 
the cell than the miR sequences [233, 244]. microRNA processing has been shown to 
exhibit strand bias and the strand that is less tightly paired at the 5' end is preferentially 
loaded into the RISC complex[245, 246].
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Figure 1.5: Schematic showing the outline of the biogenesis of microRNAs. Adapted 
from Winter, J et al, Nature Cell Biology 11, 228 - 234 (2009).
1.7.5. Mechanism of action of microRNAs
1.7.5.1. Transcriptional regulation
One method of microRNA-mediated target suppression is by RISC-mediated cleavage of 
the target sequence, facilitated by high sequence complementarity between the
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microRNA and the target mRNA[242; 247]. The most important microRNA-mRNA pairing 
is that at the 2-8nt "seed region" of the microRNA[248]. microRNA-mediated cleavage 
occurs between nucleotides pairing at residues 10-11 of the microRNA, identical to 
cleavage mediated by siRNAs[242, 249]. Similar to siRNAs, microRNAs are themselves 
left intact following cleavage and able to cleave other targets.
I.7.5.2. Post-transcriptional regulation
The exact mechanism behind microRNA-mediated post-transcriptional suppression of 
target gene expression remains unclear; and several methods have been proposed[250- 
257]. Repression at the adenylation stage may occur by progressive shortening of the 
polyA tail following binding of the RISC complex to mRNA 3' UTR, resulting in decay of 
target mRNAs[250, 251]. Alternatively, miRNPs can repress translation initiation at 
either the cap-recognition stage, by inhibiting eukaryotic initiation factor EIF4e/cap and 
polyA tail function, or by preventing the 60S ribosomal subunit joining the 40s initiation 
complex [252-254], microRNAs may also effect translational repression at post-initiation 
phases either by slowing elongation or ribosome 'drop-off [255-257]. Another 
hypothesis is that repression may occur through proteolytic cleavage of nascent 
polypeptides by an as yet unidentified protease[256]. microRNAs have been postulated 
to each suppress multiple gene targets, both from bioinformatic as well as experimental 
studies[20, 206-209]. Several recent studies have demonstrated suppression of 
hundreds of proteins to a modest degree by a single microRNA[207-209]. It has
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therefore been suggested that microRNAs may exist as a fine-tuning mechanism, 
designed to modulate the expression of many targets but only to a relatively small 
degree[207].
1.7.6. Rhythmicity of microRNA expression
Circadian rhythmicity has been described in 5-10% of gene transcripts[165, 193, 258, 
259]. Of greater interest, an even greater fraction of proteins demonstrate circadian 
rhythmicity, for instance almost half of the proteins demonstrating circadian rhythmicity 
in the mouse liver lack a corresponding cycling transcript[260]. Regulation of this 
rhythmicity at both the transcriptional and post-transcriptional level suggests a role for 
microRNAs in this process.
MicroRNAs have been found to demonstrate circadian rhythmicity in a number of 
tissues[17, 203, 229]. Cheng et al found circadian rhythmicity in the expressions of miR- 
132 and miR-219 in murine brain, with up to a 3-fold difference in microRNA levels 
between subjective day and night[203, 229]. A subsequent study demonstrated 
rhythmicity of 12 microRNAs in the retina[203]. Two of these microRNAs- miR-96 and 
miR-182 - were shown to mediate rhythmic expression of the adenylate cyclase 6 
{AdcyB) gene[203]. microRNAs were also found to exhibit circadian rhythmicity in 
Drosophila; two miRNAs [dme-miR-263a and -263b) demonstrated circadian rhythmicity
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in Drosophila head which persisted in complete darkness, further supporting the
circadian nature of this rhythmicity[261]. Another recent study identified circadian 
rhythmicity of miR-122 precursors in the liver[17]. To date there have been no studies 
examining the temporal expression profile of microRNAs in the intestine.
1.7.7. Distinction between microRNAs and siRNAs
Although microRNAs can function very similarly to siRNAs, particularly when causing 
mRNA cleavage, a number of clear distinctions between these two classes of regulatory 
RNAs were described by Bartel[262], First, miRNAs derive from genomic loci separate 
from other known genes while siRNAs often derive from mRNAs, transposons, viruses, 
or heterochromatic DNA. Second, miRNAs are processed from transcripts which form 
RNA short hairpin structures, while siRNAs result from long bimolecular RNA duplexes or 
extended hairpins. Third, each miRNA hairpin precursor molecule only produces two 
RNA sequences which pair as a single miRNA:miRNA* duplex, in contrast, each siRNA 
precursor molecule produces a multitude of siRNA duplexes resulting in many different 
siRNAs accumulating from both strands of this extended hairpin. Fourth, miRNA 
sequences often demonstrate evolutionary conservation, while endogenous siRNA 
sequences are rarely conserved. Fifth, microRNAs specify hetero-silencing, as they 
silence genes distinct from the gene of origin. In contrast, siRNAs specify auto-silencing, 
as they silence loci similar to that from which they originate.
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1.8.Short bowel syndrome
1.8.1. Aetiology
Current estimates suggest the prevalence of short bowel syndrome in Europe to be 
approximately 2 patients per miliion[2]. Short bowel syndrome is defined as a remnant 
length of <200cm of small intestine, resulting in compromised absorption which may 
lead to intestinal failure, defined by the requirement for specialised nutritional support 
to maintain adequate nutritional status[2]. Short bowel syndrome may rarely be of 
congenital origin as a result of jejunal or ileal atresia[2]. In the majority of cases 
however, short bowel syndrome occurs as a result of surgical resection of small 
intestine. This may occur in the form of multiple resections for relapsing and remitting 
inflammatory conditions such as Crohn's disease, or as a result of massive small bowel 
resection for conditions of irretrievable vascular infarction and mesenteric ischaemia[2]. 
Sparing the colon in these patients improves absorptive capacity as the colon is able to 
absorb water, sodium and some amino acids, thereby allowing patients to tolerate 
greater loss of small intestinal length and avoiding supplemental nutrition[263j.
1.8.2. Morphologic and physiologic adaptation to short bowel syndrome
Loss of a significant length of intestine is associated with adaptive changes, first
described in by Dowling and Booth in 1967 using the model of massive small bowel
resection in the rat[264j. This adaptive response includes increases in intestinal length
as well as villus height and diameter to increase absorptive surface area[265, 266]. The
decreased absorptive surface area in short bowel syndrome may also be compensated
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for by increased food consumption (hyperphagia). The adaptive response to short bowel 
syndrome in rats is also associated with upregulation of SGLT1[267]. The diurnal 
rhythms of glucose absorption and proliferation have not been studied in the 
experimental model of massive small bowel resection and represent interesting studies 
for the future, however any data from these experiments should be interpreted with 
caution as altered food intake rhythms are likely to be a confounding factor in these 
animals.
1.8.3. Management of short bowel syndrome
Intestinal transplantation remains an important therapeutic option for short bowel 
syndrome, however graft rejection rates (one year graft and patient survival of 20%) 
remain high[268]. Post-operative infection[269] and the complications of 
immunosuppressive therapy[270] further limit the applicability of this option in the 
management of short bowel syndrome. Other recently developed intestinal 
reconstructive options such as the Bianchi procedure[271] and serial transverse 
enteroplasty[272] have a relatively high rate of complications and limited long-term 
outcomes data.
Nutrient delivery remains the one of the biggest challenges in short bowel syndrome.
Parenteral nutrition, the delivery of nutrients via long-term intravenous access, is
frequently necessary, but associated with significant side-effects, in particular the risk of
line sepsis and the risk of cholestasis-associated liver dysfunction[273]. The morbidity
and complications from total parenteral nutrition (TPN) contribute to an overall 5-year
Page 49 of 272
survival of 60% in patients requiring home parenteral nutrition[274]. For a thorough 
review of the aetiology and management of short bowel syndrome readers are 
recommended the review articles by Wales et al[270] and Buchman[2].
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1.9. Previous work from our group
Previous studies from our laboratory have confirmed the presence of diurnal rhythms in 
intestinal absorption. SGLT1 was found to exhibit a diurnal rhythm of expression at both 
the mRNA and protein level in the intestine, with peak mRNA and protein expression 
occurring at 1600h (just before the arrival of nutrients at 1900h) and during peak 
feeding time at 2200h[13, 63]. These studies suggested that rhythmicity of SGLT1 may 
mediate the known rhythms in intestinal glucose absorption and implicated the 
existence of rhythmic molecular pathways that increased SGLT1 expression in 
anticipation of nutrient arrival. Rhythmicity in SGLT1 was also confirmed at the mRNA 
level in duodenal biopsies from Rhesus monkeys[63], with peak expression of Sgltl 
occurring during the morning feeding period, confirming that this phenomenon also 
existed in non-human primates[63]. Subsequent studies used the SGLTl-specific 
inhibitor phloridzin to specifically examine the contribution of SGLTl-mediated glucose 
uptake to diurnal rhythmicity of glucose absorption[13, 69]. Patterns of rhythmicity in 
glucose uptake corresponded with rhythms in SGLT1 protein expression, which in turn 
was preceded by a peak in Sgltl mRNA expression[69]. These studies highlighted the 
need for further studies to identify the molecular pathways behind these rhythms. The 
intestine is known to exhibit rhythms in cellular proliferation, allowing peak absorptive 
capacity during the period of maximal nutrient availability, which are likely to contribute 
to the rhythmicity in glucose absorption. The mechanisms behind this remain poorly 
characterized.
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1.10. Purpose of the proposed studies
The work in this thesis aims to investigate the molecular pathways behind the 
rhythmicity in intestinal glucose absorption. To decipher the molecular mechanisms 
behind this, this thesis will use two approaches - first, to identify the role of clock genes, 
implicated in the regulation of other diurnally expressed intestinal transporters, in the 
regulation of SGLT1 rhythmicity. Secondly, this thesis aims to identify the role of 
microRNAs, known to regulate proliferation in other experimental models, in the 
regulation of rhythmicity in intestinal proliferation.
AIMS:
• To correlate rhythms in Sgltl expression with rhythms in clock gene expression 
and identify clock genes that may be potential transcriptional regulators of Sgltl 
using in vitro studies.
• To identify microRNAs exhibiting diurnal rhythmicity in expression in the 
intestine and determine the effects of these microRNAs on enterocyte 
proliferation in vitro and to correlate rhythmicity in this microRNA with rhythms 
in morphology and proliferation in vivo
Page 52 of 272
Chapter 2: Methods
2.1. Animal studies
Ali animal study protocols were prospectively approved by the Harvard Medical Area 
Standing Committee on Animals. Animals were maintained in a dedicated small animal 
facility in Thorn Building in Brigham & Women's Hospital, Boston. This animal facility is 
regulated by the Harvard Medical School ARCM and is fully accredited under the 
Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALAC) guidelines. Standard temperature (22°C) and humidity (70%) was maintained. 
An automated timer was used to control the light cycle; lights were switched-on at 7AM 
Eastern Standard Time and switched-off 12-hours later at 7PM. All time points used in 
the following experiments are expressed as Zeitgeber Time (ZT), where 7AM is ZTO.
All rats used were Sprague-Dawleys, an outbred albino rat species, purchased at 7 
weeks of age from Harlan World (Indianapolis, IN) and housed in the Thorn Building 
Animal Research Facility at the Brigham and Women's Hospital, Boston, MA. Rats were 
caged in pairs in Perspex cages with wood chipping bedding. All animals had 
unrestricted access to water. All rats were fed Picolab Rodent Diet 20, Catalog no. 5053, 
LabDiet, Brentwood, MO, containing 21% protein, 9.9% fat, 4.4% fiber and a caloric 
value of 3.42kcal/gm.
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2.1.1. Feeding patterns
2.1.1.1. Ad libitum and restricted feeding regimens
For examination of the temporal profiles of clock genes and SGLT1 in ad libitum and 
restricted fed rats in Chapter 3, 100 male Sprague-Dawley rats were acclimatized to a 
12: 12-h light: dark photoperiod for 5 days with ad libitum access to food and water. In 
the control arm (n=50, designated "AL"), rats were culled at 3-hourly intervals after the 
5 day acclimatization period, beginning at ZT 0 (0=6-7 per time. Figure 2.1(A)). A second 
group of rats (n=50) were randomly assigned after the 5 day acclimatization period to be 
fed for 7 days either during only the dark phase (designated "DF", ZT 12-24, Figure 
2.1(B)), or light phase (ZT 0-12, designated "LF", Figure 2.1(C)). DF rats were pair-fed to 
LF rats to ensure equal food intake. Rats were housed in pairs in cages. LF animals were 
given lOOg of food per cage at 0700. The remaining food at 1900 was weighed and 
subtracted from lOOg to calculate the amount consumed per pair of rats (it was 
assumed that both rats consumed equal amounts of food). The mean daily consumption 
of LF animals was calculated, multiplied by 2 and provided to each pair of DF animals at 
1900. No food remained in the cages of DF animals at 0700 the next day. To minimize 
disruption during restricted feeding, rats were weighed only 3 times (days 0, 4 and 8). 
On day 8, rats (n=6-7) were culled at 6-hourly intervals beginning at ZT 3.
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Figure 2.1: Schematic showing light cycle, time of food availability and harvest times. 
Harvest times are indicated in black arrows in AL (A), DF (B) and LF (C) rats, n=6-7 per 
time for all groups.
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2.1.1.2. Diurnal ad libitum feeding regimens
For the microRNA and proliferation experiments in Chapter 5, 50 male Sprague-Dawley 
rats were acclimatized to a 12: 12-h light: dark photoperiod for 5 days with ad libitum 
access to food and water. Rats were injected with BrdU (5-bromo-2-deoxyuridine, 
50mg/kg; Catalog no. B5002, Sigma, St Louis, MO) 1 hour before harvest to label DNA as 
an index of S-phase. Rats were culled at 3-h intervals over 24 hours (n=6-7 per time) and 
jejunum harvested for microRNA microarrays, RNA and protein determination and 
morphological analysis.
2.1.2. Harvest protocols
2.1.2.1. Anaesthesia
Rats were harvested in groups of 6-7 animals per time at the times described above. 
Tissue collection was performed while animals were still alive but anaesthetized to 
ensure the intestine remained perfused to ensure integrity of RNA, protein and 
morphology during harvest. Rats were anaesthetized by intraperitoneal injection with 
sodium pentobarbital (50mg/kg, Ovation Pharmaceuticals, Deerfield, IL). Adequate 
depth of anaesthesia was ensured by monitoring respiratory rate, response to paw or 
tail pinch and loss of corneal blink reflex. At the end of tissue harvest, animals were 
euthanised by thoracotomy and exsanguination by transecting the heart.
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2.1.2.2. Tissue harvest and preservation
A midline laparotomy was performed and the ligament of Treitz identified, demarcating 
the duodenojejunal flexure and the beginning of the jejunum. The small intestine was 
cut at the ligament of Treitz and flushed with ice cold Ringer's lactate using a blunt 
needle on a 20ml syringe while still on the mesenteric pedicle to remove luminal 
contents. The entire length of small intestine was stripped off the mesentery, measured 
along the length of a ruler and sections of jejunum divided with a scalpel as follows 
(Figure 2.2): the first 2 cm distal to the ligament of Treitz was discarded. The following 
10cm of intestine was divided along the mesenteric border and the mucosa scraped off 
the muscular layers over glass plates on ice, then divided into 3 equal aliquots. Two of 
these aliquots were snap-frozen in liquid nitrogen for subsequent analysis of RNA and 
total protein expression. Snap-frozen mucosa was stored at -80°C until further analysis. 
The remaining aliquot was added to 1ml of ice-cold Nxtract lysis buffer (CellLytic Nuclear 
Extraction Kit, Catalog no NXTRACT, Sigma, St Louis, MO), then processed to obtain 
nuclear protein extracts as per manufacturer's instructions[275j. Nuclear protein 
extracts were stored at -80°C until further analysis.
For the microRNA and proliferation experiments in Chapter 5, tissue harvest was 
performed as above, but in addition a further 2cm of intact jejunum was removed, 
immersed in 10% formalin (Catalog no. 23-245-684, Fisher Scientific, Pittsburgh, PA) and
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fixed overnight at 4°C (Figure 2.2). An additional 2cm of intact jejunum was cut in
transverse "doughnut"-shaped sections, embedded in a mould containing OCT (optimal 
cutting temperature) compound (Catalog no. 4583, Sakura FineTek, Torrance, CA) and 
frozen slowly over dry ice immersed in isopentane (Catalog no. 03551-4, Fisher 
Scientific, Figure 2.2). The formalin fixed sections were sent to the Brigham and 
Women's Histopathology Core Facility for processing the following day, while the fresh 
frozen sections were stored at -80°C until further analysis.
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2.2. RNA
2.2.1. RNA extraction
Total RNA was extracted from snap-frozen scrapings of rat jejunum or rat 1EC-6 cells 
using the mirVana kit as per manufacturer's instructions (Catalog no. AM1560, Ambion; 
Austin, TX)[276]. Extracted RNA was quantified using a 1:50 dilution (in 
diethypyrocarbonate (DEPC)-treated water) by measurement of absorbance at 260nm 
(A260) in a final volume of lOOpI on a Spectramax M5 microplate reader (Catalog no. M5, 
Molecular Devices, Sunnyvale, CA). RNA purity was assessed using the A26o to A280 ratio, 
with levels over 1.8 taken as sufficient purity. RNA concentration was abstracted from 
calculations performed by the Spectramax M5 software. Extracted RNA was stored at - 
80°C until further use.
2.2.2. Reverse transcription
1.6pg of each RNA sample was reverse transcribed using the Superscript III kit according 
to manufacturer's instructions (Cat no: 18080-051, Invitrogen, Carslbad, CA)[277]. A no 
template control and a no reverse transcriptase control were included in each reverse 
transcription (RT) to exclude contamination. All samples in any individual experiment 
were reverse transcribed simultaneously to minimise variability.
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2.2.3. Real-time quantitative PCR
The resulting cDNA was diluted 1:50 to 1:100 with DEPC-treated water. Primers were 
designed using the PRIMERS software available online[278], using mRNA sequences 
available from UCSC Genome Browser[279]. Primer sequences (with the exception of rat 
Ccndl, rat Per2, human SGLT1 and human Perl) were custom-ordered from Invitrogen; 
primer sequences are available in Table 2.1 to 2.3. A mastermix consisting of the 
commercially available SYBR Green PCR Mastermix (Catalog no. 4309155, Applied 
Biosystems, Foster City, CA) diluted cDNA and specific forward and reverse primers 
(12.5pmol of each primer) was created and real-time PCR cycling performed as per 
manufacturer's instructions[280]. The final ratio of SYBR green in the mastermix was 
1:1. Rat Ccndl, rat Per2, human SGLT1 and human Perl were quantified using primers 
commercially available from Applied Biosystems (Catalog nos Rn00432359_ml, 
Rn01427704_ml, Hs00165793_ml, Hs00242988_ml respectively) as the custom 
designed primers for these genes resulted in multiple non-specific products. PCR was 
carried out as part of the Taqman primer-probe system with Taqman mastermix 
according to manufacturer's instructions (Cat no 4324018, Applied Biosystems)[281]. 
Thermal cycler conditions used were 2 min 50°C; 10 min OST; followed by 40 cycles of 
15 sec at 95°C and 1 min 60°C. Dissociation curves were obtained to ensure a single 
amplicon and to exclude non-specific amplification and primer-dimerization. All samples 
were run in triplicate. Use of 384-well plates allowed simultaneous analysis of all 
samples being compared. Expression of the gene of interest was normalised against [5- 
actin as the loading control.
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Gene Primer sequence
Ccnd2
5'- TTACCTGGACCGTTTCTTGG
3'- CCTCACGACTTCATTGAGCA
Ccnd3
5'- TGGTCAAAAAGCATGCTCAG
3'- TCACAGGCACTGAAGTGGAC
Ccnel
5'- GTGAAAAGCGAGGATAGCAG
3'- CGTTACATGGCATCACAACA
Cdk4
5'- AAGCGGCCTAGATTTCCTTC
3'- TGTTGGCTGTATCTTCGCAG
Cdk6
5'- TGTTTCAGCTTCTCCGAGGT
3'- GAAGTCCTGCTCCAGTCCAG
fi-actin
5' GGATCAGCAAGCAGGAGTACGA 3'
3' AACGCAGCTCAGTAACAGTCCG 5'
Table 2.1: Rat qPCR primers for Gl/S regulators as used in Chapter 5. Thermal cycler 
conditions used were 2 min 50°C; 10 min 95°C; followed by 40 cycles of 15 s at 95°C and 
1 min 60°C. Dissociation curves were obtained to ensure a single ampiicon.
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Gene Primer sequence
Perl
S' CG CACTTCGG GAG CTCAAACTTC 3*
3' GTCCATGGCACAGGGCTCACC 5'
Bmall
S' TCCGATGACGAACTGAAACAC 3'
3' CTCGGTCACATCCTACGACAA 5'
Clock
5' IT CG AT C AC AG CCCA ACT CC 3'
3' ACCTCCGCTGTGTCATCTTCTC 5'
Reverb A
5' TAG G CACCT CACCT G G C A ACT 3'
3' GCACTGTGGAGTGGTAGCCG S'
Reverb B
5' 1 1 1 1GAGGTTTTAATGGTGCG 3'
3' GTGACAGTCCGCTCCTTTGC 5'
Cryl
5' GGGAAGCGCCCAAGTCAGGAAG 3'
3' CCTCCCGCATGCTTTCATATC 5'
Cry2
5' TTCAGAAGGCCGCTAATTGC 3'
3' AG AT CT G CTT CATCCG CT CAA S'
Sgltl
S' CCAAGCCCATCCCAGACGTACACC 3'
5' _CTTCCTTAGTCATCTTCGGTCCTT 3'
fi-actin
S' GGATCAGCAAGCAGGAGTACGA 3'
3' A ACG CAG CTC AGT A AC AGTCCG 5'
Table 2.2: Rat qPCR primers for dock genes, the sodium glucose co-transporter Sgltl 
and 6-actin as used in Chapter 3. Thermal cycler conditions used were 2 min SOX; 10 
min 95X; followed by 40 cycles of 15 s at 95X and 1 min 60X. Dissociation curves were 
obtained to ensure a single amplicon.
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Gene Primer sequence
PER2
S' GACCCGTGATGAACCCTCAGAC 3'
3' GCCGGAGGATTTGGAGGACG 5J
BMALI
5' GTTTGTCGTAGGATGTGACCG 3'
3' TG TCGGTCTTACTAG ACTAACCA 5'
CLOCK
S' GCCGTCTCAGACCCTTCCTC 3'
3' GCCTATGCTCGTGAGGTGGG 57
REVERB A
5' G CCACCAGTCC A ACAG C A AC 3'
3' G C AC AT ACGT CG G G GT CTT C 5'
REVERB B
5' CG ATG AG CTTCACTCCAG CAG 3'
3' GCATAAGGACCCAAGTCTCTA 5'
CRY1
5' GTGAGGCAATTCTCTTGGAAGC 3'
3' GCCTCGGAGGAAGGAACTTAAA S'
CRY2
S' AAGGAATGGGGAGTGACCCG 3'
3' TTCTTGCCCTACGTCGGTAG 5'
6-ACTIN
5' AGCAGGAGTATGACGAGTCCG 3'
3' ACGAAGATCCGCCTGATACTGA 5'
Table 2.3: Human qPCR primers for clock genes, and 6-ACTIN as used in Chapter 4. 
Thermal cycler conditions used were 2 min SOT; 10 min 95T; followed by 40 cycles of 
15 s at 95T and 1 min 60T. Dissociation curves were obtained to ensure a single 
amplicon.
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2.3.microRNA profiling
2.3.1. In situ hybridization on microRNA microarrays
microRNA in situ hybridization was performed by the Harvard Partners Centre for 
Genetics and Genomics, Cambridge, Massachusetts on total RNA extracted from rats 
harvested at diurnal timepoints as above. Samples were hybridized against a reference 
sample consisting of RNA pooled from ZTO rats. 3 arrays were used per timepoint. RNA 
from 2 animals was used per timepoint and one sample per timepoint was run with the 
dye swapped to act as a biological replicate and control for any dye bias. 21 arrays were 
used in total.
2.3.2. Validation by qPCR
Conserved microRNAs exhibiting a two-fold or greater change in expression between 
timepoints were validated by qPCR. Total RNA extracted from rats harvested at 3-hourly 
intervals (n=6 to 7 per timepoint) as described above was subjected to reverse 
transcription using the Taqman microRNA reverse transcription kit (Catalog no. 
4366596, Applied Biosystems) according to manufacturer's instructions[282j. microRNA- 
specific reverse transcription and PCR primers were obtained from Applied Biosystems 
(the list of microRNAs validated and catalog numbers of RT and PCR primer pairs are 
given in Table 2.4).
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Catalog numbers
microRNA Part number Assay ID
mir-16 4427975 000391
mir-141 4427975 000463
mir-20a 4427975 000580
mir-142 4427975 000464
mir-21 4427975 000397
mir-503 4427975 001048
mir-17 4427975 002308
mir-26a 4427975 000405
Table 2.4: Catalog numbers of microRNAs validated by reverse transcription and qRCR. 
microRNA RT-PCR primer probe pairs were purchased from Applied Biosystems and RT- 
PCR performed as per manufacturer's protocols.
snoRNA, a small nucleolar RNA, was used as a housekeeping gene to normalize for RNA 
loading in microRNA quantification experiments (Catalog no 4386738, Applied 
Biosystems). 200ng of RNA was used in each reverse transcription reaction. The 
resulting cDNA was subjected to real-time PCR analysis using Taqman mastermix and 
thermal cycling conditions as per manufacturer's instructions as described above[281].
Page 66 of 272
2.4. Laser capture microdissection (LCM)
2.4.1. Laser capture of crypts, villi and smooth muscle
Sections of jejunum were fresh-frozen in OCT as previously described. Sections from ZT 
6 and ZT 18 were chosen for LCM as the respective peak and trough in expression of the 
rhythmic microRNA of interest, mir-16. These sections were cut at 9pm thickness after 
equilibration in the cryostat (Thermo Shandon SME, Thermo Scientific, Waltham, MA) 
just prior to laser capture. Sections were prepared and stained for laser capture 
microdissection using the Histogene LCM Frozen Section Staining Kit (Catalog no. 
KIT0401, Molecular Devices, Sunnyvale CA) according to manufacturer's 
instructions[283j. Crypts (lower half), villi (top half), or smooth muscle were isolated by 
laser capture microdissection (Veritas Microdissection System, Molecular Devices). An 
approximate 5000 cells were obtained from each fraction of each sample. Purity of 
isolation was confirmed by measuring PCNA (proliferating cell nuclear antigen, denoting 
isolation of the crypt fraction), SMA (smooth muscle actin, denoting isolation of the 
smooth muscle fraction) and IFABP (intestinal fatty acid binding protein, denoting 
isolation of the differentiated cells of the villi).
2.4.2. Real-time PCR of laser captured samples
Total RNA was extracted from each section (RNAqueous micro RNA extraction kit, 
Catalog no: AM 1931, Ambion, Austin, TX) according to manufacturer's
instructions[284j. The extracted total RNA was subjected to microRNA reverse
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transcription using the mir~16 specific RT/PCR primer pair (Catalog no 000391, Applied
Biosystems) and the Taqman microRNA reverse transcription kit and subsequently 
underwent real-time PCR using the Taqman PCR mastermix according to manufacturer's 
instructions as described above[281, 282].
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2.5. Protein
2.5.1. Protein extraction and quantification
2.5.1.1. Protein extraction from cultured cells
Cells were grown in 10cm cell culture dishes as previously described and at the time of 
harvest, washed once with 10ml sterile phosphate-buffered saline (PBS, Catalog no. 
P5638, Sigma, autoclaved at 140°C for 75 minutes then stored at 4°C). The PBS was 
aspirated off the cells and 200|il of radioimmunoprecipitation assay (RIPA) buffer 
(Catalog no. BP115, Boston Bioproducts) containing an added 2ui of protease inhibitor 
cocktail (Catalog no. P8340, Sigma) added to each dish. Ceils were scraped off into the 
RIPA buffer mixture using a disposable cell lifter (Catalog no. 3008, Corning, Lowell, MA) 
and the lysed cell mixture pipetted into 1.5ml microcentrifuge tubes for storage (Catalog 
no. 05-408-129, Fisher Scientific, Pittsburgh, PA). Cells were snap-frozen in liquid 
nitrogen and stored at -80°C until further analysis.
For protein extraction, snap-frozen cells were thawed on ice, then sonicated for 30 
seconds, before incubating for 30 minutes on ice. Cells were centrifuged 10,000rpm for 
15 minutes and the supernatant transferred into another microcentrifuge tube and 
stored at -80°C until further analysis. For chapter 4, nuclear protein was extracted from 
cultured cells using the QProteome Nuclear Protein Kit (Catalog no. 37582, Qiagen). 
Cells were grown in 10cm tissue-culture treated dishes under routine conditions and
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nuclear protein extracted according to manufacturer's instructions[285] and stored at -
80°C until further analysis.
2.5.1.2. Protein extraction from tissue
Snap-frozen jejunal mucosal scrapings were transferred into chilled Falcon tubes (15ml 
capacity) on ice, each tube containing 750p.l Triton lysis buffer (Catalog no. BP-117, 
Boston Bioproducts, Wocester, MA) and 7.5pl protease inhibitor cocktail (Catalog no. 
P8340, Sigma). Samples were incubated for 20 min on ice, then each sample was 
homogenized using a polytron on ice for 30 seconds until the sample appeared uniform 
in consistency. Following homogenization, samples were sonicated on ice for 1 min, 
then centrifuged at 4°C at ll,000g for 15mins. The resulting supernatant was 
transferred into another microcentrifuge tube and stored at -80°C until further analysis.
2.5.2. Quantification of extracted protein (BCA assay)
The extracted total and nuclear protein from each sample was quantified using the 
bicinchoninic acid assay (BCA, Catalog no. BCA1, Sigma) by measurement of absorbance 
at 562nm of each sample relative to a standard curve according to manufacturer's 
instructions[286j. Measurements were performed in 96-well clear-bottom plates 
(Catalog no. 351172, BD Falcon, BD Biosciences, San Jose, CA) each well containing a 
single sample, in a Spectramax M5.
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2.5.3. Gel electrophoresis
75pg or ISpg of protein (from tissues or cells respectively) was added to lp.mol 
dithiothreitoi (DTT, 154pg), sterile water and 4x lithium dodecyl sulphate (IDS) buffer 
(Catalog no. LP0007, Invitrogen) to achieve a final volume of 14pl of prepared protein 
sample under denaturing reducing conditions. Prepared protein samples were linearized 
at 95°C for 6 minutes. A 15-well NuPAGE IMovex 10% Bis-Tris gel (Catalog no. 
NP0303BOX, Invitrogen, Carlsbad, CA) was assembled into an XCell SureLock Mini-Cell 
(Catalog no. EI0001, Invitrogen) and the assembly filled with NuPAGE Running Buffer 
(Catalog no. NP0002, Invitrogen) according to manufacturer's instructions[287]. Each 
14pl prepared protein sample was loaded into a single well of the 15-well gel. The first 
well of each well was filled with lOpI of a protein ladder (Novex Sharp Pre-stained 
Protein Standard, Catalog no. LC5800, Invitrogen). Gel electrophoresis was performed at 
room temperature at 150V for 45 minutes.
2.5.4. Western blotting
Transfer buffer was prepared by adding 40ml of Novex Tris-Glycine Transfer Buffer
(Catalog no. LC3675, Invitrogen) to 200ml of 100% methanol (Catalog no. A456-500,
Fisher) and 760ml of distilled water and the polyvinyldifluoride (PVDF) membrane
(Catalog no. LC2002, Invitrogen) removed from between the two pieces of pre-cut filter
paper and "wet" by brief immersion in 100% methanol. After gel electrophoresis was
complete, the gel was sandwiched between two pieces of filter paper and the PVDF
membrane placed on top of the gel. This assembly was placed between 5 pieces of
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sponge above and below and the transfer carried out at 4°C overnight (approximately
16 hours) at 22V within the transfer blot module (XCell II Blot Module, Catalog no. 
EI9051, Invitrogen) according to manufacturer's instructions[288].
2.5.4.1. Incubation with antibodies
Following transfer, the membrane was washed with PBS with Tween 20 (PBST, Catalog 
no. P3563, Sigma, diluted in 1L distilled water) then blocked with 10ml 2.5% w/v non-fat 
dry milk for 1 hour at room temperature. The membrane was then washed three times 
for five minutes each with PBST, then incubated with 10ml of a 1:200 dilution of primary 
antibody in PBST for 2 hours at room temperature or overnight at 4°C, depending on the 
instructions of the antibody manufacturer.
The primary antibody solution was drained off and the membrane washed five times for 
10 minutes each with PBST. The membrane was then incubated with 10ml of a 1:5000 
dilution in PBST of secondary antibody to the appropriate species for 1 hour at room 
temperature, then washed 5 times for 10 minutes each with PBST. All secondary 
antibodies used were from Vector Labs, Burlingame, CA. The catalog number, species 
and concentrations for all antibodies used are detailed in Table 2.5.
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Protein
Primary antibody Secondary antibody
Cat no Manufacturer Concentration Species Cat no Concentration
PERI
sc-
25362
SCSI 1:200 Rabbit
PI-
1000
1:5000
SGLT1
07-
1417
Chemicon
International
1:4000 Rabbit
PI-
1000
1:5000
CCND1 H-295 SCBT 1:200 Rabbit
PI-
1000
1:5000
CCND2 H-289 SCBT 1:200 Rabbit
PI-
1000
1:5000
CCND3 H-292 SCBT 1:200 Rabbit
PI-
1000
1:5000
CCNE1 M-20 SCBT 1:200 Rabbit
PI-
1000
1:5000
CDK4 C-22 SCBT 1:200 Rabbit
PI-
1000
1:5000
CDK6 H-230 SCBT 1:200 Rabbit
PI-
1000
1:5000
P-
ACTIN
MS-
1295-
PCL
Labvision 1:1000 Mouse
PI-
2000
1:5000
Table 2.5: List of antibodies, manufacturers and concentrations used for Western 
blotting in Chapters 3, 4 and 5. Western blotting was carried out as described in Section 
2,5, and incubation with antibodies carried out as per antibody manufacturer's protocol.
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2.5.4.2. Detection and quantification of the protein
The membrane was covered with 4ml of enhanced chemiluminescence solution (ECU 
Catalog no. RPN2106, GE Healthcare, Piscataway, NJ) and exposed to according to 
manufacturer's instructions[289]. The membrane was exposed to autoradiography film 
(Kodak Biomax XAR ready film pack, Catalog No. 1651579001EA, Kodak) for varying 
durations depending on the antibody used. (3-ACTIN was used as the housekeeping gene 
to control for protein loading. Membranes probed for the protein of interest were 
stripped after exposure using the Western Blot Recycling Kit (Catalog no. 90100-T, Alpha 
Diagnostic International, San Antonio, TX) according to manufacturer's instructions to 
remove the first primary antibody then blocked using 10ml 2.5% w/v non-fat dry milk 
for 1 hour at room temperature. After blocking, membranes were washed 3 times with 
PBST for five minutes each, then incubated for 1 hour with a 1:1000 concentration of p- 
ACTIN antibody. Membranes were then washed, probed with secondary antibody and 
exposed as described above.
The film was scanned using a Canoscan 4200F plate scanner (Canon, Lake Success, NY) 
and ArcSoft Photostudio V5.5 software (ArcSoft, Fremont, CA). For semi-quantitative 
densitometry, images were imported into Image J (National Institutes of Health, 
Bethseda, MD) and band densities calculated. The expression of the protein of interest 
was expressed relative to fS-ACTIN.
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2.6. Routine cell maintenance
2.6.1. CHO cells
Chinese Hamster Ovary (CHO) cells were purchased from the American Type Culture 
Collection (ATCC, Catalog no. CCL-61, Manassas, VI). The aliquot of purchased cells was 
thawed and centrifuged at 220g for 5 minutes to remove the cryopreservative DMSO 
(dimethylsulfoxide), the cell pellet resuspended in 10ml of F12K medium (Catalog no. 
21127022, Invitrogen) containing 10% foetal bovine serum (FBS, Catalog no. 10091-148, 
Invitrogen) and 1% penicillin-streptomycin (Catalog no. 15140163, Invitrogen) and the 
resuspended cells added to a 10cm tissue-culture treated cell culture dish (Catalog no. 
430167, Corning). Ceils were maintained in an incubator at 37°C at 95% humidity and 
5% C02. CHO cells were subcultivated at a ratio of 1:5 every 5 days by washing with 
sterile PBS, then detached with 3ml of trypsin per 10cm dish and centrifuged at 220g for 
5 minutes. Cell pellets were resuspended in 5ml of F-12K with FBS and penicillin- 
streptomycin and divided into 5 equal aliquots which were each plated into a 10cm dish 
with an additional 9ml of media.
2.6.2. Caco-2 cells
Caco-2 cells, human colonic carcinoma-derived cells, were purchased from the ATCC 
(Catalog no. HTB-37). Thawing, propagation and subculturing were performed as for
CHO cells described above, except that Caco-2 cells were grown in Dulbecco's Modified
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Eagle Media (DMEM; Catalog no. 11965-092) containing 10% FBS and 1% peniciliin-
streptomycin.
2.6.3. I EC-6 cells
I EC-6 cells, rat intestinal crypt-derived cells, were purchased from the ATCC (Catalog no. 
CRL-1592). Thawing, propagation and subculturing were performed as for CHO cells 
described above, except that IEC-6 cells were grown in Dulbecco's Modified Eagle Media 
(DMEM, Catalog no. 11965-092) containing 10% FBS and 1% penicillin-streptomycin, as 
well as 0.001% bovine insulin (Catalog no. 10516, Sigma).
2.6.4. HEK293 cells
HEK293 cells, an embryonic kidney derived cell line, were purchased from the ATCC 
(Catalog no. CRL-1573). Thawing, propagation and subculturing were performed as for 
CHO cells described above, except that HEK293 cells were grown in Dulbecco's Modified 
Eagle Media (DMEM, Catalog no. 11965-092) containing 10% FBS and 1% penicillin- 
streptomycin.
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2.7. Cell transfection
2.7.1. CHO transfection
All transfections of CHO cells were carried out using the transfection reagent Effectene 
(Catalog no. 301425, Qiagen) according to manufacturer's instructions[290]. The effect 
of PERI overexpression on the SGLT1 promoter was assessed in CHO cells passages 10- 
12 transfected at 80% confluence with combinations of reporter vector (pGL3-Basic, 
wild-type SGLT1 pGL3/WT-SGZ.niuc, or mutated SGLT1 promoter constructs) and 
expression vector (pcDNA3.1(+) with or without PERI cDNA). Conversely, the effect of 
PERI knockdown on SGLT1 promoter activity was assessed by co-transfection of shRNA 
vectors in place of expression vectors. Renilla luciferase (Catalog no. E2241, pRL-TK; 
Promega) was cotransfected into ail wells in all experiments to normalize for 
transfection efficiency. After 24 hours, the media was aspirated from each well and 
replaced with fresh media (F12K containing 10% FBS and 1% penicillin-streptomycin) 
and cells returned to the incubator. Each sequence of transient transfection to 
measurement of luminescence was performed three times and each well in triplicate.
2.7.2. Caco-2 cell transfection
Caco-2 cells at passages 10-12 were transfected at 40% confluence with knockdown 
vectors for PERI using Effectene according to manufacturer's instructions[291j. At 24 
hours post-transfection the media was aspirated and replaced with fresh DMEM
containing 10% FBS and 1% penicillin-streptomycin and cells returned to the incubator.
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At 48 hours, the transfected cells were trypsinized and re-plated at 40% confluence in 
DMEM containing 10% FBS, 1% penicillin-streptomycin but this time also containing 
4pg/ml puromycin (Catalog no. ant-pr-1, Invivogen, San Diego, CA) to allow stable 
selection of transfected cells. This concentration of puromycin was determined by a 
previously performed kill-dose curve using normal untransfected Caco-2 cells plated at 
40% confluence in media containing antibiotic concentrations ranging from lug/ml to 
lOpg/ml. Cells were returned to the incubator and maintained under routine cell culture 
conditions, with the media changed every 3 days. Cells were monitored for the onset of 
confluence and harvested for RNA analysis at 7-days post-confluence.
2.7.3. I EC-6 transfection
IEC-6 cells at passages 6-8 were transfected at 90% confluence with the transfection
reagent Lipofectamine 2000 (Catalog no. 11668-019, Invitrogen) according to
manufacturer's instructions[292]. At 24 hours post-transfection the media was aspirated
and replaced with fresh DMEM containing 10% FBS, 1% penicillin-streptomycin and
0.001% insulin and cells returned to the incubator. At 48 hours post-transfection, the
transfected cells were trypsinized and re-plated at 40% confluence in DMEM containing
10% FBS, 1% penicillin-streptomycin and 0.001% insulin, but this time to allow stable
selection of transfected cells, the media also contained 2pg/ml puromycin (Catalog no.
ant-pr-1, Invivogen, San Diego, CA). This concentration of puromycin was determined by
a previously performed kill-dose curve using normal untransfected IEC-6 cells plated at
40% confluence in media containing antibiotic concentrations ranging from Ipg/ml to
lOpg/mi. Cells were returned to the incubator and maintained under routine cell culture
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conditions, with the media changed every 3 days, mir-16 expression was induced by
addition of 2pg/ml doxycycline (Clontech, Mountain View, CA) to the cell culture media 
72 h prior to plating for each assay.
2.7.4. HEK293 transfection
HEK293 cells at passages 10-12 were transiently transfected with knockdown sequences 
for PERI or the control scrambled shRNA in 10cm tissue culture dishes at 70% 
confluence using the transfection reagent Effectene (Catalog no. 301425, Qiagen) 
according to manufacturer's instructions[290]. After 24 hours, the media was aspirated 
from each well and replaced with fresh media (DMEM containing 10% FBS and 1% 
penicillin-streptomycin) and cells returned to the incubator. Cells were harvested after 
48 hours for determination of PERI mRNA expression.
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2.8. DNA plasmids and site-directed mutagenesis
All sequencing to confirm accurate insertion of DNA was carried out by technicians at 
the Brigham and Women's Hospital DNA Sequencing Core facility.
2.8.1. PCR amplification of PERI
The PERI expression vector was generated by amplifying human PERI cDNA obtained 
from reverse transcription of Caco2 cell mRNA using the Platinum Taq High-Fidelity DNA 
polymerase (Catalog no. 11304-011, Invitrogen) using primer-encoded Nhel and Notl 
restriction sites (cloning primers listed in Table 2.6). The following thermal cycling 
conditions were used: 1 cycle at 94°C for 1 minute then 35 cycles of 94°C for 30 sec, 
55°C for 30 sec and 68°C for 4 min.
Cloning primer Sequence
Perl
5' GGCCGCTAGCGCGACCAGGTACTGGCTGT6ATCGAA 3'
3' GGCCGCGGCCGCCAACTTTGTCCAGGGGAGGGAAGGATTC 5'
Table 2.6: Primers for amplification of PERI for creation of the PERI overexpression 
plasmid. Thermal cycler conditions used were 1 cycle at 94°C for 1 minute then 35 cycles 
of 94°C for 30 sec, 55°C for 30 sec and 68°C for 4 min.
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2.8.2. Gel electrophoresis
To identify successful amplification of the target region, 2pl of the PCR product {total 
50ul volume) was added to 2pl of DIMA loading buffer (created by addition of 25mg of 
xylene cyanol to 4g of sucrose and making the solution up to 10ml with distilled water) 
and 8pl of DEPC-treated water and run alongside 2pl of a DNA ladder added to 2pl of 
DNA loading buffer and 8pl of DEPC-treated water on a 1% agarose gel. Gels were 
prepared by adding Ig of agarose gel powder (Catalog no. 16500-100, Invitrogen) to 
lOOmi of distilled water, microwaving until all agarose fragments had dissolved 
(approximately 2 minutes), then pouring the molten agarose while still hot into gel 
casting trays fitted with combs. Once cooled, gels were transferred to the 
electrophoresis module and TAE (Iris-Acetate EDTA buffer, Catalog no. T4038, Sigma) 
added into the module to completely immerse the gel. The prepared PCR product and 
DNA ladder were slowly pipetted into one well each. Gels were run at 50V for 20mins, 
then removed from the module and transferred into a deep pipette tray containing 
100ml of water and 20p.g of ethidium bromide. Gels were incubated in this for 5 
minutes, then visualised on an UV transilluminator. A 4kb PCR fragment was identified 
on UV transillumination, corresponding to the expected weight of PERI cDNA, 
confirming successful amplification.
2.8.3. Digestion of PCR products and vectors
Once amplification was confirmed, the remaining 48pl of PCR product was digested
using restriction enzymes Notl (10U, Catalog no. R3189, NEB) and Nhel (10U, Catalog no.
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R3131, NEB) according to manufacturer's recommendations. The pcDNA3.1(+) vector
(Catalog no. V790-20, Invitrogen) was digested under similar conditions, gel 
electrophoresis performed as described in section 2.8.2 above and DNA extracted from 
the band of 5.4kb and quantified.
2.8.4. Ligation of insert and vector and amplification
The ligation was performed with 50ng of insert, 50ng of vector and l|il each of T4 
reaction buffer and T4 DNA ligase (Catalog no. M0202S, NEB) according to 
manufacturer's recommendations. A no-insert control ligation was also performed to 
assess the rate of self-circularization of any single cut vector fragments, omitting the 
insert from the reaction. After ligation, the plasmids were amplified by transforming 
E.coli (One-Shot ToplO Chemically Competent E.coli, Catalog no.C4040-10, Invitrogen) 
with 4pl of the ligation reaction (~50ng) according to manufacturer's instructions[293].
2.8.5. Plasmid preparation
5 colonies were picked using a sterile toothpick and each colony added to a 50ml 
microcentrifuge tube containing 5ml LB (prepared as described above). These miniprep 
cultures were incubated overnight at 37°C (~16 hours) with shaking, then plasmids 
extracted using the Qiaprep Spin Miniprep Kit (Catalog no. 27104, Qiagen) according to 
manufacturer's instructions[294] and the DNA quantified as described above. Accurate 
cDNA insertion was confirmed by sequencing (primers are listed in Table 2.7).
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Sequencing primer Sequence
IPISeq 5' GTC A AGC AG GIG C AG G CCA ACCAG G AAT ACTACCAG CA 3'
2PlSeq 5' GGGGAGTATGTCACCATGGACACCAGCTGGGCTGGCTTTGT 3'
SPISeq S' ACCCCACGGAAGGAGCCAGTGGTGGGAGGCACCCTGAGCC 3'
4PlSeq 5' TCCAGCTATCCTTATGGGGCACTCCAGACCCCTGCTGAAG 3'
SPISeq 5' CTGCT CATGGCCAAT G CTG ACCAGCG CGI CAT G ATG ACC 3'
Table 2.7: Sequencing primers for PERI overexpression plasmid. Sequencing was carried 
out by technicians at the Brigham and Women's Hospital DNA Sequencing Core Facility.
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2.8.6. Knockdown vectors and sequences
Knockdown vectors containing short-hairpin RNA sequences against PERI (pLKO.l-puro) 
were purchased from Sigma (Catalog no. SHCLNG-NM_002616), consisting of 5 shRNA 
sequences designed against the PERI RefSeq sequence NMJD02616 (sequences listed in 
Table 2.8). BLAST searches were conducted for each shRNA sequence against human 
GenBank and RefSeq databases (http://www.ncbi.nlm.nih.gov.ezp- 
prodl.hul.harvard.edu/BLASTA accessed on 11th November 2008) to exclude homology 
of the PERI shRNA to other genes. The pLKO.l-puro vector containing a scrambled 
oligonucleotide sequence (Catalog no. SHC001; Sigma) was used as a negative control. 
Knockdown efficiency of each sequence was determined by measuring PERI mRNA 
expression after transient transfection of HEK293 cells with either knockdown 
sequences for PERI or the control scrambled shRNA sequence. The two constructs with 
the highest knockdown efficiency were chosen for stable knockdown of PERI in Caco2 
cells and promoter assays (co-transfected with the SGLT1 promoter) in CHO cells.
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Catalog No. Sequence
TRCN0000074183 CCGGCCCAATTCTCAGAACTCAGATCTCGAGATCTGAGTTCTGAGAATTGGG1 1 II 1G
TRCN0000074184 CCGGCCAGCACCACTAAGCGTAAATCTCGAGATTTACGCTTAGTGGTGCTGGTTTTTG
TRCN0000074185 CCG G C AG CC AC ACA AG C A AATACT! CT CG AG A AGTATTTG CTT GT GTGG CTGTTTTTG
TRCN0000074186 CCGGCCATGGACATGTCCACCTATACTCGAGTATAGGTGGACATGTCCATGG'I 1 11 IG
TRCN0000074187 CCGGGCACAAACTCTCAGAGCCCATCTCGAGATGGGCTCTGAGAGTTTGTGCTTTTTG
Table 2.8: shRNA vectors used for knockdown of PERI. Plasmids were purchased from 
Sigma.
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2.8.7. Creation of the mir-16 overexpression vector
2.8.7.1. Identification of the necessary mir-16 sequence
The sequence and coordinates of mir-16 were identified using the microRNA database 
miRBase[295] and Genome Browser at University of California Santa Cruz[279], In 
accordance with previous reports, primer sequences were designed to include the 
proximal and distal 200bp flanking sequences in the mir-16 overexpression insert. 
Primers were designed using Primer 3 software as described above and are listed in 
Table 2.9.
Cloning primers Sequence
mir-16
5' GCGGACGCGTTGTTTTATCCCAAGTAAAAATCTGAA 3'
3' ATGCArCGATTTCTTTAGGCGCGAATGTG S’
Table 2.9: Primers used for amplification of mir-16 for creation of the mir-16 
overexpression vector in Chapter 5. Primers used for cloning mir-16 from human 
genomic DNA. Restriction sites are highlighted in bold and italicized. Thermal cycling 
conditions were as follows: initial denaturation of 94°C for 30 sec, then 35 cycles of 
denaturation at 94°C for 30 seconds, 61“C for 30 seconds and 68°C for 1 minute.
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2.8.7.2. Cloning the mir-16 sequence
The mir-16 insert was amplified from human genomic DNA acquired from Promega 
{Catalog no. G3041, Promega, Madison, Wl) using the forward and reverse primers 
designed above and the Elongase Amplification System (Catalog no. 10480010, 
Invitrogen) according to manufacturer's instructions[296]. The following thermal cycling 
conditions were used: 1 cycle at 94°C for 30 sec then 35 cycles of 94°C for 30 sec, 61DC 
for 30 sec and 68°C for 1 min. Products were identified by agarose gel electorphoresis as 
described in section 2.8.2.
The vector chosen for expression of the mir-16 insert was the pTRIPZ vector (Catalog no. 
RHS4750, Open Biosystems, Huntsville, AL}. The vector was amplified as per 
manufacturer's instructions in Dam-/- E.coli (Catalog no. C2925I, New England Biolabs, 
Ipswich, MA)[297]. Plasmids were prepared from the amplified E.coli using the GenElute 
HP Plasmid Maxiprep Kit (Catalog no. NA0310, Sigma) as per manufacturer's 
instructions[298]. Prepared DNA was quantified using the protocol employed for RNA 
quantification as described above, with calculations performed by Spectramax MS 
software using specific concentration constants for DNA rather than RNA. The amplified 
vector was stored at -20°C until further use.
2pg of the pTRIPZ vector and the amplified PCR product were individually digested using 
5pJ of the restriction enzyme Mlul (Catalog no. R0198S, NEB) and 2.5pl of the restriction 
enzyme Clal (Catalog no. R0197, NEB) according to manufacturer's instructions. The cut
vector and PCR products were identified by gel electrophoresis and extracted using the
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QJAquick Gel Extraction Kit (Catalog no. 28704, Qiagen, Valencia, CA) according to 
manufacturer's instructions[299]. The ligation was performed with a ratio of 6:1 
insert:vector and the resulting plasmids amplified by transforming E.coli as previously 
described in section 2.8.4.
10 colonies were amplified in miniprep cultures. Plasmids were prepared as described in 
section 2.8.5 and were sent for sequencing. The primers used for sequencing are 
provided in Table 2.10.
Sequencing primer Sequence
pTRseq 5’ GGAAAGAATCAAGGAGG 3'
Table 2.10: Primers used for sequencing the mir-16 overexpression plasmid in Chapter 
5. Sequencing was carried out by technicians at the Brigham and Women's Hospital DNA 
Sequencing Core Facility.
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2.9. SGLT1 promoter constructs (wild-type and mutants)
For promoter assays used in Chapter A, the previously characterized human SGLT1 
promoter (-1968/+14, designated WT SGLTl-luc) [31] was cloned by PCR from human 
genomic DNA (Promega) using the Eiongase DNA polymerase (Invitrogen) and PCR 
conditions as described in section 2.8.1 above. Primers used encoded Miul and Bglll 
restriction sites at the 5' and 3' ends respectively (listed in Table 2.11). Successful 
amplification was confirmed using gel electrophoresis of 2pl of the PCR product, which 
revealed the expected 2kb band on UV transillumination.
The remaining 48pl of PCR product and the pGL3 basic empty vector (Catalog no. E1751, 
Promega), were individually digested using restriction enzymes Mlul(10U, Catalog no. 
R0198, NEB) and Bglll(10U, Catalog no. R0144, NEB) according to manufacturer's 
instructions. The cut vector and PCR product were identified by gel electrophoresis and 
DNA extracted and quantified.
The ligation was performed with a ratio of 2:1 insertivector and plasmids amplified by 
transforming E.coli as previously described in section 2.8.4. Seven colonies were 
amplified in miniprep cultures. Plasmids were prepared as described in section 2.8.5 and 
were sent for sequencing. The primers used for sequencing are provided in Table 2.12.
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Sequencing primers Sequence
RVprimer3 5' CTAGCAAAATAGGCTGTCCC 3'
GLprimer2 5' CTT1ATGTTTTTGGCGTCTTCCA 3'
Table 2.12: Sequencing primers used to confirm the introduction of the wild-type SGLT1 
promoter and mutations (Chapter 4). Sequencing was carried out by technicians at the 
Brigham and Women's Hospital DNA Sequencing Core Facility.
The E-box sites within the SGLT1 promoter were mutated by conversion to Nhel 
restriction sites (GCTAGC) and designated SGLTl-luc mutEBl, mutEB2; mutEBB and 
mutEB4. Site-directed mutagenesis was performed on the pGLB-SGLTl vector created 
above using the Phusion Site-directed Mutagenesis kit (Catalog no. F-541, NEB). Primers 
were designed according to instructions for the Phusion kit[300]. Forward primers for 
the site-directed mutagenesis were designed to incorporate the Nhel restriction site in 
place of the E-box sequence and including 15-20bp of the proximal and distal flanking 
sequences; while reverse primers did not incorporate any mutations. All primers for 
site-directed mutagenesis were acquired from Invitrogen. Primers were designed to 
incorporate single E-box mutations as well as combinations of E-box mutations 
(designated mutEBl+2, 1+3 and 1+2+3), by adding a further mutation onto a mutated 
promoter, to assess synergistic interactions. All constructs were sequenced to confirm 
successful mutation. Mutagenesis primers are listed in Table 2.11 and sequencing 
primers listed in Table 2.12.
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2.10. SGLT1 promoter reporter assays
For reporter assays carried out in Chapter 4, CHO cells were transfected as described in 
section 2.7.1 above. The effect of PERI overexpression on the SGLT1 promoter was 
assessed in CHO ceils passages 10-12 transfected at 80% confluence with combinations 
of reporter vector (pGL3-Basic, wild-type SGLT1 pGL3/WT-5G/.niuc, or mutated SGLT1 
promoter constructs) and expression vector (pcDNA3.1(+) with or without PERI cDNA). 
Conversely, the effect of PERI knockdown on SGLT1 promoter activity was assessed by 
co-transfection of shRNA vectors in place of expression vectors. Renilla luciferase 
(Catalog no. E2241, pRL-TK; Promega) was co-transfected into all wells in all 
experiments to normalize for transfection efficiency.
After 48 hours, cells were washed once with PBS, then reporter expression measured 
using the Promega Dual Luciferase Reporter Assay System (Catalog no. E1960, Promega, 
Madison, Wl) according to manufacturer's instructions[301]. Luminescence was 
measured on an MS Spectramax using the provided software.
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2.11. Quantification of apoptosis
Apoptosis in IEC-6 ceils in Chapter 5 was quantified using the FITC-Annexin-V Apoptosis 
Detection Kit I (BD), Cells were counter-stained with the nucleic acid stain Sytox Blue 
(Catalog no. S34857, Invitrogen) to specifically identify dead or necrotic cells which also 
stain Annexin-V positive. IEC-6 cells stably overexpressing either mir-16 or the 
scrambled negative control were grown in 10cm tissue-culture treated dishes in the 
presence of 2pg/ml puromycin and 2pg/ml of doxycycline to induce mir-16 or control 
expression. After 48 hours, cells were trypsinized and counted and stained with Annexin 
V-FITC and Sytox Blue according to manufacturer's recommendations[302, 303]. Stained 
cells were analyzed at 10,000 events per sample by Miss Ashley Lansing, a technician at 
the Dana Farber Cancer Institute Flow Cytometry Core Facility on an LSRII flow 
cytometer (BD). The percentage of cells in each of the four quadrants (live, early 
apoptosis, late apoptosis and necrosis) was determined by Ashley Lansing using the 
software Diva (BD) and the results provided to me for further analysis.
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2.12. Measurement of cell proliferation
2.12.1. In vitro proliferation
Cell proliferation was measured using the CellTiter96 Aqueous One Solution Cell 
Proliferation Assay (MTS assay. Catalog no. G3582, Promega, Madison, Wl) according to 
manufacturer's instructions[304].
2.12.2. Cell growth rate (counting method)
Cell growth rates were confirmed by manual cell counting. IEC-6 cells were trypsinized, 
stained with trypan blue and counted at lOx magnification. 5 high-powered fields were 
counted per sample.
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2.13. Measurement of cell cycle changes
Cell cycle analysis was performed using propidium iodide. Cells were trypsinized and 
counted and each sample resuspended at 5000 cells/pl PBS. Resuspended cells were 
added dropwise into ice-cold 70% ethanol in a 50ml conical centrifuge tube while 
vortexing (250,000cells/mi of ethanol); and incubated overnight at -20°C. The next day 
cells were centrifuged at l,200rpm for 10 minutes at 4°C, the ethanol aspirated off and 
the cell pellet resuspended in propidium iodide containing RNAse (Catalog no. 550825, 
BD) at a final density of 0.5 x 106 cells/ml. Resuspended cells were incubated for BOmins 
at 37°C in darkness and analyzed at 10,000 events per sample by Ashley Lansing at the 
Dana Farber Cancer Institute Flow Cytometry Core Facility on a BD FACScan flow 
cytometer (BD). The percentage of cells in each of the cell cycle stages (Gl, S, G2 and M) 
was determined by Ashley Lansing using the software ModFit (Verity, Topsham, ME) and 
the results provided to me for further analysis.
2.14. Statistical analysis
All experiments were performed a total of three times. Data are presented as means ± 
SE. Graphical analysis was performed using Graphpad Prism (San Diego, CA). Unless 
mentioned otherwise all statistical analysis was performed using Microsoft Excel 2007 
(Microsoft, Redmond, WA). For all experiments the probability of p < 0.05 was taken as 
significant.
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Chapter 3: Restricted feeding phase shifts circadian rhythmicity in clock gene and 
sodium glucose co-transporter expression in rat jejunum
3.1. Introduction
The mammalian intestine is known to exhibit diurnal rhythmicity in a number of 
physiologic functions, including absorption[12, 13, 69, 70], enzyme activity[305], 
motiiity[306] and proliferation[307]. Glucose absorption in particular is known to exhibit 
a robust diurnal rhythmicity in the jejunum, mediated entirely by rhythmicity in the 
expression of the intestinal sodium glucose co-transporter SGLT1[12, 13, 69]. The 
mechanisms governing rhythmicity in SGLT1 expression remain unclear. Clock genes 
exhibit diurnal rhythmicity in the intestine and have been implicated in the regulation of 
intestinal proteins such as Peptl [16] and Mdrl [15], however no studies have 
examined the role of clock genes in the regulation of SGLT1 rhythmicity in the intestine 
and thereby the rhythmicity of intestinal glucose uptake.
Clock genes were first characterized in the SCN, the master circadian clock[158]. These 
genes interact to create positive and negative molecular feedback loops, resulting in a 
circadian pattern of gene expression with 24 hour periodicity[158]. The negative- 
feedback loop involves the rhythmic induction of three Period genes (designated Perl- 
3) and two Cryptochrome genes [Cryl and Cry2) by the binding of CLOCK and BMAL1 to 
E-boxes (sequences of CAnnTG) on Per and Cry promoters [158]. PER and CRY 
subsequently inhibit transcription of Clock and Bmall[156], inducing rhythmicity of 
Bmall expression with a phase opposite to that of Per or Cry, resulting in a positive-
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feedback loop[134]. An accessory loop involving the orphan nuclear receptors Rora and
Rev-erbA and B links the positive and negative limbs of the circadian oscil!ator[308]. 
ReverbA and B and Rora transcription is driven by BMAL1/CLOCK[309]. Reverbs and Rora 
in turn suppress and activate Bmall expression respectively[309].
More recently clock genes have been shown to form peripheral circadian oscillators in 
tissues outside the SCN, including the retina[177, 310], heart[177, 179], lung[177], 
kidney[177]/ peripheral blood cells[176,178] and liverfrZS], with rhythms exhibiting a 3- 
9 hour phase delay compared to the SCN. As yet, clock gene expression in the intestine 
has not been completely profiled. A few clock genes {Bmall, Clock, Perl-2 and Cryl) 
have been shown to exhibit rhythmicity in rodent jejunum[16, 311], however further 
work is required to fully characterize the expression of clock genes in the small intestine.
While circadian clock rhythmicity in the SCN is known to be entrained to light[130,134] 
clock gene expression in certain peripheral tissues[180, 182] is entrained by nutrients - 
restricted feeding regimens have been shown to shift the oscillatory rhythms of clock 
genes in the colon[182] and liver[180] but not in the light-entrained SCN[180, 182]. 
Nutrient availability may therefore have a similar effect on the entrainment of clock 
genes in the intestine, another organ exposed to wide fluctuations in nutrient exposure.
I hypothesized that members of the clock gene family exhibit circadian rhythmicity in 
the intestine and that this rhythmicity in clock gene expression mediates the rhythmicity
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in expression of the sodium glucose co-transporter S6LT1. The cues entraining
rhythmicity in clock gene expression in the intestine have not been identified and I 
proposed that nutrient availability is likely to act as a strong cue for entrainment of 
rhythmicity in the intestine. In particular I aimed to determine whether restricting food 
availability to the light phase, which would disrupt the normal nocturnal feeding pattern 
of rats, would shift the pattern of rhythmicity of clock genes and/or Sgltl. Altering the 
timing of nutrient availability would impose a new feeding pattern on the rats, thereby 
altering the period of nutrient exposure in the jejunum and resulting in a shift in the 
pattern of rhythmicity of clock genes and Sgitl expression. By simultaneously examining 
the temporal profiles of clock gene expression and Sgltl expression under conditions of 
ad libitum and restricted feeding, I hoped to identify the clock gene(s) that shifted in 
phase (to the same degree) as Sgltl and thereby identify potential clock genes capable 
of regulating the transcriptional rhythmicity of Sgltl.
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3.2.Clock genes and Sgltl display diurnal rhythmicity in the jejunum of ad libitum
fed rats
Rats were maintained in a 12-houriy light dark cycle (lights turned on at 2T 0 or 7am and 
turned off at ZT 12 or 7pm), fed ad libitum over the 24 hour period with free access to 
water, then after 5 days killed at 3 hourly intervals (n=6-7 per time point) beginning at 
ZT 0 (7am). To facilitate comparison to subsequent restricted-fed rats, these ad libitum 
fed rats will be designated "AL" rats.
Total RNA was extracted from jejunal mucosal scrapings from these rats and subjected 
to reverse transcription and qPCR as described in section 2.2. The rat fi-actin gene was 
used as a housekeeping gene to normalize for RNA loading. The means and spread of 
Perl expression (taken as a representative clock gene) and of fi-actin expression for ZT 0 
(taken as a representative timepoint) are similar, as shown in Figure 3.1.
The data (expression of each gene relative to fi-actin for each rat) were loaded into the 
Cosinor program (freely available at www.circadian.org). Cosinor analysis uses the least 
squares method to fit a sine wave to time series data assuming a 24-h period [312]. 
Clock genes were considered to display diurnal rhythmicity in ad libitum fed animals if a 
significant fit to a 24-hour period (as indicated by the p-value) was determined by the 
cosinor analysis performed by the program. For clock genes that were shown to display 
diurnal rhythmicity, the acrophase (time of peak expression) was determined by the 
program. The significance of fit to a 24-hour period, mesor (rhythm-adjusted mean),
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amplitude of rhythmicity and the acrophase for each clock gene are expressed in Table
3.1. Amplitudes (abstracted from the cosinor program) have been expressed as 
percentages of the mesor to allow for comparisons to be made across genes. Cosinor 
analysis can often be inaccurate in small sample sizes and with a limited number of 
diurnal harvest timepoints, hence ANOVA with post-hoc Tukey analysis was also used to 
identify a significant difference (p<0.05) between timepoints.
o
£
(3 - actin
Figure 3.1: Expression of Perl and fi-actin at ZT 0. RNA from the jejunum of rats (n=6) 
killed at ZT 0 (7am) was extracted, reverse transcribed and subjected to qPCR. PCR was 
performed twice for each gene and each sample was plated in triplicate for each PCR. 
The mean expression of each gene for each sample at ZT 0 is shown as a circle [Perl) or 
a square (the housekeeping gene fl-actin) and the mean expression and standard error 
of the mean for each gene per timepoint indicated.
To allow ease of visual comparisons of rhythmicity and amplitude to be made, the mean 
expression for each gene at each timepoint for the AL rats has been expressed as a ratio 
to the mean expression of the same gene at ZT3, chosen as the reference timepoint as it 
was common to AL, DF and LF rats. These values are displayed graphically in Figure 3.2A- 
H (clock genes) and Figure 3.3 (Sgltl).
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Gene p-value Acrophase 
{ZT, hh:mm)
Mesor Amplitude(%) p value on 
ANOVA
Perl 0.0014 09:28 1.29 48 0.0249
Perl 0.0008 15:59 3.02 57 <0.0001
Bmall <0.0001 23:04 0.71 100 <0.0001
Clock 0.0008 21:23 0.80 38 0.0151
ReverbA <0.0001 06:21 0.57 76 <0.0001
ReverbB 0.0003 08:34 0.81 41 <0.0001
Cryl 0.0015 20:08 1.41 17 <0.0001
Cry2 0.0097 18:41 1.47 36 0.0029
Sgltl <0.0001 10:44 1.60 51 <0.0001
Table 3.1: Circadian rhythmicity of clock genes and Sgltl. The expression of each gene 
was normalized to the expression of the housekeeping gene fi-actin for the same 
sample. The data were arranged as if a single animal was harvested at 3-hourly intervals 
over 6 days and cross-sectional pattern analysis was performed with the cosinor 
procedure, freely available at www.circadian.org. This software was used to determine 
the significance of fit of the temporal expression of the data to a cosinor pattern with a 
24-hour period. The p-values indicate the significance of fit of the data to a cosinor 
pattern with 24-hour periodicity as determined by the cosinor program, with a p value 
of 0.05 indicating a 5% probability that the observed 24-hour periodicity occurred by 
chance alone. The acrophase, abstracted from the cosinor program, is expressed as 
hours after light onset (ZT, lights on is at 0700 hence ZT 0 is 0700). The mesor is the 
rhythm adjusted mean, also abstracted from the cosinor program. The amplitude has 
been expressed as a percentage of the mean to facilitate comparison across genes.
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Ail clock genes exhibited diurnal rhythmicity with a 24 hour periodicity in the jejunal
mucosa of ad libitum fed rats on cosinor analysis (Table 3.1, Figure 3.2A-H), however 
significant differences between individual timepoints could not be demonstrated for 
Clock. The time of peak expression varied across genes. Both Perl and Per2 were 
rhythmic in the jejunum, however had opposite patterns of rhythmicity. Perl peaked 
during the lights-on phase at ZT 9 (F7'42=2,666, p=0.0249, Figure 3.2A), while Per2 
peaked at ZT12-18 (F7,42=6.704, p<0001, Figure 3.2B). Such a marked difference in peak 
expression was not noted for the other clock gene homologue pairs such as ReverbA and 
B and Cryl and 2 (Figure 3.2E-H). ReverbA peaked at ZT 3-9 (F7,42=6.370, pcO.OOOl, 
Figure 3.2E), while ReverbB had a more sustained peak from ZT3-15 (F7'42=6.424, 
pcO.OOOl, Figure 3.2F). Similarly Cryl peaked at ZT 18-0 (F7,42-6.370, pcO.OOOl, Figure 
3.2G), while its homologue Cry2 peaked atZT 21 (F7,42=3.881, p=0.0029, Figure 3.2H).
Bmall and Clock, two clock genes known to dimerize to act as transcriptional
regulators[161, 162], peaked at similar timepoints as would be expected (Figures 3.2C
and D). Bmall peaked at ZT 21-0 (F7'42=9.609, pcO.OOOl, Figure 3.2C) while Clock did not
demonstrate a statistically significant peak on post-hoc Tukey test but displayed higher
expression at the end of the dark phase (F7,42=2.899, p=0.0151, Figure 3.2D, Table 3.1).
The pattern of expression of Bmall and Clock showed that these genes, which activate
transcription of Perl and Per2[161, 162], peaked in antiphase to Perl (out of phase by
almost 12 hours. Figures 3.2A, C and D, Table 3.1) but were only 6 hours out of phase
with Per2 (Figures 3.2B-D, Table 3.1). The expression of Cryl and Cry2, known to
suppress Bmall and Clock[156, 158], was similarly only ~3 hours out of phase with
Bmall and Clock (Figures 3.2C, D, G and H, Table 3.1). ReverbA and ReverbB are known
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to be stimulated by Bmall and Clock[164, 309] and correspondingly peaked between 6- 
15 hours after the peak in Bmall and Clock expression (Figures 3.2C-F, Table 3.1).
The amplitude of change also varied dramatically across the clock genes examined. The 
mesor of each gene (the rhythm-adjusted mean) was abstracted from the cosinor 
program. The amplitude of each gene (calculated as the absolute difference in value 
between the peak level and the mesor) was also abstracted from the cosinor program, 
then expressed as a ratio to the mesor to allow comparisons of amplitude to be made 
across genes.
The greatest amplitude was displayed by Bmall, which showed a 100% increase in 
expression between the mesor and the peak (Figure 3.2C, Table 3.1). ReverbA also 
showed high amplitude of rhythmicity across timepoints (76%, Figure 3.2E, Table 3.1) 
and to a lesser degree ReverbB (41%, Figure 3.2F, Table 3.1). Although widely dissimilar 
in the time of peak expression, paralogues Perl and Per2 showed similar amplitudes of 
change, at 48% and 47% respectively (Figure 3.2A and B, Table 3.1). The smallest 
amplitudes were displayed by Clock and Cryl (38% and 17% respectively. Figure 3.2D 
and G, Table 3.1). In contrast to Perl and Per2, Cryl and Cry2 peaked at around the 
same timepoint but displayed a more profound difference in the amplitude; Cry2 had a 
higher amplitude of rhythmicity than Cryl at 36% (Figure 3.2H and G, Table 3.1).
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Figure 3.3: Sgltl mRNA expression in AL rats. Rats fed ad libitum ("AL") were culled at 3 
hourly intervals (6-7 rats per timepoint) beginning at ZT 0 (7am). mRNA was extracted 
from jejunal mucosal scrapings and subjected to reverse transcription and qPCR to 
determine the expression of Sgltl. Each well was plated in triplicate and the qPCR 
reaction performed twice for each experiment. mRNA expression of Sgltl was expressed 
as a ratio to the expression of the housekeeping gene fi-actin for the same sample. The 
graphs show the mean and standard error at each timepoint. To facilitate comparisons 
of rhythmicity and amplitude, mean expression at each timepoint has been expressed as 
a ratio to the mean expression at ZT 3. ANOVA with post-hoc Tukey test was used to 
identify significant differences between timepoints.
Like clock genes, Sgltl mRNA also exhibited robust 24 h rhythmicity (F742=17.22, 
p<0.0001, Figure 3.3), with peak expression between ZT 6-15 (Table 3.1), overlapping 
that for Perl (ZT 9, Figure 3.2A, Table 3.1) as well as ReverbB (ZT 3-15, Figure 3.2F, Table 
3.1). The amplitude of rhythmicity of Sgltl (51%, Figure 3.3) was similar to the 
amplitudes of Perl (48%, Figure 3.2) and Per2 (57%, Figure 3.2B, Table 3.1).
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As described above, AL rats displayed rhythmicity in all examined clock genes as well as
Sgltl (Figures 3.2 A-H, 3.3 and Table 3.1). While light is the dominant entraining cue for 
the master clock in the SCN[130, 134], nutrient availability has been shown to be the 
dominant zeitgeber in the liver[180]. I therefore next investigated the entraining effect 
of food on the rhythmicity of clock genes and Sgltl in the jejunum.
3.3. Nutrient consumption and body weight normalize within 7 days of lights-on 
restricted feeding
To determine the effect of nutrient availability on clock gene and Sgltl expression, rats 
(n=50) were fed for 7 days either during only the dark phase (designated "DF", ZT 12- 
24), or light phase (ZT 0-12, designated "IF"). DF rats were pair-fed to IF rats to ensure 
equal food intake. Rats were housed in pairs in cages. LF animals were given lOOg of 
food per cage at 0700. The remaining food at 1900 was weighed and subtracted from 
lOOg to calculate the amount consumed per pair of rats (it was assumed that both rats 
consumed equal amounts of food). The mean daily consumption of LF animals was 
calculated and provided to each pair of DF animals at 1900. No food remained in the 
cages of DF animals at 0700 the next day. Food consumption by LF rats over the 7 day 
study period is displayed graphically in Figure 3.4.Food consumption by LF rats on day 1 
averaged 16g (Figure 3.4), about 4g less than the 20g/day consumed by rats of similar 
weight fed ad libitum[89] but had normalised by day 3.
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To confirm acclimatization to the feeding pattern, body weights for each group were 
measured over the 7 day study duration and are shown graphically in Figure 3.5. A 
restricted feeding regimen of sufficient duration to allow acclimatization of LF rats to 
the new feeding schedule would be expected to result in equal weights between the 
groups at the end of the study period. To minimize disruption to the rats' circadian 
behaviour during restricted feeding, rats were weighed only 3 times during the study 
period - days 0 (the beginning of the study period), 4 and 8 (prior to harvest). A two-way 
ANOVA was performed to identify the effects of feeding pattern and duration of feeding 
(0, 4 or 8 days) on the weights of rats in the two groups and to identify any interaction 
between the two factors. Feeding time was a significant factor in the difference in 
weights in LF vs DF rats at day 4 (244g +1.4g vs 251g +1.5g respectively, f1,96=4.14, 
p<0,05, Figure 3.5) but not at days 0 or 8. The weights of both groups of rats increased 
significantly across day 0 to day 8 (F2,96=481, pcO.OOOl, Figure 3.5). No significant 
interaction was observed between duration of feeding and feeding time (Fz,96=2.02 
p=0.139).
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Figure 3.4: Daily food intake in rats fed during only the lights-on period. Rats (n=25) 
were maintained in a 12-hourly light-dark cycle (lights turned on at ZT 0 or 7am and 
turned off at ZT 12 or 7pm) and fed for 7 days during only the lights-on phase (ZT 0-12, 
7am to 7pm). Rats were given a fixed excess of food each day (lOOg) at ZT 0; remaining 
food was removed at ZT 12 and weighed. DF rats were given the exact amount of food 
consumed by LF rats and fed between ZT 12 and ZT 24. Values are expressed as means 
and standard error of the mean.
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Figure 3.5: Increase in weight in DF and LF rats. Rats (n=50) were maintained in a 12- 
hourly light-dark cycle and fed during either the lights-off period (DF rats, n=25, 
indicated by black circles) or lights-on period (LF rats, n=25, indicated by grey squares) 
for 7 days. Rats were weighed at days 0 (at the beginning of the study period), 4 and 8 
(before harvest). Weights are expressed as means and standard error of the mean. A 
two-way ANOVA was used to identify the effects of feeding time and duration of feeding 
on weight as well as any interaction between the two factors.
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3.4. Restricted feeding induces a similar phase shift in clock genes and Sgltl in rat
jejunum
DF and LF rats were maintained on the feeding regimens shown above for 7 days and on 
day 8 were killed (n=6-7 per time point per group) at 6-hourIy intervals beginning at ZT 3 
(10am). Total RNA was extracted from jejunal mucosal scrapings from these rats and 
subjected to reverse transcription and qPCR as described in section 2.2. The rat (3-actin 
gene was used as a housekeeping gene to normalize for RNA loading. The level of each 
gene was expressed as a ratio to the level of fi-actin in the same sample. The temporal 
profiles of all genes examined are displayed graphically in Figure 3.6A-H and Figure 3.7.
Page 110 of 272
11 
S ;! 
§ §
00
^ 'S
>•
d)
k_00
i_0J
T3
ro
$
<
2cc
E
Eroo
' ' oo
O ^
O)
Cl
O
00 
c 
'c 
.E 
00
^ ?
4-> • —
0) Q. 
J= OJ
•t; E
a>
00 »_ 
C QJ 
•C Q-
-2 ^ 
T3 *->
T3 2
- ^ 
co CD4-1 •---rocc ro
co > 
ro
■a
cro
Q CD
4->—i ro
< -D
C
o
'ui w
CL
X
<u
<u
cai
00
-X
u
_o
u
O)
5
"ITT_QJ
oo
cro
>-
<uc_
00
PO
c- »
3 LL. 
00 —I
JZ
uro
QJ
k_'5 o
5 Ct—
00 QJ
u
CO $4->
<N T3c. OJ
OJ
CL Ec_
<
o
t:
OJr~H
L. CL
Qj cCL o
c/> 4J
OJ o
c ro
OJ QJ
00 t—
QC
u u
o CL
u CT
ct— QJ
o JZ
L->
c
o ~oc‘co
c/i ro
OJc-
CL
OJ4->roX u
OJ
OJ
^o.
JC4-*
‘c_
4->
OJ c
c
T3
E QJ
c_ 4->
QJ ro4->
OJ CL
-a COro
o
*-> $
oc
u QJ
CL §
CT
-C
T3 u
C roro LLI
c
o X
*4—1
Q.
i_
CO o
Cro ■ac_ c
4-1 ro
QJ _ _
COc_
^QJ
>
QJc_ b
o
O4->
-a LL
QJ
4-< coU
OJ -5
in
3
CO
Qj
>
Qj
QC
T3
C
ro LU
CO
00 -Q
c C—
Qj
Q.
ro Qji_
u QC
CO -
"ro O
CO
O
u U
3 O
E o
T3
at
c
o
CL
(D
E
ro
c
o
a.
x
<u
a>
c
OJ
OJ
CL
Ero
CO
a*
Ero
CO
0)
O
>4-
c
4o
O
O
O4->
o
ro
ro
COro
~o
OJ
CL
X
OJ
coro
$
c
o
'co
coaic_
CL
X
a»
<
cc
E
c
OJ
E
C—0)
CL
X
OJ lib
itu
m
 ("
AL
") 
as
 d
es
cr
ib
ed
 in
 th
e 
pr
ev
io
us
 se
ct
io
n h
av
e b
ee
n c
o-
pl
ot
te
d 
fo
r c
om
pa
ris
on
 (b
la
ck
 sq
ua
re
s)
. G
ra
ph
s s
ho
w
 m
ea
n 
an
d s
ta
nd
ar
d 
er
ro
r 
fo
r e
ac
h 
ge
ne
 a
t e
ac
h t
im
ep
oi
nt
. T
o 
fa
ci
lit
at
e 
co
m
pa
ris
on
s 
of
 rh
yt
hm
ic
ity
 a
nd
 a
m
pl
itu
de
, m
ea
n 
ex
pr
es
si
on
 fo
r e
ac
h 
gr
ou
p 
at
 e
ac
h t
im
ep
oi
nt
 ha
s 
be
en
 e
xp
re
ss
ed
 as
 a 
ra
tio
 to
 th
e 
m
ea
n 
ex
pr
es
si
on
 o
f t
he
 s
am
e 
gr
ou
p 
at
 Z
T 
3.
Pa
ge
 11
1 
of
 2
72
ZT9 ZT15 
Zeitgeber time (ZT)
Lights on Lights off
Figure 3.7: Sgltl expression in AL, DF and LF rats. Rats fed during either the lights-off 
period ("DF") or lights on period ("LF") were culled at 6 hourly intervals (6-7 rats per 
timepoint) beginning at ZT 3 (10am). mRNA was extracted from jejunal mucosal 
scrapings and subjected to reverse transcription and qPCR to determine the expression 
of Sgltl. Each well was plated in triplicate and the qPCR reaction performed twice for 
each experiment. mRNA expression of Sgltl was expressed as a ratio to the expression 
of the housekeeping gene fi-actin for the same sample. The graphs show the mean and 
standard error at each timepoint. DF rats are shown in dark grey circles and LF rats in 
light grey triangles. Sgltl expression at the same timepoints in rats fed libitum ("AL") as 
described in the previous section have been co-plotted for comparison (black squares). 
To facilitate comparisons of rhythmicity and amplitude, mean expression for each group 
at each timepoint has been expressed as a ratio to the mean expression of the same 
group at ZT 3.
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Gene Effect of 
feeding 
time 
(p value)
Effect of 
harvest
time 
(p value)
Interact!
on
{p value)
Significant differences in gene 
expression at specific timepoints
AL vs DF AL vs LF DF vs LF
Perl 0.0006 0.0005 0.0067 None ZT9 and
ZT15
ZT9
Per2 <0.0001 <0.0001 <0.0001 ZT9, ZT
15 and
ZT21
ZT9, ZT15
and ZT21
ZT 9 and
ZT15
Bmall <0.0001 0.2041 <0.0001 None ZT9 and
ZT15
ZT 9 and
ZT15
Clock 0.2233 0.6724 0.3344 None None None
ReverbA <0.0001 <0.0001 <0.0001 ZT9, ZT15 
and ZT21
ZT9 and
ZT15
ZT15 and
ZT21
ReverbB <0.0001 <0.0001 <0.0001 ZT9 and
ZT15
ZT9 and
ZT15
ZT9 and
ZT21
Cryl <0.0001 0.0012 <0.0001 None ZT21 ZT15 and
ZT21
Cry2 <0.0001 0.3301 0.0138 ZT15 and 
ZT21
ZT15 and
ZT21
None
Sgltl <0.0001 <0.0001 <0.0001 ZT9 ZT9 and
ZT15
ZT9 and
ZT15
Table 3.2: Effect and interaction of feeding times and harvest times on clock gene and 
Sgltl expression in DF and IF rats. A two-way ANOVA was used to identify effects of 
feeding time and harvest time on gene expression in AL, DF and LF rats and to 
determine any interaction between the two variables.
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Rats fed under ad libitum conditions consume the majority of their food intake during 
the lights off periodElS, 313]. Feeding time would therefore be expected to influence 
gene expression patterns of both clock genes and Sgltl. This hypothesis was borne out 
by two-way ANOVA analysis of the expression levels of clock genes and Sgltl in AL, DF 
and IF rats, which showed that feeding had a significant effect on the differential 
expression of the majority of genes in these three groups (p<0.001 for all genes 
examined except Clock, Table 3.2, Figure 3.6). Harvest time also had a significant effect 
on gene expression for most genes with the exception of Clock, Bmall and Cry2 for 
which no effect was seen (Table 3.2, Figure 3.6} Feeding time showed a significant 
interaction with harvest time in this two-way ANOVA across all clock genes with the 
exception of Clock, indicating that the specific feeding regimen used influenced gene 
expression at the designated harvest times.
A number of clock genes examined (Perl, Bmall, Clock and Cryl) showed no difference 
in expression when subjected to feeding during only the lights off phase (the DF group) 
compared to ad libitum feeding (AL group), as would be expected given the known 
nocturnal feeding behaviour of rats[13, 313] (Table 3.2, Figure 3.6A,C, D and G). In 
contrast differences in gene expression between DF and AL rats were noted for Per2, 
Reverb A and Reverb B and Cry2 (Table 3.2, Figure 3.6 B, E, F and H).
Restricting feeding to the lights on period resulted in significant differences in gene 
expression for almost all clock genes with the exception of Clock and Cry2 (compared to
Page 114 of 272
DF rats, Table 3.2, Figure 3.6 C and H). Feeding during the lights on period induced 
increased levels of gene expression of Bmall, Clock, Cryl and Cry2 at ZT9 but 
suppressed levels of gene expression of Perl, Per2, Reverb A and Reverb B (Table 3.2, 
Figure 3.6).
Each clock gene displayed differential response to restricting feeding to either the dark 
phase or light phase compared to ad libitum feeding. Perl expression in DF and AL rats 
was broadly similar across the diurnal period however IF animals exhibited suppressed 
expression of Perl at ZT 9 and ZT 15 (Figure 3.6A, Table 3.2). Per2 expression was higher 
at ZT 9 and ZT 15 in DF rats compared to AL or LF rats; similar to Perl, levels of Per2 in LF 
rats were suppressed AT ZT9 and ZT 15 compared to DF or AL rats (Figure 3.6B, Table 
3.2). In contrast to Perl, Bmall expression, while similar in AL and DF animals, was 
increased at ZT 9 and ZT 15 in DF rats (Figure 3.6C, Table 3.2). Clock expression did not 
display significant rhythmicity in LF and DF rats, possibly due to the large variation in 
expression levels across rats within the same timepoints (Figure 3.6D, Table 3.2). 
ReverbA levels increased across the diurnal period in DF rats compared to AL rats (Figure 
3.6E, Table 3.2) The expression of ReverbA decreased at ZT9 and ZT15 in LF rats 
compared to DF rats (Figure 3.6E, Table 3.2). Diurnal differences in ReverbB expression 
were blunted in DF rats compared to AL rats, and ReverbB levels suppressed at ZT9 
compared to both DF and AL rats (Figure 3.6F, Table 3.2). Cryl expression in AL and DF 
rats increased between ZT3 and ZT21, but decreased between ZT9 and ZT21 in LF rats 
(Figure 3.6G, Table 3.2). Restricting feeding to the dark phase increased levels of Cry2 at
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ZT15 and ZT21 compared to AL rats, while restricting feeding to the lights on phase
decreased Cry2 levels at these timepoints (Figure 3.6H, Table 3.2).
Both feeding time and harvest time had a significant effect of Sgltl expression, and 
were shown on two-way ANOVA to interact to influence gene expression of Sgltl 
(F6/61=40.78, p<0.0001. Table 3.2, Figure 3.7). Restricting feeding to only the dark phase 
resulted in a significantly higher level of gene expression at ZT9 compared to rats fed ad 
libitum (Table 3.2, Figure 3.7). In contrast, restricting feeding to the lights on phase only 
significantly reduced Sgltl expression at ZT9 and ZT15 compared to AL and DF rats 
(Table 3.2, Figure 3.7).
Clock genes responsible for mediating diurnal rhythmicity in Sgltl transcription would 
be expected to demonstrate similar patterns of expression as Sgltl upon restricted 
feeding. I therefore examined the effect of restricted feeding on the individual clock 
genes and compared this to the effects on Sgltl. Clock genes Perl and ReverbB both 
displayed similar patterns of expression to Sgltl both ad libitum and under the two 
restricted-feeding regimens. As the Sgltl promoter does not contain binding elements 
for Reverbs (analysis of the Sgltl promoter is detailed further in Chapter 4), but does 
contain E-boxes which mediate the actions of the main clock gene feedback loops 
involving Bmall, Clock, Per and Cry genes, Perl was therefore considered of particular 
interest. To explore this further I examined the temporal expression of PERI protein 
expression in rat jejunum to compare the profiles of PERI and Sgltl expression.
Page 116 of 272
3.5. PERI rhythmicity in rat jejunum occurs in antiphase to the temporal profile of
Sgltl
AL and DL rats were culled at 6 hourly intervals (6-7 rats per group per timepoint) as 
described above and jejunum harvested for subsequent analysis of protein expression. 
Protein was extracted from jejunal mucosal scrapings of these rats and Western blotting 
performed as described in section 2.5. Protein expression for PERI and SGLT1 was 
expressed as a ratio to the expression of the housekeeping gene /7-ACTIN for the same 
sample. The mean and standard error of protein expression for each gene at each 
timepoint was calculated and is displayed graphically in Figure 3.8. A two-way ANOVA 
was used to identify effects of feeding time and harvest time on gene expression in DF 
and IF rats and to determine any interaction between the two variables; values are 
shown in Table 3.3.
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Figure 3.8: PERI and SGLT1 protein expression in rat jejunum. Rats fed ad lib were 
culled at 6 hourly intervals (6-7 rats per timepoint) beginning at ZT 3 (10am) and 
jejunum harvested for analysis of protein expression of PERI (A) and SGLT1 (B). Protein 
was extracted from jejunal mucosal scrapings and Western blotting performed. Blot 
images were quantified by densitometry and protein expression for each gene 
expressed as a ratio to the expression of the housekeeping gene /TACTIN for the same 
sample. Values represent the mean and standard error for each gene at each timepoint. 
DF rats are represented in the graphs by black circles and LF rats by grey squares.
Page 118 of 272
Gene Effect of 
feeding 
time 
(p value)
Effect of
harvest 
time 
(p value)
Interaction
(p value)
Significant differences in gene 
expression at specific timepoints
between DF and LF
PERI 0.0364 0.0063 0.1070 None
SGLT1 0.0009 0.5901 0.9707 None
Table 3.3: Expression of PERI and SGLT1 in DF and LF rats. The expression of each 
protein was normalized to the expression of /?-ACTlN for the same sample. A two-way 
ANOVA was used to identify effects of feeding time and harvest time on gene 
expression in DF and LF rats and to determine any interaction between the two 
variables.
PERI protein expression was influenced by both feeding time and harvest time in DF 
and LF rats. PERI levels were highest at ZT3 in DF animals but at ZT21 in LF animals, 
however this difference did not meet statistical significance (Figure 3.8A, Table 3.3). in 
addition no interaction was noted between feeding time and harvest time for PERI on 
two-way ANOVA (F3'42=2.16, p=0.107, Table 3.3). Feeding time had a significant effect 
on SGLT1 expression, as evidenced by higher levels of expression in LF animals than in 
DF animals at all timepoints, however harvest time did not have any effect on SGLT1 
expression at the protein level (Figure 3.8B, Table 3.3). No interaction was 
demonstrated between the effects of feeding time and harvest time on SGLT1 
(F3'42=0.08, p=0.971. Figure 3.8, Table 3.3).
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Given the similar phase shifts in Perl and Sgltl expression, it was proposed that PERI 
might act as a transcription factor regulating Sgltl expression. The temporal profiles of 
PERI and Sgltl in DF and LF rats were therefore juxtaposed and compared. The 
decrease in PERI protein between ZT 3 to 15 in DF rats coincided with the increase in 
Sgltl mRNA expression between ZT 3 to 9 (Figures 3.8A and 3.7). Similarly the 
reduction in PERI protein between ZT 21 to 9 in LF rats coincided with the increase in 
Sgltl mRNA expression between ZT 21 to 3 (Figures 3.8A and 3.7).
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3.6. Discussion
My findings above demonstrate the presence of a robust peripheral clock in the 
intestine in rats, which is likely to be cued by nutrient availability. All clock genes 
exhibited diurnal rhythmicity with 24 hour periodicity in jejunal mucosa of AL rats 
(Figure 3.2, Table 3.1). Sgltl also displayed diurnal rhythmicity in AL rats (Figure 3.3, 
Table 3.1), consistent with previous findings[13, 69]. Restricting food availability to only 
the lights-on period shifted the peak expression of rhythmic clock genes (Figure 3.6, 
Table 3.2), showing that nutrient availability is a stronger Zeitgeber in the intestine than 
light cycle. Notably, expression patterns of both Sgltl mRNA and protein were also 
altered by restricted feeding to only the lights-on period (Figures 3.7 and 3.8B, Tables 
3.2 and 3.3). These results therefore establish nutrient availability as a key Zeitgeber for 
the peripheral intestinal clock as well as the expression rhythm of the glucose 
transporter SGLT1.
Circadian rhythmicity was demonstrated for Perl-2, Small, Clock, ReverbA, ReverbB and 
Cryl-2 in this study on cosinor analysis, although no significant differences between 
individual timepoints could be demonstrated for Clock on ANOVA (Figure 3.2A-H). 
Previous studies have examined diurnal rhythmicity in a more limited group of clock 
genes in the intestines of ad libitum fed rodents[16, 311]. Froy et al[311] examined the 
temporal profile of Small, Clock, Perl-2 and Cryl in mouse jejunum while Saito et al[16] 
examined the expression of the same five genes in rat jejunum. Both groups showed
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diurnal rhythmicity in all five genes with patterns of expression similar to those 
demonstrated in my results (Figure 3.2A-D and G, Table 3.1). The acrophases of Bmall 
and Clock in the above mentioned studies occurred at ZT 0, similar to their peaks at ZT 
23 and 21 respectively as noted in my study (Figure 3.2C and D and Table 3.1). The Per 
and Cry genes are known to suppress transcription of Clock and Bmall, acting as the 
negative limb of the clock gene feedback loop[134, 158]. As expected therefore peak 
expression of the Per and Cry genes occurred in the light-dark transition period (Figures 
3.2A-B and G-FI, Table 3.1) in antiphase to peak expression of Bmall and Clock in the 
early lights-on period (Figures 3.2C-D, Table 3.1), in keeping with findings from other 
groups[16, 311]. Neither of the two previous studies profiling clock genes in the 
intestine examined the temporal expression of ReverbA or B or Cry2[16, 311]. My study 
was the first to examine rhythmicity of these genes in jejunum and demonstrated that 
all three genes exhibited diurnal rhythmicity (Figures 3.2E-F and H, Table 3.1).
The temporal expression of Per3 was not examined in my studies as previous 
studies[314] showed that mPer3-/~ mice demonstrate only subtle effects on circadian 
rhythmicity. Loss of PER3 did not alter despite rhythmicity of core clock genes[314]. 
Mutant mice in this study displayed persistent rhythmicity in a 24-hour dark-dark cycle 
(DD); the only effect of PER3 loss noted was a shortening of the circadian period[314]. 
These findings were corroborated by a further study showing that similar behavioural 
rhythms in mPerl/mPer3 and mPer2/mPer3 double-mutant mice and mice with 
disruption of mPerl or mPer2 alone[159]. Indeed it has been proposed that PER3 may in
fact act as a clock output protein rather than a core clock gene[314]. This lack of
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evidence for a substantial role for Per3 in the circadian clock led me to investigate only
Perl and Per2 in my experiments.
The peak expression of ReverbA and B at ZT 6 and 9 respectively (Figures 3.2E-F, Table 
3.1) occurred in antiphase to the peak in expression of Bmall and Clock (Figures 3.2C-D, 
Table 3.1). This is consistent with the known role of REVERBA and B, which act as 
transcriptional suppressors of Bmall expression via ROREs (retinoic acid receptor- 
related orphan receptor responsive element), a GGTCA consensus core motif preceded 
by a 6A/T rich region, on the Bmall promoter[164, 309]. Another orphan nuclear 
receptor RORA (retinoic acid receptor-related orphan receptor alpha) competes with 
REVERBA and B to bind to the RORE on the Bmall promoter, but in contrast to the 
suppressive effect of REVERBA and B[309] RORA stimulates the Bmall promoter[308, 
309]. In contrast to the profound rhythms in gene expression of ReverbA and B in most 
peripheral tissues[309, 315] Rora does not display circadian rhythmicity in the majority 
of peripheral tissues (including skeletal muscle, kidney and thymus[315] and brown 
adipose tissue and liver[309]) and shows only weak circadian oscillation in white adipose 
tissue[315]. Rora was therefore not examined in my studies however the expression of 
Rora in the intestine and the response to a restricted feeding schedule may be worthy 
of investigation in future studies.
Other studies have confirmed that circadian rhythmicity in peripheral clock gene 
expression is not only restricted to the jejunum but is also present at other sites along
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the gastrointestinal tract. While rhythmicity of clock genes in the liver is well- 
described[180,193], rhythmicity of clock genes in the stomach[182] and colon[182, 316] 
have only recently been characterized. Hoogerwerf et al examined the expression of 
Small, Clock, Perl-3 and Cryl-2 in the stomach, proximal, mid and distal colon of ad 
libitum fed mice[182], but did not examine rhythmicity of clock gene expression in the 
small intestine. The authors showed rhythmicity of the peripheral clock throughout the 
length of the gastrointestinal tract examined, with acrophases broadly similar to that 
noted for clock genes in the jejunum in my study (Figure 3.2A-H, Table 3.1). These 
findings were corroborated by Sladek et al, who described similar rhythmicity in the 
colon[316].
Determining the relative shifts in glucose transporter and clock gene rhythms in 
response to restricted feeding was a major study aim. Nocturnal food restriction (DF 
rats) would not be expected to produce a shift in intestinal clock gene or Sgltl 
expression as only a modest amount of food is usually consumed during the day (10- 
20% daily intake)[13, 313]. It was therefore surprising to find that nocturnal food 
restriction significantly affected expression of Per2, ReverbA, ReverbB and Cry2 as well 
as Sgltl (Figures 3.6B, E, F and H, 3.7 and Table 3.2). Restriction of food to the lights-off 
period only in DF rats effectively prevented "early phase eating" - consumption of food 
in the late light phase - and may have enhanced entrainment signals normally produced 
by hunger or hormonal responses, thereby sharpening the anticipatory intestinal gene 
induction and altering peak expression in DF rats. In either case, it is clear that
restricting food access to 12 hours during the lights-off period led to detectable
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alterations in the expression of selected clock genes and Sgltl (Figures 3.6A-H, 3.7 and
3.8, Table 3.2).
The majority of clock genes continued to exhibit peaks and troughs of expression in LF 
and DF animals despite the change in period of nutrient availability (Figures 3.6A-H, 
Table 3.2). Notable exceptions were Clock and Cry2, which exhibited blunted expression 
in DF and LF animals rhythmicity in both these genes was abolished by both LF and DF 
restricted feeding patterns (Figures 3.6D and H and Table 3.2). Clock is known to be 
arrhythmic in the SCN[158, 317, 318] and its rhythmicity in peripheral tissues such as 
colon[182, 316] and liver[319] has not been conclusively demonstrated. Cry2 similarly 
lacks robust rhythmicity along the gastrointestinal tract, displaying lack of rhythmicity in 
the stomach and proximal colon but relatively robust rhythmicity in the mid and distal 
colon[182]. Overall these findings suggest weak rhythmicity in these clock genes in the 
gastrointestinal tract. Knockout studies to date suggest a redundant role for both these 
genes in maintaining rhythmicity of circadian behaviour; circadian rhythmicity persists in 
both Clock -/- mice[320] and Cry2-/~ mice[321] but with an extended circadian period. 
The effects on intestinal gene expression have not been investigated and would be of 
interest in future studies.
After 7 days of restricting feeding to either the light or dark period, phase differences of 
6-12 hours were observed in the peak expression of Sgltl and 6 of the 8 clock genes 
examined {Perl, Per2, Small, ReverbA and ReverbB and Cryl, Figures 3.6A-C and E-G,
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3.7 and 3.8, Table 3.2). This is similar to the phase shift of 7-12 hours and 8-12 hours 
observed in the colon of mice in two previous studies after a 2 day and 14 day study 
duration respectively of restricted feeding during the lights-on period only compared to 
ad libitum feeding[182, 316], The lack of a complete 12 hour phase shift in clock gene 
expression between dark- and light-fed rats may reflect the influence of other factors on 
clock gene expression. Glucocorticoids in particular are known to exhibit circadian 
rhythmicity in expression and have been shown to regulate clock gene expression in 
other organs such as the liver[85, 322]. Of further interest, rhythmicity in clock gene 
expression persisted in glucocorticoid receptor null mice[85], confirming that 
glucocorticoids are not sole mediators of the regulation of the phase-setting of clock 
gene expression in peripheral tissues.
The duration of nutrient availability may have also affected the degree of phase shift. A 
shorter period of food availability (chow available only between ZT 2-8) was used by 
Saito et al[16] with an attendant full 12 hour phase shift in the expression of selected 
clock genes in the intestine, greater than the 1.7 hour phase shift observed in my study 
(Figure 3.8). Moreover, peripheral clocks have been noted to adapt to restricted feeding 
at different rates - for example clock genes in the liver phase shift much more quickly 
than clock genes in the lungs[180]. While it is possible that the small intestine would 
achieve a complete phase shift following a longer duration of restricted feeding (such as 
2 weeks rather than the 7 days used in this study), the sufficiency of 4 days adaptation 
as previously reported[16], the similarity in phase shift of clock gene expression in the
colon following 2 days[182] versus 14 days[316] of restricted feeding and the equal
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weights between the DF and LF rats and the plateau in food intake in the IF rats
(matching that expected for rats of that weight[89]) by the end of the study period in 
this study all suggest that the partial phase shift noted in my study was due to factors 
other than incomplete adaptation.
The rapid adaptation observed in liver in other studies[180] may result from more direct 
(i.e. local) stimulus-response pathways. Adaptation in the intestine, particularly for 
diurnally rhythmic functions, is indirect (as shown by isolated loops)[323] and may entail 
cephalic and other inputs. The apparently longer period required for adaptation by 
intestine vs. liver may reflect a tissue-specific feature necessary to stabilize the rhythms 
in intestinal functions despite moderately varying nutrient intake patterns. Linkage of 
phases of critical intestinal functions such as proliferation and absorption to external 
stimuli such as nutrient availability could serve to optimally coordinate the rhythms in 
DNA synthesis and peak absorption.
In this study, the difference between peak and trough SGLT1 protein expression was 
blunted over the diurnal period in LF rats (Figure 3.8B, Table 3.3). Previous studies from 
our group and others have shown that rhythmicity of SGLT1 protein expression 
correlates with functional rhythmicity in the form of intestinal glucose uptake[13, 69], 
Rhythmicity of glucose uptake in ad libitum fed rats in these previous studies was 
abolished in the presence of the SGLTl-specific inhibitor phloridzin[13, 69], confirming 
that rhythmicity in glucose uptake was mediated entirely by SGLT1. Peak glucose uptake
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at ZT 15 in ad libitum fed rats corresponded with the peak in SGLT1 protein expression
at ZT 15 in the abovementioned study. Although glucose uptake was not measured in 
my studies, the data from these previous studies[13, 69] suggest that glucose uptake in 
this study would be likely to show similar diurnal rhythmicity in both AL and DF rats, 
which displayed rhythmicity in SGLT1 expression, but not in LF rats.
Overall SGLT1 protein expression was higher in LF rats compared to DF rats (Figure 
3.8B), suggesting that regulation of SGLT1 expression may be occurring at the post- 
transcriptional level and is consistent with previous data from our laboratory showing 
that post-transcriptional events are also important in regulating intestinal SGLT1 
expression[89, 323]. The increase in overall SGLT1 protein expression in LF rats may be 
an attempt to increase nutrient absorption to compensate for the loss of the diurnal 
peak in SGLT1 expression that would normally be expected to occur at times of maximal 
nutrient availability. In light of reports that SGLT1 expression is increased in 
experimental models of obesity in rodents[38] and diabetes (both in experimental 
models[326] and in humans[327]), it would be interesting to assess the functional 
consequences of this observation by comparing glucose homeostasis in light vs. dark fed 
rats, as well as measuring SGLT1 expression in shift workers, who are forced to eat off- 
scheduie and have increased risk of developing glucose intolerance[328].
In AL rats, Perl and ReverbB mRNA expression peaked in phase with Sgltl (Figure 3.2A 
and F and Figure 3.3), slightly preceding Sgltl expression by l-2h. Restricted feeding
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produced similar patterns of expression for Sgltl, Perl and ReverbB (Figure 3.7 and 
Figure 3.6A and F and Table 3.2). The presence of 4 canonical E-boxes in the Sgltl 
promoter raises the possibility that PERI may be involved in controlling Sgltl 
rhythmicity. If so, occurrence of the Sgltl mRNA nadir (Figure 3.7) when the PERI 
protein level is rising (Figure 3.8A) suggests that PERI exerts a negative influence. Lack 
of REVERB response elements in the Sgltl promoter argues against REVERBB 
involvement but does not preclude indirect regulation or binding to a non-canonical 
element. The relationship between PERI and Sgltl is explored further using in vitro 
studies in the following chapter.
The mechanisms cuing the adaptation of clock gene rhythmicity to the shift in nutrient 
availability remain unknown. The SCN in the hypothalamus acts as the master 
pacemaker in mammals by receiving direct retinohypothalamic input and entraining 
circadian rhythmicity in visceral functions to the light cycle[81, 329]. SCN-lesioned 
rodents display loss of behavioural[330, 331], endocrine[329] and cardiovascular 
rhythms[81], however the effects of SCN lesions on the entrainment to nutrient 
availability are less profound[332]. Lesioning the SCN abolishes spontaneous circadian 
rhythmicity and hence disrupts the normal pattern of ad libitum feeding[333-335]; 
however these rodents are still able to entrain to a scheduled feeding regimen[192, 333] 
both in the form of meal-associated behaviour[333] as well as in phase shifting clock 
gene expression in the liver[192]. These studies suggest that while the SCN may play a 
role in mediating nutrient-associated rhythmicity, it is unlikely to be the main cue
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regulating these rhythms. No studies to date have examined the effect of SCN-lesioning
on clock gene expression in the intestine.
Neuronal factors may also mediate the entrainment of gene expression to nutrient 
availability. The vagus nerve, the main extrinsic nerve supply to the intestine, has been 
implicated in regulating rhythmicity in the expression of intestinal nutrient transporters 
which are known to display a robust 24-hour periodicity abrogated at the post- 
transcriptional level by vagotomy[88, 89]. Although the effects of vagotomy in clock 
gene expression in the small intestine have yet to be investigated, Hoogerwerf et al 
found no difference in the rhythmicity or acrophase of clock genes Bmall, Perl-3 and 
Cryl rhythmicity in the colon between vagotomised and control mice[182]. In the above 
mentioned study gene expression was measured at the transcriptional level only and 
hence a post-transcriptional effect of vagotomy on clock gene rhythmicity cannot be 
excluded.
These findings support the hypothesis that clock genes cue intestinal rhythmicity in 
response to nutrient availability. Clock genes are clearly important transcriptional 
regulators[14-16]. Clock genes and clock-controlled genes have been implicated in the 
regulation of other genes such as the Na+/H+ exchanger Nhe3 in the kidney[14]; the 
oligopeptide transporter Peptl [16]; and the multidrug resistance 1 {Mdrl) gene[15]. To 
date no studies have examined the role of clock genes in the regulation of SGLT1 
rhythmicity and thereby the rhythmicity of glucose uptake in the intestine.
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The glucose concentration generated from digestion may be a major stimulus in
regulating the expression of clock and Sgltl genes in the intestine. In an intriguing study, 
glucose was shown to down-regulate Perl and Per2 mRNA expression in rat-1 
fibroblasts[336j. The authors hypothesized that glucose itself (which displays a modest 
circadian rhythm in rodents[337]) provides a Zeitgeber for peripheral clocks, acting to 
downregulate Perl and Per2 via other transcriptional regulators. This hypothesis is 
consistent with decreased Perl mRNA levels during the period of nutrient consumption 
in both AL and DF rats (Figure 3.2A and 3.6A, Tables 3.1 and 3.2). Enterocytes are likely 
to experience abrupt increases in glucose supply and intracellular concentrations 
following feeding. Thus, glucose suppression of Per expression may be the molecular 
basis for resetting intestinal clocks by nutrient availability. The ability of the intestine to 
respond rapidly to nutrient intake patterns via the peripheral circadian clock would have 
great adaptive value by optimally coordinating absorptive functions with nutrient 
delivery.
In summary, we have shown that nutrients provide a major Zeitgeber for intestinal clock 
genes and that shifting the period of availability simultaneously phase shifts expression 
of dock genes and intestinal transporters. Further studies are required to define the 
molecular mechanism linking clock genes to Sgltl rhythmicity. The regulatory 
mechanisms governing diurnal rhythmicity of intestinal function may have a 
considerable role in obesity and diabetes and a better understanding could lead to new 
therapies for these worsening epidemics.
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Chapter 4: PERI modulates SGLT1 transcription in vitro independent of E-box status
4.1. Introduction
Clock genes are known to control the rhythmicity behind many circadian functions[128, 
129] by regulating a large number of circadian genes[14-16]. These molecular feedback 
loops have themselves been shown to express circadian rhythmicity in several 
peripheral tissues[176-179]. In the intestine in particular clock genes have been 
implicated in the regulation of the diurnal rhythmicity of other intestinal transporters 
such as the Peptl gene[16] and the Mdrl gene[15]; making clock genes candidate 
regulatory factors for rhythmicity of Sgltl expression. Sgltl is known to demonstrate 
profound diurnal rhythms in expression in the intestine, as shown in Chapter 3, however 
the molecular pathways regulating this rhythmicity of expression remain unclear.
The studies detailed in the previous chapter (Chapter 3) demonstrated rhythmicity of all
clock genes as well as Sgltl in ad libitum fed rats. The similar phase shifts of 2 specific
clock genes, Perl and ReverbB, with Sgltl under the two restricted-feeding regimens led
me to consider these two genes as potential regulators of Sgltl. To explore this further I
analysed the SGLT1 promoter for binding sites for either of these genes. I found that this
promoter does not contain binding elements for REVERBs but does contain E-boxes -
binding sites for PERI in association with the CLOCK-BMAL1 heterodimer (analysis of the
SGLT1 promoter is detailed further in section 4.5). PERI was therefore considered a
potential candidate clock gene which might act to mediate rhythmicity in SGLT1
expression. Subsequent examination of the rhythmicity of protein expression of PERI
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showed a decrease in PERI protein between ZT 3 to 15 in DF rats coincident with the
increase in S6LT1 mRNA expression between ZT 3 to 9 (Figures 3.9A and 3.7). This 
suggests a potential suppressive role for PERI on 5GLT1 mRNA expression in 
enterocytes. To explore this further, I examined the effects of manipulating PERI 
expression levels on SGLT1 transcription in vitro by using knockdown of PERI and 
attempted to decipher the specific effects of PERI on binding elements on the SGLT1 
promoter.
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4.2.Testing the knockdown efficiency of acquired shPERl sequences
To determine the effects of PERI on SGLT1 in vitro, I decided to knockdown PERI 
expression in Caco-2 cells. Knockdown vectors containing short-hairpin RNA sequences 
against PERI {pLKO.l-puro) were purchased from Sigma, consisting of 5 shRNA 
sequences designed against the PERI RefSeq sequence NM_002616. The pLKO.l-puro 
vector containing a scrambled oligonucleotide sequence (Sigma) was purchased for use 
as a negative control. Knockdown efficiency of each sequence was determined by 
measuring PERI mRNA expression after transient transfection of HEK293 cells with 
either knockdown sequences for PERI or the control scrambled shRNA sequence. The 
HEK293 cell line is human embryonic kidney derived and was used to test the 
knockdown efficiencies of PERI shRNA sequences as it has endogenous clock gene 
expression and was recommended by the shRNA sequence manufacturers to test shRNA 
knockdown efficiency due to its property of being easy to transfect. HEK293 cells were 
maintained as described in section 2.6.4 and transiently transfected at passages 10-12 
with knockdown sequences for PERI or the control scrambled shRNA at 70% confluence 
using the transfection reagent Effectene. Cells were harvested after 48 hours for 
determination of PERI mRNA expression. RNA was extracted, reverse transcribed and 
subjected to qPCR. PERI expression was expressed relative to the expression of the 
housekeeping gene /? -ACTIN. Knockdown efficiency of each of the shRNA vectors is 
shown in Figure 4.1 and residual expression and significance of difference compared to 
the control shown in Table 4.1.
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All 5 sequences produced significant levels of knockdown compared to the scrambled 
control vector as tested by one-way ANOVA with post-hoc Tukey (F5,1Z=21.63; pcO.OOOl, 
Figure 4.1, Table 4.1). ShPERl sequences A and B showed the greatest knockdown 
efficiency with 0.28 and 0.29 the expression of the control respectively (Figure 4.1, Table 
4.1). ShPERl sequence C had a slightly lower knockdown efficiency with residual 
expression of 0.34 of the control while sequences D and E were least successful with 
residual expression of 0.62 and 0.57 of the control respectively {Figure 4.1, Table 4.1).
ShPERl sequences A and B, the two constructs with the highest knockdown efficiency, 
were chosen for stable knockdown of PERI in Caco-2 cells to determine the effects of 
PERI on endogenous SGLT1 expression in vitro and co-transfected with the SGLT1 
promoter for promoter-reporter assays in CHO cells.
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p<0.05 vs control
C SeqA SeqB SeqC SeqD SeqE
Figure 4.1: Knockdown efficiency of shPERl vectors in HEK293 cells. Each of the five 
acquired sequences or the scrambled negative control was transfected transiently into 
HEK293 cells, which were harvested for RNA after 48 hours. PERI expression was 
quantified by qPCR and expressed relative to fi -ACTIN expression for the same sample. 
One-way ANOVA with post-hoc Tukey was used to identify significant differences in 
PERI expression between cells transfected with each knockdown sequence versus 
controls. The experiment was carried out thrice and each sample was plated in 
triplicate. The graphs show the mean and standard error of the mean. Expression of 
PERI in knockdown vector-transfected cells has been expressed as a ratio to the 
expression in control cells, labelled C.
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Sequence
Expression relative
to control
p-value
SeqA 0.28 <0.0001
SeqB 0.29 <0.0001
SeqC 0.34 <0.0001
SeqD 0.62 <0.01
SeqE 0.57 <0.01
Control 1.00
Table 4.1: Residual expression of PERI following knockdown in HEK293 cells. PERI 
expression was measured in HEK293 cells transiently transfected with either one of 5 
knockdown sequences for PERI or the scrambled negative control. mRNA expression 
was measured by qPCR and PERI expression expressed relative to fi-ACTIN. Expression 
of PERI in knockdown vector-transfected cells is shown relative to expression in control 
cells. Differences in expression from the control were considered significant if p<0.05 as 
calculated by one-way ANOVA with post-hoc Tukey.
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4.3.Downregulation of PERI increases SGLT1 expression in Caco-2 cells
Caco-2 cells are human colonic carcinoma-derived cells. These cells were chosen as the 
cell type for assessing the effects of clock genes on endogenous SGLT1 expression as 
Caco-2 cells are known to express SGLT1 upon reaching confluence, wherein they 
differentiate into cells with features of small intestinal epithelium[338]. Caco-2 cells at 
passages 10-12 at 40% confluence were transfected with ShPERl knockdown vectors A 
and B using the transfection agent Effectene. At 48 hours, the transfected cells were 
trypsinized and re-plated at 40% confluence with 4ug/ml puromycin to allow stable 
selection of transfected cells. A previously performed kill-dose curve using normal 
untransfected Caco-2 cells plated at 40% confluence in media containing antibiotic 
concentrations ranging from lug/ml to lOug/ml showed that 4ug/ml puromycin was 
sufficient to kill all untransfected cells within 5 days of plating, hence this concentration 
of puromycin was used for selection of stably transfected cells. Cells were monitored for 
the onset of confluence and harvested for RNA at 7 days post-confluence. mRNA was 
reverse transcribed and PERI and SGLT1 expression quantified by qPCR. The 
housekeeping gene fi-ACTIN was used to control for RNA loading. PERI mRNA and 
protein expression in transfected cells is shown in Figure 4.2A and B. SGLT1 expression 
in transfected cells is shown in Figure 4.3. Residual expression and significance of 
difference compared to the control shown in Table 4.2.
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Figure 4.3: SGLT1 mRNA expression following PERI knockdown in Caco-2 cells. Caco2 
cells were stably transfected with knockdown vectors for PERI or the scrambled 
sequence negative control, then harvested for RNA and protein expression 7 days after 
reaching confluence. SGLT1 expression was measured using qPCR and normalised to fi- 
ACTIN. Samples were plated in triplicate and the experiment was performed a total of 
three times. The graph shows mean and standard error and significant differences 
(p<0.05) between each knockdown group and the control group were identified using 
one-way ANOVA with post-hoc Tukey.
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Gene/ protein Expression
relative to
control
p-value on
ANOVA
p-value on
post-hoc
Tukey
PERI shPERl SeqA 0.49 0.0273 <0.05
shPERlSeqB 0.51 <0.05
PERI shPERlSeqA 0.64 0.0016 <0.01
shPERlSeqB 0.55 <0.01
SGLT1 shPERlSeqA 2.65 0.0076 <0.05
shPERlSeqB 3.62 <0.01
Table 4.2: PERI mRNA and protein expression and SGLT1 mRNA expression following 
knockdown of PERI in Caco-2 cells. Caco-2 cells were stably transfected with one of two 
knockdown vectors for PERI or the scrambled sequence negative control then 
harvested for protein and mRNA 7 days post-confluence. mRNA expression was 
measured by qPCR and protein by Western blotting; both were normalized to the 
housekeeping gene fl-ACTIN, Expression of PERI, PERI and SGLT1 in knockdown vector- 
transfected cells was expressed relative to control cells and significant differences 
(p<0.05) between each knockdown cell line and the control cell lines were identified 
using one-way ANOVA with post-hoc Tukey.
Stable transfection of Caco-2 cells with the two shRNA knockdown vectors shPERl SeqA 
and SeqB, each bearing distinct shRNA sequences to PERI, reduced PERI expression to 
0.49 and 0.51 the level of controls (cells transfected with scrambled shRNA, F2,6=6.95, 
p=0.027, Figure 4.2A and Table 4.2). PERI protein expression similarly decreased in 
PERI knockdown vector-transfected cells. PERI expression in cells transfected with
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either shPERl SeqA or shPERl SeqB was 0.64 and 0.56 that of controls (F2'6=3.04, 
p=0.0016,, Figure 4.2B; Table 4.2).
Coincident with PERI knockdown, SGLT1 expression in cells transfected with shPERl 
SeqA or shPERl SeqB was 2.6-fold and 3.0-fold that of controls {F2,6=15.06, p=0.0076 on 
ANOVA and p<0.05 and p<0.01 vs controls respectively on post-hoc Tukey, Figure 4.3 
and Table 4.2). These results indicate that PERI acts to suppress SGLT1 expression in 
enterocytes in vitro.
Page 142 of 272
4.4.Downregulation of PERI does not significantly alter expression of other clock 
genes
Clock genes are known to form interconnected molecular feedback loops due to their 
ability to stimulate or repress the expression of other clock gene family members. 
Altering the expression of one clock gene, in this case PERI, would therefore be 
expected to change the expression of other clock genes. To investigate this, ! examined 
the mRNA expression of PER2, BMAL1, CLOCK, REVERBA, REVERBB, CRY1 and CRY2 in 
Caco-2 cells stably transfected with either shPERl SeqA or shPERl SeqB or the 
scrambled sequence negative control. mRNA expression was quantified using qPCR and 
expressed relative to fi-ACTIN and shown in Figure 4.4 and Figure 4.5. The fold-changes 
and p-values are shown in Table 4.3.
There was no significant difference in the expression of PER2 in either of the sequences 
vs the control vector (F2'6=1.68, p=0.29 on ANOVA). PER2 expression increased slightly in 
Caco-2 cells transfected with shPERl SeqB but this was not statistically significant {1.5- 
fold; p>0.05 vs. control, Figure 4.4 and Table 4.3). PER2 expression was unchanged in 
cells transfected with shPERl SeqA (p>0.05 vs. control, Figure 4.4 and Table 4.3).
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Figure 4.4: PER2 mRNA expression following PERI knockdown in Caco-2 cells. Caco-2 
cells were stably transfected with knockdown vectors for PERI or the scrambled 
sequence negative control, then harvested for RNA and protein expression 7 days after 
reaching confluence. PER2 expression was measured using qPCR and normalised to [1- 
ACTIN. Samples were plated in triplicate and the experiment was performed a total of 
three times. The graph shows mean and standard error. One-way ANOVA with post-hoc 
Tukey was used to identify significant differences between each knockdown group and 
the control group.
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Gene
Expression
relative to control
p-value on
ANOVA
p-value on 
post-hoc Tukey
PER2 shPERl SeqA 1.035 0.2949 >0.05
shPERlSeqB 1.481 >0.05
BMAL1 shPERlSeqA 0.865 0.4811 >0.05
shPERlSeqB 1.067 >0.05
CLOCK shPERlSeqA 0.973 0.7474 >0.05
shPERlSeqB 1.200 >0.05
REVERBA shPERlSeqA 0.613 0.0535 >0.05
shPERlSeqB 1.117 >0.05
REVERBB shPERlSeqA 0.923 0.7009 >0.05
shPERlSeqB 1.109 >0.05
CRY1 shPERlSeqA 1.137 0.9443 >0.05
shPERlSeqB 1.108 >0.05
CRY2 shPERlSeqA 1.288 0.5386 >0.05
shPERlSeqB 1.462 >0.05
Table 4.3: Relative expression of clock gene mRNA expression following knockdown of 
PERI in Caco-2 cells. Caco-2 cells were stably transfected with one of two knockdown 
vectors for PERI or the scrambled sequence negative control then harvested for RNA 7 
days post-confluence. mRNA expression of PER2, BMAL1, CLOCK, REVERBA, REVERBB, 
CRY1 and CRY2 was measured by qPCR and normalized to the housekeeping gene /?- 
ACTIN. Expression of PER2, BMAL1, CLOCK, REVERBA, REVERBB, CRY1 and CRY2 in 
knockdown vector-transfected cells was expressed relative to the control cells and 
significant differences (p<0.05) between each knockdown cell line and the control cells 
were identified using one-way ANOVA with post-hoc Tukey.
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Similarly, none of the remaining clock genes showed a significant alteration in
expression following PERI knockdown. CRY2 showed the greatest change in expression, 
with levels increased to 1.3-fold and 1.5-fold in shPERl SeqA and B respectively, 
however this did not meet statistical significance (F2'6=0.725, p=0.54 on ANOVA and 
p>0.05 for each sequence vs control, Figure 4.5F and Table 4.3). REVERBA showed 
inconsistent changes with the two knockdown vectors, showing no change in expression 
with shPERl SeqB but a decrease in expression with shPERl SeqA (0.6-fold vs 1.1-fold 
difference, F2,6=4.96, p=0.054 on ANOVA and p>0.05 for each sequence vs control on 
post-hoc Tukey testing, Figure 4.5C and Table 4.3). Other clock genes were only mildly 
altered following PERI knockdown (0.86-1.20-fold vs. control cells, p>0.05, Figures 4.5A, 
B, D and E, Table 4.3).
Clock genes are known to regulate gene transcription and I therefore hypothesized that 
the actions of PERI on SGLT1 were likely to occur via the SGLT1 promoter, possibly via E- 
boxes, binding sites which are known to mediate the actions of clock proteins on other 
genes[14, 339-341]. To investigate this I next examined the effects of PERI on the SGLT1 
promoter in vitro and the effects of E-boxes on the SGLT1 promoter in regulating SGLT1 
transcription.
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4.5. Analysis of the SGLT1 promoter
The sequence of the human SGLT1 promoter, which has been previously 
characterized[31], was obtained from the University of California Santa Cruz (UCSC) 
Genome Browser, freely available at http://genome.ucsc.edu (accessed 16th April 2008). 
Analysis of the SGLT1 promoter sequence showed the presence of two non-canonical E- 
box consensus sequences (CANNTG) within this minimal promoter at -306 and -352 
relative to the transcription start site. A further two non-canonical E-box consensus 
sequences were identified more distally at -827 and -837 relative to the transcription 
start site. E-box sequences within the SGLT1 promoter are shown in Figure 4.6.
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-905
-845
-785
-725
-665
-605
-545
-485
-425
-365
-305
-245
-185
-125
-65
-5
CTTGGGCAAG
CATGTG
CT7GGAAAGG 
CTGGGAGAGG 
TTCTTCCTCT 
GTCAGGAATG 
TTTTTTTCCA 
AAGACTTGAC 
CCTTAGAAGG 
CCTAGCCCCA 
TGGTGGCGCT 
ACCCCCTGGC 
AGCCAACAGC 
GTGCAGCCGC 
GTCCCCTCCC
cgagaBH
TCATGCCTCC
CAGATG
GTTCTCTAGT
GACAGGGCAA
TTACAGTGGG
TGGGTGGGTG
GTGACACCCA
7GATTCTTCA
CATGGGACTA
GGTS5CCTGT
GCTGGTGCCT
TGGCCCCTCC
TCAGCCGGGT
AAGGCATCGC
CTGGTfcCTGEA
TCTCTTGGTC
GTGAGCTGAG
ATCTTCCCTT
GGAAATAGCT
GGTAACAGTG
GGTGGCTGTC
GCAACTCTCT
GAAGAGTGCT
GTCCAAGGAT
TCCCTCAATG
GCTGTGGGAG
CCATTCGCAG
GCTCCTTCCT
AGGGGCCCCG
GGACGCAACG
TCATTAAC 
CTGCCAC(
ATCTCTGTTC 
TCCCCAGGAA 
CTGCTGCCTC 
CCCGGTGAGA 
GACCTGGGGG 
CTTGTGGCCA 
GTCCTCTCAA 
GCACCCATTT 
GGGTGGCAGG 
GAGCCACTCC 
TACAGTGGGC 
GACAGCTCTT 
GGGCTCCACG 
CGCTACTGCC 
GGAGGCCCTA
TGAGCCCTGG
GGTCAGGGTT
TGGAGGGCCC
TCCCTTCCCC
CTGCAGGCTG
AGAGATTAGG
GAA7GTTCTC
TACAAGCGGA
TGATCTGAAG
AGCTCTGGCA
CTTTGTGCCA
ACCTGCCGGG
CCCGGAGCTG
CTGCTCCCTC
TAAC-GAGCTA
EB4 EBB 
J l
EB2 EB1 HNF1 TATA
^I
CTTGCTGTTT
TGATGAACTC
7GCATCAATA
CAGTCTCAGT
TGGAGGGGGA
ATTGTGCTGG
CAGGGAGAAC
CAAGCCAAGT
CCTCTAGGCT
AGGGpLGGTG
GGCGGGCACC
CCGCCGCCCC
CTTCCTGACG
AAAGTCCCAG
GCGGCCCTGG
-837 -827
^ I
-B52 -306
r
-38 -23 -+1
Figure 4.6: The SGLT1 promoter sequence. The four E-box non-canonical consensus 
sequences (CANNTG) at -306, -352, -827 and -837 are shown in highlighted in green. 
Also shown are the non-canonical HNF sequence (GCTGATCATTAAC) at -50 to -38 in pink 
and the TATAA site at -28 to -23 in blue. The dark grey highlighting and black arrow 
indicate the SGLT1 transcription start site, with the translation start site (ATG) 
underlined.
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4.6. Creation and validation of the SGLT1 promoter construct
The proximal Ikb of the human SGLT1 promoter (-1000/+33, designated WT SGLT1- 
Luc)[31] was cloned by PCR from human genomic DNA using PCR conditions as 
described in section 2.8.3. Primers used encoded Mlul and Bglll restriction sites at the 5' 
and 3' ends respectively (listed in Table 2.11). The amplified PCR product was digested 
using restriction enzymes Mlul and Bglll and ligated into the similarly digested pGL3 
basic empty vector, containing the firefly ludferase expression cassette driven by the 
inserted promoter and chosen for the lack of any native eukaryotic promoter or 
enhancer sequences. After ligation the plasmids were amplified in E.coli and grown on 
agar at 37°C overnight. Colonies were cultured in LB and plasmids extracted and sent for 
sequencing. To confirm a functional clone of the human SGLT1 promoter, reporter 
assays were carried out using expression vectors for a known activator of the SGLT1 
promoter, HNFla (kindly donated by Dr David B Rhoads), which binds to the HNF1 
consensus sequence GCTGATCATTAAC at -50 to -37 on the SGLT1 promoter (Figure 4.6).
Chinese Hamster Ovary (CHO) cells were chosen as the cell type to be used for all 
promoter-re porter assays to assess the effect of clock genes on SGLT1 promoter activity 
as this cell type is easy to maintain and easily transfected. While the use of enterocytes 
such as Caco-2 cells might have provided a more relevant genetic background for 
investigation of the role of clock genes on SGLT1, the low efficiency of transient 
transfection in these cells would have made interpretation of the resulting data difficult.
Furthermore the non-intestinal phenotype allows CHO cells to act as a blank canvas
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facilitating manipulation of clock gene expression levels without the confounding effects
of other intestinal transcription factors.
Cells at passages 10-12 were transiently transfected at 70% confluence using the 
transfection reagent Effectene with combinations of the wild-type SGLT1 promoter 
reporter construct pGL3/WT-SGiniuc) and the expression vector (pcDNAS.l with or 
without HNFla cDNA}. Renilla luciferase was co-transfected into all wells in all 
experiments to normalize for transfection efficiency. Measurement of Firefly and Renilla 
luciferase-induced luminescence was carried out after 48 hours. Each sequence of 
transient transfection to measurement of luminescence was performed three times and 
each combination transfected in triplicate. The relative luciferase expression induced by 
transfection with HNFla is shown in Figure 4.7.
Transfection with HNFla induced 3.7-foid higher luciferase expression than that 
induced by transfection with the empty vector pcDNA {p=0.009, Figure 4.7). This 
increase in expression is similar to the effect of HNFla noted in previous studies[31]. 
These findings, corroborated by sequencing which confirmed insertion of the correct 
sequence without mutations, indicated a functioning 5GLT1 promoter suitable for 
further investigation of the effects of PERI on SGLT1.
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HNFla
pcDNA-
* p<0.05 vs 
pcDNA/WT-SGLTILuc
0 1 2 3 4 5
Relative luciferase expression
Figure 4.7: Activation of the SGLT1 promoter by HNFla in CHO cells. CHO cells were 
transiently transfected with the wild-type SGLT1 promoter (designated WT-SGLTIluc) 
and either the overexpression vector for HNFla or the empty pcDNA vector. Renilla 
luciferase was co-transfected into each well to normalize for transfection efficiency. 
Each combination was plated in triplicate and the experiment performed three times. 
Luciferase expression induced by HNFla was expressed relative to that of the pcDNA 
control. Graphs show the mean and standard error. Student's t-test was used to identify 
any significant difference between the two groups.
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4.7. Creation and validation of the PERI overexpression construct
To assess the effect of PERI on the SGLT1 promoter, a PERI overexpression construct 
was created by cloning the human PERI sequence into the pcDNA 3.1 (+) vector, which 
constitutively overexpresses the insert under the control of the cytomegalovirus (CMV) 
promoter. Human PERI cDNA was amplified from Caco-2 cDNA, reverse transcribed 
from extracted Caco-2 mRNA. PCR amplification of PERI was carried out using the 
Platinum Taq High-Fidelity DNA polymerase using primer-encoded Nhel and Notl 
restriction sites (cloning primers listed in Table 2.6). This DNA polymerase was used for 
its ability to amplify large fragments of DNA such as the 4kb PERI cDNA fragment with 
high-fidelity. Thermal cycling conditions and other details can be found in Section 2.8.1.
The PCR product and the pcDNA 3.1 vector were individually digested using restriction 
enzymes Notl and Nhel at 37°C overnight, then ligated using T4 DNA ligase at 16°C 
overnight. After ligation, the plasmids were amplified by transforming E.coli, colonies 
grown on agar plates then amplified in LB before plasmids were extracted and sent for 
sequencing.
To confirm overexpression of PERI, CHO cells were transiently transfected with either 
the PERI overexpression construct or the pcDNA empty vector. Transfections were 
carried out in CHO cells between passages 8 and 9 at 80% confluence using the 
transfection agent Effectene. Cells were harvested at 48 hours for analysis of RNA and 
protein expression. mRNA expression was measured via qPCR and protein expression via
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Western blotting. PERI mRNA and protein levels were expressed relative to p-ACTIN) 
results are shown in Figure 4.8A and B and Table 4.4.
Cells transfected with the overexpression vector for PERI had significantly higher levels 
of PERI mRNA compared to controls (222-fold the levels of controls, p=0.0033, Figure 
4.8A and Table 4.4). PERI protein levels were similarly elevated, at 185-fold the level of 
controls, p=0.0408, Figure 4.8B and Table 4.4), confirming successful overexpression of 
PERI using this construct.
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Fold-change vs control p-value
PERI 222.5 0.0033
PERI 185.2 0.0408
Table 4.4: Overexpression of PERI in CHO cells. CHO cells transfected with either 
overexpression vectors for PERI or the empty pcDNA vector as a control were 
harvested after 48 hours and mRNA expression quantified by qPCR and protein 
expression quantified by Western blotting. PERI levels were expressed relative to 3- 
ACTIN. The experiment was performed three times. PERI levels in PER1- 
overexpressing cells have been expressed relative to levels in the empty vector- 
transfected control cell line. Student's t-test was used to identify significant 
differences (p<0.05) in PERI expression between overexpression vector-transfected 
cells and controls.
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4.8. PERI represses SGLT1 promoter activity in vitro
Reporter assays were performed in CHO cells to determine the effect of PERI on the 
human SGLT1 promoter (-1000/+33; Figure 4,6). CHO cells were transfected as 
described in section 2.7.1 above. The effect of PERI overexpression on the SGLT1 
promoter was assessed in CHO cells passages 10-12 transfected at 80% confluence with 
combinations of the wild-type SGLT1 promoter reporter construct pGL3/WT-SG/.niuc 
and expression vector (pcDNAS.l with or without PERI cDNA). Conversely, the effect of 
PERI knockdown on SGLT1 promoter activity was assessed by co-transfection of shRNA 
vectors shPERl SeqA and B or the scrambled negative control with the wild-type SGLT1 
promoter pGL3/WT-SG/.niuc. Renilla luciferase was co-transfected into all wells in all 
experiments to normalize for transfection efficiency. Luminescence (firefly and Renilla) 
was measured after 48 hours. The results are displayed graphically in Figures 4.9A and B 
and Table 4.5.
PERI overexpression did not alter SGLT1 promoter activity from baseline (0.89-fold vs 
pcDNA control, p=0.24, Figure 4.9A, Table 4.5). In contrast the reduction in PERI levels 
concomitant with transfection of PERI knockdown vectors resulted in increased SGLT1 
promoter activity (1.46 and 1.47-fold that of controls with transfection of shPERSeqA 
and B respectively, F2'6=6.26, p=0.0098, Figure 4.9B and Table 4.5), suggesting that PERI 
suppresses the SGLT1 promoter.
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pcDNA+ WTSGLTl-Luc
PERI + WT SGLTl-Luc
Relative luciferase expression
B
* p<0.05 vs shNeg + WT SGLTl-\uc
shNeg + WT SGLTl-Luc
shPerl Seq B + WT SGLTl-Luc
shPerl Seq A + WT SGLTl-Luc
Relative luciferase expression
Figure 4.9: Effect of PERI overexpression and knockdown on SGLT1 promoter activity. 
(A) CHO cells were transfected at 80% confluence with combinations of the wild-type 
SGLT1 promoter reporter construct pGL3/WT-SG/.niuc and expression vector 
(pcDNAB.l with or without PERI cDNA). (B) The effect of PERI knockdown on SGLT1 
promoter activity was assessed by co-transfection of shRNA vectors shPERl SeqA and B 
or the scrambled negative control with the wild-type SGLT1 promoter reporter construct 
pGL3/WT-SGZ.niuc. Renilla luciferase was co-transfected into all wells in all experiments 
to normalize for transfection efficiency. Luminescence (firefly and Renilla) was 
measured after 48 hours. Graphs show mean and standard error and luminescence 
levels are expressed relative to the corresponding control. Student's t-test was used to 
compare expression between overexpression of PERI versus control and one-way 
ANOVA to compare effects of knockdown of PERI versus control
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Vector combination Fold change in promoter
p-value
Expression vector Reporter vector activity vs. control
PERI WT-SG/Tlluc 0.89 0.24
shPERlSeqA \NT-SGLTl\uc 1.46 <0.05
shPERlSeqB WT-SGLHIuc 1.47 <0.05
Table 4.5: Effect of PERI overexpression and knockdown on SGLT1 promoter activity. 
CHO cells were transfected at 80% confluence with combinations of the wild-type SGLT1 
promoter pGL3/WT-5(j/.T2luc reporter vector and either expression vectors {pcDNA3.1 
with or without PERI cDNA) or shRNA vectors shPERl SeqA and B or the scrambled 
negative control. Renilla luciferase was co-transfected into all wells in all experiments to 
normalize for transfection efficiency. Luminescence (firefly and Renilla) was measured 
after 48 hours. Student's t-test was used to compare expression between 
overexpression of PERI versus control and one-way ANOVA to compare effects of 
knockdown of PERI versus control
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4.9. E-boxes are negative elements in the SGLT1 promoter
E-boxes are known to act as binding sites for clock genes and other transcription factors 
and thereby affect gene promoter activity and transcription. The most proximal Ikb of 
the SGLT1 promoter contains 4 non-canonical E-boxes (CANNTG), potential binding sites 
for PERI, situated at -306/-311, -352/-3S7, -S27/-832 and -837/-842 relative to the 
SGLT1 transcription start site. To explore the role of E-boxes in mediating SGLT1 
promoter activity, mutations were introduced into each of the four present in the SGZ.n 
promoter, designated EB1-EB4 starting from the most proximal. These E-box sites were 
mutated by conversion to Nhel restriction sites (GCTAGC) and designated SGLTl-luc 
mutEBl, mutEB2, mutEB3 and mutEB4. Site-directed mutagenesis was performed on 
the pGLS-SGLTl vector created above using the Phusion Site-directed Mutagenesis kit. 
Forward primers for the site-directed mutagenesis were designed to incorporate the 
Nhel restriction site in place of the E-box sequence and including 15-20bp of the 
proximal and distal flanking sequences; while reverse primers did not incorporate any 
mutations.
To assess whether E-boxes might act cooperatively to mediate the activity of the SGLT1 
promoter, 2 or more E-box sites were mutated in combination. For this, a further set of 
primers was designed to incorporate combinations of E-box mutations (designated 
mutEBl+2, 1+3 and 1+2+3), which were created by adding a further mutation onto a 
mutated promoter. All constructs (single and combinatorial mutants) were sequenced 
to confirm successful mutation. Mutagenesis primers are listed in Table 2.11 and
sequencing primers listed in Table 2.12.
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I aimed to first investigate the effects of E-boxes on SGLT1 promoter activity without
exogenous transcription factors or clock genes. For this, CHO cells were transfected at 
80% confluence as previously described with the empty pcDNA vector and reporter 
vectors bearing either the intact wild-type SGLT1 promoter or single or multiple E-box 
site mutations. No overexpression vectors were used in this experiment. Renilla 
luciferase was co-transfected into all wells to normalize for transfection efficiency. Cells 
were harvested after 48 hours and both firefly and Renilla luminescence measured. 
Results are displayed graphically in Figure 4.10. Fold-changes are shown in Tables 4.6 
and 4.7.
The effect of mutating two or more E-box sites was compared to the effect of individual 
mutations by a previously published method termed "interaction response"[32]. This 
was determined by the mean logarithm of the ratio of the effect observed with two or 
more mutations to the sum of effects observed with two or more single mutations (e.g., 
log {(EB1+2+3)/ [{EB1) + (EB2) + (EB3)]}). Interaction values from -0.1 to +0.1 were 
defined as additive, with values > +0.1 considered synergistic and values < -0.1 
considered antagonistic.
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Relative luciferase expression
Figure 4.10: Effect of E-box mutations on SGLT1 promoter activity in CHO cells. E-boxes 
at -306/-311, -352/-3S7, -827/-832 and -837/-S42 on the SGLT1 promoter were mutated 
either singly or in combination using site-directed mutagenesis to the Nhel site. CHO 
cells were transfected with either the wild-type SGLT1 promoter or the four E-box 
mutants (single or combinatorial). Renilla luciferase was used to normalize for 
transfection efficiency. Firefly and Renilla luciferase activity were measured after 48 
hours. All experiments were performed three times. Graphs show means and standard 
error. One-way ANOVA with post-hoc Tukey was used to identify significant differences 
between luciferase expression of mutants and the wild-type promoter.
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Expression
vector
Single E-box mutant Fold change vs wild-type
pcDNA SGLTl-luc mutEBl 2.23
pcDNA SGLTl-luc mutEB2 1.85
pcDNA SGLTl-luc mutEB3 1.68
pcDNA SGLTl-luc mutEB4 1.14
Table 4.6: Effect of single E-box mutations on 5GLT1 promoter activity in CHO cells. E- 
boxes at -306/-311, -352/-3S7, -827/-S32 and -837/-S42 on the SGLT1 promoter were 
mutated using site-directed mutagenesis to the Nhel site. CHO cells were transfected 
with either the wild-type SGLT1 promoter or any one of the four E-box mutants. Renilla 
luciferase was used to normalize for transfection efficiency. Firefly and Renilla luciferase 
activity were measured after 48 hours. All experiments were performed three times. 
One-way ANOVA with post-hoc Tukey was used to identify significant differences 
between luciferase expression of mutants and the wild-type promoter.
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Transient transfection of CHO cells with the E-box mutants revealed that promoter
activity increased 2.2- and 1.9- fold with mutations in the E-boxes EB1-2, respectively 
(F7,22=8.433, pcO.OOOl on ANOVA and p<0.01, <0.05 and >0.05 vs. wild-type SGLT1 
promoter respectively on post-hoc Tukey, Figure 4.10, Table 4.6). Mutation of the most 
distal two E-boxes EB3 and EB4 had smaller effects which did not meet statistical 
significance {1.7 and 1.1-fold increase in promoter activity vs. wild-type SGLT1 
promoter, p>0.05, Figure 4.10, Table 4.6). These data indicate that the two proximal E- 
boxes have a repressive function on the SGLT1 promoter. Mutant EB4 had a negligible 
effect on SGLT1 promoter activity and hence was not included in the combinatorial 
mutants. Mutant EB1 had the strongest effect on the SGLT1 promoter hence mutant 
EB1 was included in all combinatorial mutants.
Mutating E-boxes in combination had a slightly greater effect on SGLT1 promoter 
activity than individual mutants. Mutant combination EB1+2+3, involving mutations of 
all three of the most proximal E-boxes, had the strongest effect on SGLT1 promoter 
activity however this was not statistically significant (2.4-fold the activity of the wild- 
type SGLT1 promoter, p<0.001, Figure 4.10, Table 4.7). Mutant combination EB1+3 had 
a smaller but significant effect on SGLT1 promoter activity (2.3-fold the activity of the 
wild-type SGLT1 promoter, p<0.01, Figure 4.10, Table 4.7). Mutant combination EB1+2 
had the smallest effect on SGLT1 promoter activity, inducing a 2.2-fold increase in 
luciferase activity compared to the wild-type SGLT1 promoter, this was also statistically 
significant (p<0.01, Figure 4.10, Table 4.7).
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Although each mutant combination ied to a greater than 2-fold increase in activity over 
wiid-type, the interaction between the individual E-boxes as determined by the 
interaction response was antagonistic in all cases (interaction response <-0.1). This 
shows that the effect of mutating these E-boxes in combination is less than the sum of 
effects of each individual mutant. These findings suggest that the E-boxes on the SGLT1 
promoter do not act cooperatively and that each E-box suppresses promoter activity 
independently.
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4.10. Repression of SGLT1 promoter activity by PERI occurs despite mutation of E- 
boxes
PERI activates target gene transcription by its interaction with other transcription 
factors that bind to E-boxes. To determine whether PERI repression of the SGLT1 
promoter was mediated via E-boxes, the effect of PERI overexpression on the mutant 
promoters was measured. CHO cells were transfected with the PERI overexpression 
vector and either the wild-type SGLT1 promoter or the four E-box mutants (single or 
combinatorial). Renilla luciferase was used to normalize for transfection efficiency. 
Firefly and Renilla luciferase activity were measured after 48 hours. The results are 
displayed graphically in Figure 4.11 and fold-changes and p-values shown in Tables 4.8 
and 4.9.
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Figure 4.11: Effect of PERI on the SGLT1 promoter bearing E-box mutations in CHO cells. 
E-boxes at -306/-311, -352/-3S7, -827/-832 and -837/-842 on the SGLT1 promoter were 
mutated either singly or in combination using site-directed mutagenesis to the Nhel site. 
CHO cells were transfected with the PERI overexpression vector and either the wild- 
type SGLT1 promoter or the four E-box mutants (single or combinatorial). Renilla 
luciferase was used to normalize for transfection efficiency. Firefly and Renilla luciferase 
activity were measured after 48 hours. All experiments were performed three times. 
Graphs show mean and standard error. One-way ANOVA with post-hoc Tukey was used 
to identify significant differences between luciferase expression of mutants and the 
wild-type promoter.
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T
T
Expression vector Single E-box mutant Fold change vs 
wild-type 
promoter
PERI SGLTl-luc mutEBl 1.14
PERI SGLTl-Luc mutEB2 1.15
PERI SGLTl-luc mutEB3 0.87
PERI SGLTl-luc mutEB4 1.21
Table 4.8: Effect of PERI on single E-box mutations in the SGLT1 promoter in CHO cells. 
E-boxes at -306/-311, -352/-357; -S27/-832 and -S37/-842 on the SGLT1 promoter were 
mutated using site-directed mutagenesis to the Nhel site. CHO cells were transfected 
with the PERI overexpression vector and either the wild-type SGLT1 promoter or any 
one of the four E-box mutants. Renilla luciferase was used to normalize for transfection 
efficiency. Firefly and Renilla luciferase activity were measured after 48 hours. All 
experiments were performed three times. One-way ANOVA with post-hoc Tukey was 
used to identify significant differences between luciferase expression of mutants and 
the wild-type promoter.
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Mutation of E-boxes increased SGLT1 promoter activity in the absence of exogenous 
transcription factors as shown above (Figure 4.10 and Tables 4.6 and 4.7). PERI was 
shown earlier in this chapter to suppress SGLT1 promoter activity. If E-boxes mediated 
this suppression, transfection of PERI overexpression vectors would not be expected to 
alter the increase in SGLT1 promoter activity induced by mutation of the E-boxes. In 
contrast, PERI overexpression reduced activities of mutated promoters mutEBl, 
mutEB2, mutEBB and mutEB4 such that there was no significant difference to luciferase 
activity of the unmutated wildtype SGLT1 promoter on one-way ANOVA (F7,24=4.720, 
p=0.0019) with post-hoc Tukey analysis (1.1-fold, 1.1-fold, 0.9-fold and 1.2-fold 
luciferase activity of the wildtype promoter, p>0.05, Figure 4.11, Table 4.8).
The three combination mutants (mutEBl+2, EB1+3 and EB1+2+3) were similarly 
inhibited by PERI overexpression. Combinatorial mutation of the 3 proximal E-boxes in 
the SGLT1 promoter resulted in increased levels of luciferase activity compared to the 
wildtype SGLT1 promoter. The interaction of all three E-box mutations in the presence 
of PERI was antagonistic (Table 4.9). This shows that the effect of PERI on the SGLT1 
promoter containing E- boxes mutated in combination is less than the sum of effects of 
PERI on each individual mutant.
To analyse the relationship between PERI activity on the SGLT1 promoter and E-box 
status a two-way ANOVA with post-hoc Bonferroni was performed (Figure 4.12). The 
analysis showed a significant interaction between PERI activity and E-box mutation
(F7,46=5.78, pO.OOOl). In addition, PERI continued to suppress SGLT1 promoter activity
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despite single mutations of EB1-3 or combinatorial mutation of EB1+2, 1+3 or 1+2+3
(pcO.OOl vs pcDNA, Figure 4.12), indicating that the effects of PERI on the SGLT1 
promoter are independent of the status of E-boxes 1-3. PERI had no effect on the SGLT1 
promoter compared to pcDNA upon mutation of EB4 ^>0.05, Figure 4.12), however this 
mutation did not appear to significantly alter SGLT1 promoter activity on one-way 
ANOVA in the absence of PERI (p>0.05. Figure 4.10), suggesting that the EB4 binding 
site does not contribute to SGLT1 promoter activity.
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Relative luciferase expression
Figure 4.12: Effect of PERI vs pcDNA on the SGLT1 promoter bearing E-box mutations in 
CHO cells. The data shown in Figures 4.10 and 4.11 have been juxtaposed to allow 
comparison of the effects of PERI on the wild-type and mutated SGLT1 promoter. E- 
boxes at -306/-311, -352/-3S7, -827/-S32 and -837/-S42 on the SGLT1 promoter were 
mutated either singly or in combination using site-directed mutagenesis to the Nhel site. 
CHO cells were transfected with the PERI overexpression vector and either the wild- 
type SGLT1 promoter or the four E-box mutants (single or combinatorial). Renilla 
luciferase was used to normalize for transfection efficiency. Firefly and Renilla luciferase 
activity were measured after 48 hours. All experiments were performed three times. 
Graphs show mean and standard error. Two-way ANOVA with post-hoc Bonferroni was 
used to identify any interaction between the effects of PERI and mutation of E-boxes on 
the SGLT1 promoter.
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4.11. Discussion
My data show for the first time an effect of clock genes on SGLT1 in vitro. Knockdown of 
PERI increased native SGLT1 expression in Caco-2 enterocytes (Figure 4.3, Table 4.2), 
while promoter studies confirmed that the inhibitory activity of PERI on SGLT1 occurs 
via the proximal Ikb of the SGLT1 promoter (Figure 4.9, Table 4.5). E-box sites exerted a 
suppressive effect on the SGLT1 promoter (Figure 4.10, Table 4,6), however mutation of 
E-boxes had little effect on the inhibitory activity of PERI on the SGLT1 promoter (Figure 
4.11, Table 4.8) suggesting that the actions of PERI on SGLT1 are independent of E- 
boxes EB1-3. Overall the above findings suggest that PERI exerts an indirect suppressive 
effect on SGLT1, possibly acting via other clock-controlled genes binding to non-E-box 
sites on the SGLT1 promoter.
PERI inhibition of SGLT1 expression was demonstrated by showing that knockdown of 
PERI in Caco-2 cells by two independent shRNAs increased SGLT1 expression (Figure 
4.3, Table 4.2). The lack of major changes in other clock genes following PERI 
knockdown (Figure 4.4, Table 4.2) suggests that the effect is mediated by PERI itself or 
indirectly via a non-clock PERI target. The absence of a significant effect of PERI 
knockdown on other clock genes noted in this study is in contrast to previous studies 
showing decreased expression of Bmall, Clock, Per2 and Cryl in the peripheral tissues 
of PERI-/- mice, indicating that PERI regulates other clock genes at a transcriptional 
level in peripheral tissues[342j. In the SCN of PERI-/- mice however the effect of PERI 
knockdown on other clock genes is only seen at a translational and not at a
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transcriptional level[159; 343], suggesting that PERI may play different roles in clock
gene molecular feedback loops in the peripheral clock versus the SCN.
Several other alternatives may exist to explain the lack of effect of PERI knockdown on 
the expression of other clock genes in Caco-2 cells (Figure 4.4, Table 4.2). One possibility 
is that the lack of synchronization in cultured Caco-2 cells may have dampened 
interactions of PERI with other clock genes. Synchronized cells in culture (for example 
with a serum shock) are known to exhibit circadian oscillations in clock gene 
expression[84]. Synchronization of Caco-2 cells was not possible as the protocol for 
synchronization requires non-confluent rapidly growing cells; in contrast the expression 
of SGLT1 by Caco-2 cells only occurs in the confluent state upon which Caco-2 cells 
differentiate into a small bowel enterocytic phenotype[338]. Confluence is associated 
with reduced growth and proliferation rate and the attendant reduction in cell turnover 
and metabolism suggests that confluent cells may thus be less responsive to expression 
changes of clock components. Alternatively, the extent of PERI knockdown in this study 
may have been insufficient to modulate expression other clock genes. Regardless, these 
findings demonstrate that reducing PERI expression alone is sufficient to increase SGLT1 
expression in enterocytes without requiring cooperation of other clock genes (Figure 
4.3, Table 4.2).
The increase in SGLT1 promoter activity following PERI knockdown in CHO cells (Figure 
4.9B, Table 4.5) suggests that the suppressive effects of PERI on SGLT1 transcription as 
demonstrated in Caco-2 cells (Figure 4.3, Table 4.2) are mediated at least in part by
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effects on the SGLT1 promoter. Surprisingly, overexpression of PERI did not induce a 
significant decrease of SGLT1 promoter activity in CHO cells as would be expected 
(Figure 4.9A, Table 4.5). CHO cells are not an enterocytic cell line and the inability of 
PERI overexpression to decrease SGLT1 transcription may be due to the already low 
basal SGLT1 promoter activity in these cells[31]. Promoter studies using the SGLT1 
promoter construct in an enterocytic cell line such as Caco-2 may have added some 
insights into the contribution of other innate intestinal transcription factors in 
cooperative regulation of the SGLT1 promoter with PERI, however the low transfection 
efficiency of Caco-2 cells made transient transfections for promoter studies impractical. 
One alternative that may be suitable for future studies is the use of Caco-2 cells stably 
transfected with each of the promoter and expression vector combinations. The 
promoter studies in CHO cells carried out in this chapter nevertheless provide valuable 
data showing that clock genes, specifically PERI, are able to exert an effect on the SGLT1 
promoter even in the absence of other known SGLT1 transcriptional modulators.
PERI traditionally regulates genes by its indirect actions on canonical and non-canonical 
E-boxes in cooperation with other proteins [344]. I therefore next examined the SGLT1 
promoter for E-boxes. 4 non-canonical E-box consensus sequences (CANNTG) are 
present in the Ikb region proximal to the transcription start site (Figure 4.6). Promoter 
studies showed that the proximal E-boxes in this region appear to modulate SGLT1 
transcription (Figure 4.10, Table 4.6). The presence of E-box rich regions in circadian 
genes has been previously demonstrated[162, 345, 346]. Some clock gene family 
members, especially PER and CRY genes, contain E-boxes in their promoter regions[162,
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345, 346] allowing the binding and transcriptional activation by CLOCK and BMAL1 
which ultimately forms the positive limb of the molecular feedback loop[162]. The 
number and type of E-boxes (canonical vs non-canonical) and the presence of other 
binding sites such as RORE sites on the gene promoter are factors which have been 
postulated to determine the time of peak expression of rhythmic clock genes[346]. For 
instance the different peaks in expression of Perl and Per2 in the SCN[347, 348] and in 
peripheral tissues [181] have been suggested to be due to the presence of multiple 
canonical E-box sequences in the promoter region of PER1[162] compared to a single 
non-canonical E-box sequence in the promoter region of Pf/?2[345],
Other circadian genes outside the clock gene family also contain E-box regions in the 
promoter. A recent large-scale promoter analysis from microarray data revealed 
overrepresentation of E-box sequences in 167 circadian clock-controlled genes 
compared to randomly selected genes[349]. One example is the circadian gene 
peroxisome-proliferator-activated-receptor alpha (PPAR-a), which has been shown to 
contain 2 canonical E-box sequences and 4 non-canonical E-box sequences; clock genes 
have been shown to regulate this gene by via binding of the CLOCK-BMAL1 complex to 
this region [350].
The S6LT1 promoter was found to have 4 non-canonica! E-box sites (Figure 4.6). 
Although E-boxes are generally positive elements, mutation of 3 of the 4 E-boxes within 
the proximal 0.9kb of the SGLT1 promoter, whether singly or in combination, increased 
SGLT1 promoter activity (Figure 4.10, Tables 4.6 and 4.7), showing that E-boxes have a
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suppressive effect on SGLT1. E-box mediated gene suppression, as we observed for the 
SGLT1 gene, is not without precedent. E-boxes have been shown to mediate hormonal 
suppression of the luteinizing hormone {LH) promoter in vitro[351] and contribute to 
the regulation of the fatty acid synthase [FAS) promoter in vtvo[352]. Of greater interest, 
the circadian Na+/H+ exchanger NHE3 in the kidney, a transporter like SGLT1, has also 
been shown to bear an E-box on its promoter[14]. Binding of the CLOCK-BMAL1 
complex to this E-box has been shown to activate transcriptional activity of NHE3, while 
transfection of PER2 or CRY1 was able to suppress or abolish this transactivation 
respectively[14]. My data showed a greater effect of the proximal E-boxes on the SGLT1 
promoter than the distal E-boxes (Figure 4.10, Table 4.6). Similar to these findings, other 
studies have also shown that E-boxes more distal to the transcription start site were of 
less functional relevance for gene transcription[339].
Individual E-box sequences were able to suppress the SGLT1 promoter (Figure 4.10, 
Table 4.6); however SGLT1 promoter activity upon mutating 2 or more E-boxes in 
combination was less than would have been expected from the sum of each of the 
individual effects (Figure 4.10, Table 4.7), suggesting that these E-boxes did not exhibit 
cooperative effects on regulation of SGLT1 transcription. Cooperative activity of E-boxes 
has, however, been demonstrated for other genes. The two most proximal adjacent E- 
boxes on the rat acetylcholine receptor (3 (AChR6) promoter have been shown to be 
necessary for transcriptional regulation of this gene[339]. Both of these E-boxes were 
shown to be necessary for stimulation of transcriptional activity of the ACMd promoter; 
mutation of individual E-boxes did not exert any significant effect on promoter
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activity[339]. Combinatorial effects of E-boxes were also noted by Lenka et al on the rat 
COX VIII gene[353] and by Oishi et al on the PPAR-a promoter[350]. The lack of 
cooperativity of E-boxes in my study may have been due to the distance of 40bp 
between the 2 most proximal E-boxes on the SGLT1 promoter (Figure 4.6); in contrast in 
previous studies cooperative E-boxes have often been immediately adjacent to each 
other[339]. The degree of cooperativity of E-boxes on a promoter may be a reflection of 
a conformational change upon binding of the transcription factor to one of the E-box 
sites thereby facilitating binding to the other E-box site.
The observation that PERI continued to suppress the SGLT1 promoter in transient 
assays despite its mutations of its 4 E-boxes (Figure 4.11, Table 4.8) indicates that PERI 
suppression of SGLT1 is independent of E-boxes. These findings demonstrate that PERI 
and E-boxes are both able to suppress SGLT1 promoter activity but via independent 
mechanisms. The lack of effect of E-box mutation on PERI activity in my studies (Figure 
4.11, Table 4.8) suggests that PERI may regulate SGLT1 via non-E-box binding 
transcription factors such as clock-controlled genes. The clock controlled gene DBP has 
been shown to regulate other intestinal transporters by binding not to E-boxes but to its 
own canonical consensus sequence of GTTACGAAAC[16]. Other clock-controlled genes 
such as DEC1 and DEC2 are known to bind to and suppress E-boxes in the promoters of 
other genes(344] and may similarly be binding to E-boxes to regulate SGLT1 
transcription. DEC1 is known to be expressed in the intestine[354]; however the 
expression of DEC2 and the temporal expression profile of DEC1 and DEC2 in the 
intestine remain unknown.
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A further possibility for the indirect regulation of SGLT1 by PERI is the involvement of 
non-clock genes such as intestinal transcription factors hepatocyte nuclear factor 
(HNF1) a, HNFip, GAIA binding protein (GATA) factors or caudal-type homeobox 
protein 2 (CDX2). Rhoads et al demonstrated differential binding of the HNFlpJto the rat 
Sgltl promoter, with increased levels of binding occurring during the daylight hours 
than the hours of darkness in the evening. In contrast HNFlcx showed no circadian 
pattern of binding to the Sgltl promoter[63]. HNFla and p, GATA factors and CDX2 
all have binding sites on the SGLT1 promoter and have previously been shown to 
regulate activity of the human SGLT1 promoter [355]. PERI may act on the SGLT1 
promoter in cooperation with one of more of these transcription factors, acting via 
binding sites for these factors on the SGLT1 promoter. Further studies using EMSAs are 
currently ongoing in our laboratory to not only confirm binding of PERI to the SGLT1 
promoter, but also to identify the other transcription factors which may be acting in 
cooperation with PERI to regulate SG/Tl transcription.
Other factors besides clock genes such as microphthalmia-associated transcription 
factor (MITF)[356], TWIST[357], upstream stimulatory factor (USF)[357] and the proto­
oncogene c-myc[358] have also been shown to regulate the promoters of other genes 
via E-boxes. The expression profiles of these genes in the intestine have yet to be 
investigated.
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This study revealed a suppressive role for PERI on SGLT1 transcription (Figure 4.3, Table 
4.2). PERI has similarly been shown to suppress other genes. WEE1, a key cell cycle 
regulator is downregulated by PERI overexpression in the colon cancer HCT 116 cell 
line, suggesting direct circadian control of this gene by core clock components[359]. 
PERI has also been shown to inhibit the transcriptional activity of the androgen 
receptor {AR) gene in the prostate via effects on the AR promoter[360]. Furthermore, in 
pancreatic and hepatocellular cancer cell lines, PERI knockdown was shown to increase 
expression of the apoptosis-related proteins poly-ADP-ribose-polymerase (PARP), 
caspase 7 and BAX, as well as inducing apoptosis in these cells, in keeping with its 
known role as a tumour suppressor gene[361]. However the effects of PERI are not 
always suppressive and appear likely to be gene-specific: in the same pancreatic and 
hepatocellular cancer cell lines in the previous study PERI was shown to increase 
expression of the pro-survival protein BCL2[361],
Knockout mice have proved useful in deciphering the role of PERI in circadian 
rhythmicity. Zheng et al[343] showed reduced stability and precision of circadian 
behavioural rhythms in mice with loss of functional PERI expression. mPerl-/- and 
mPer2 -/- mice show gradual arrhythmicity in circadian behavioural patterns upon 
removal from the 12:12 light dark cycle and introduction into constant darkness, 
however the duration to onset and extent of rhythm persistence in both groups of 
knockout mice was variable[159]. In contrast, double mutant mPerl-/-mPer2-/- 
knockout mice had an abrupt immediate loss of rhythmicity upon transfer to constant 
darkness[159], leading the authors to suggest that PERI and PER2 played similar but
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redundant roles in the molecular clock. Another study showed that knockout of PERI in 
mice resulted in a delayed peak in PERI expression in peripheral tissues (kidney, heart 
and skeletal musc!e)[362]. These findings led the authors to propose that PERI may be 
specifically involved in modulation of physiological rhythmicity of the peripheral 
clock[362]. Although enterocyte gene expression in these knockout mice has yet to be 
examined, a recent study identified loss of rhythmicity of colonic motility in mPerl-/- 
mPer2-/~ double knockout mice but persistent rhythmicity in individual mPerl-/- or 
mPer2-/- mice[363].
Knockout mice are likely to be invaluable in investigating the role of PERI in mediating 
diurnal rhythmicity of SGLT1 expression in the intestine and in deciphering the effect of 
selective loss of PERI expression on the expression of other clock genes in the intestine. 
The in vitro data in this chapter (Figure 4.3, Table 4.2) suggest that loss of PERI in vivo 
would be expected to result in increased baseline SGLT1 expression with possible loss of 
circadian rhythmicity, while expression of other clock genes remained unchanged. 
Analysis of clock gene and SGLT1 expression in the intestines of PERI knockout mice 
would allow confirmation of this proposal.
In summary, the studies in this chapter show a suppressive role for the clock gene PERI 
on SGLT1 expression in enterocytes (Figure 4.3, Table 4.2). These effects are likely to be 
mediated by the SGLT1 promoter (Figure 4.9, Table 4.5), however are independent of E- 
box sites, which also have a suppressive effect on the SGLT1 promoter (Figure 4.10, 
Table 4.6). It seems likely that PERI may be acting via other clock-controlled genes
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binding to non-E-box sites on the SGLT1 promoter, while E-box sites mediate the effects 
of other genes on SGLT1 transcription. While the suppressive effect of PERI on SGLT1 is 
clear, the exact genes involved in the regulation of diurnal rhythmicity of SGLT1 
transcription unknown. It is hoped the ongoing research in our laboratory will allow 
further characterization of the molecular pathways regulating the effect of PERI on 
SGLT1.
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Chapter 5: mir-16 exhibits diurnal rhythmicity in vivo and arrests enterocyte 
proliferation in vitro via suppression of cell cycle genes.
5.1. Introduction
Circadian rhythms (24-h oscillations) play a key role in the regulation of numerous 
physiological functions. Circadian rhythmicity of up to 10% of gene transcripts and an 
even greater fraction of proteins indicate the involvement of both transcriptional and 
translational pathways[258-260, 364, 365]. The mechanisms regulating these rhythms 
remain unknown, but regulation at both the transcriptional and post-transcriptional 
level suggests that microRNAs may have a role in this process. MicroRNAs are relatively 
recently discovered non-coding RNAs, which are able to silence numerous genes 
simultaneously. microRNAs suppress protein expression following recognition of 
complementary sequences on the 3'UTR of target genes by one of two mechanisms, 
either by inducing mRNA cleavage (which manifests as changes in mRNA levels) or 
inhibiting translation (manifesting as changes in protein levels)[208, 230, 231]. The 
presence of a specific target sequence for each microRNA on the 3'UTR of multiple 
genes permits simultaneous regulation of protein expression from numerous genes by a 
single microRNA[248, 366, 367]. Bioinformatics analysis suggests that up to 30% of 
mammalian gene transcripts are regulated by microRNAs, short non-coding RNAs[232- 
234, 248]. microRNAs have been postulated to "fine-tune" the expression of multiple 
targets in both insects and mammals by effecting small changes simultaneously in the 
expression of many genes, making these molecules candidates for coordinating the 
circadian rhythmicity of many genes and proteins[17, 203, 229, 261]. microRNAs have 
been shown to exhibit circadian rhythmicity in the liver where they regulate circadian
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rhythms in several target genes[17]; however the expression and rhythmicity of 
microRNAs in the intestine has not been investigated.
The intestine displays profound rhythmicity of morphology, resulting in peak absorptive 
function (e.g. for glucose) coinciding with maximal nutrient delivery to the bowel[13; 
69], The number of enterocytes per viilus also exhibits a diurnal rhythmicity, with peak 
number occurring around the time of maximal nutrient availability[307]. Similar 
rhythmicity has been reported in human gastrointestinal mucosa[126, 127]. The exact 
pathways coordinating rhythmicity in proliferation are presently unknown.
I hypothesize that microRNAs are integral components for mediating circadian rhythms 
in intestinal proliferation, morphology and function. Prior to this study, the profile of 
microRNAs in the intestine was unknown. Identifying microRNAs that might be 
candidates for regulation of circadian rhythmicity therefore necessitated microRNA 
microarray profiling to identify the microRNAs in the intestine that exhibited circadian 
rhythmicity in expression. The studies in this chapter subsequently investigated the role 
of one of the rhythmic microRNAs, mir-16, in intestinal proliferation in vitro and 
corroborate these findings by comparing the rhythmicity of mir-16 with rhythms of mir- 
16 targets as well as rhythms of intestinal morphology and proliferation in vitro.
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5.2.microRNAs exhibit diurnal rhythmicity in rat intestine
As the profile of microRNAs in the intestine was unknown, my first aim was to 
determine the temporal profile of microRNA expression in the jejunum. Rats were fed 
ad lib then 6-7 rats per timepoint were harvested at 3 hourly intervals. I extracted total 
RNA from mucosal scrapings of jejunum then sent the RNA to the Harvard Partners 
Center for Genetics and Genomics for bioanalysis and microRNA microarray 
hybridization. Pooled RNA from rats harvested at time ZT 0 {where ZT is hours after light 
onset and ZT 0 is 7am) was used as the reference sample on the arrays. 3 arrays were 
used per timepoint. RNA from 2 animals was used per timepoint and one sample per 
timepoint was run with the dye swapped to act as a biological replicate and control for 
any dye bias. 21 arrays were used in total. Biostatistical analysis of the microarray data 
was performed by Mr Jonathan Dreyfuss and Dr Peter Park from the Harvard Partners 
Center for Genetics and Genomics. The methods used for the microRNA microarrays 
and the data analyses of the arrays are described in detail in section 2.3.1. I was 
provided with the list of the 238 microRNAs identified to be expressed in the intestine 
on the microRNA microarrays and narrowed these down to the final list of microRNAs to 
be validated using the criteria described below.
The commercially available Exiqon microRNA microarrays used had probes for a total of 
238 rat microRNAs - the total number of rat microRNAs that had been characterized at 
the time of the array production. All of these microRNAs were picked up on the arrays 
but found to be expressed to varying degrees in the intestine. The array data is stored in
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the Gene Expression Omnibus (GEO) accession database under the accession number
GSE20603[368]. I used a number of criteria to narrow down these microRNAs to the 
final number of microRNAs of interest.
The first criterion was to only consider microRNAs expressed at a reliable level in the 
intestine. For this I looked at the average intensity of expression of each microRNA on 
the arrays. The 238 microRNAs varied in intensity of expression on the microarrays, with 
a mean intensity of 6.7. Upon discussion with the biostatistics team (Dr Peter Park and 
Mr Jonathan Dreyfuss), an intensity of 8 (one standard deviation above the mean) was 
considered the threshold at which the expression was considered more reliable and less 
subject to error. 77 microRNAs had intensities of 8 and above. The 161 remaining 
microRNAs showing an average intensity of less than 8 were therefore not considered 
for further study.
The second criterion was to only consider microRNAs which exhibited a > 2-fold 
difference between any two timepoints (including non-adjacent timepoints). Q-values, 
calculated by Mr Jonathan Dreyfuss, were used to ensure that this > 2-fold difference 
was statistically significant. Of the 77 microRNAs still under consideration, 13 microRNAs 
exhibited a > 2-fold difference between any two timepoints.
The third criterion was to exclude any microRNAs that did not display sequence 
conservation across human, mouse and rat species. microRNAs whose sequences have
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been conserved across the species during evolution are more likely to be functional and 
biologically consequential and hence most suitable for further clinical analysis. 
Furthermore microRNA target specificity can be affected by a single base pair 
difference. microRNAs that do not display sequence conservation across human, mouse 
and rat species may therefore be less likely to have targets and effects conserved 
between rats and humans and were therefore excluded from further analysis. microRNA 
sequences were analysed by the use of the miRBase website, which curates the specific 
sequence of each microRNA across the major species[295]. Sequences of 5 of the 13 
microRNAs were not conserved across human mouse and rat and hence these 
microRNAs were excluded from further consideration.
Overall, of 238 known rat microRNAs tested on in situ hybridization arrays, 8 microRNAs 
met all three criteria, i.e. exhibited > 2-fold difference between any two timepoints, had 
an average intensity of > 8 and had sequences conserved across the human, mouse and 
rat species. These microRNAs were mir-16, mir-141, mir-20a, mir-142, mir-21, mir-503, 
mir-17 and mir-26a. These 8 microRNAs exhibited 2.0- to 3.4-fold difference between 
any two timepoints (q<0.05) and were subjected to further validation by qRCR.
5.2.1. mir-16, mir-141 and mir-20a demonstrate diurnal rhythmicity on qPCR.
To validate the above 8 microRNAs, the total RNA extracted from the ad lib fed rats 
harvested at 3 hourly intervals as described above (6-7 rats per timepoint) was subject
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to reverse transcription and qPCR using commercially available Taqman microRNA qPCR 
assays as described in section 2.3.2. The rat small nucleolar RNA gene (snoRNA) was 
used as a housekeeping gene to normalize for RNA loading. Figure 5.1a confirms that 
the means and spread of mir-16 expression (taken as a representative microRNA) and of 
snoRNA expression for ZT 0 (Hours After Light Onset, where ZT 0 is 7am, taken as a 
representative timepoint) are similar.
o
O
—i<
150-
100-
mir-16 snoRNA
Figure 5.1: mir-16 and snoRNA expression at ZT 0. RNA from the jejunum of rats (n=6) 
killed at ZT 0 (7am) was extracted, reverse transcribed and subjected to qPCR. Each 
reverse transcription and PCR was performed three times for each gene and each 
sample was plated in triplicate for each PCR. The mean expression of each gene for each 
sample at ZT 0 is shown as a circle (mir-16) or a square (the housekeeping gene snoRNA) 
and the mean expression and standard error of the mean for each gene per timepoint 
indicated.
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The level of each microRNA validated was expressed as a ratio to the level of snoRNA in 
the same sample. Circadian rhythmicity of microRNA expression was determined using 
the Cosinor procedure, freely available from www.circadian.org, assuming a 24-h period 
[312], Specifically, cross-sectional pattern analysis was performed on data arranged as if 
a single animal was harvested at 3-hourly intervals over 6 days. microRNAs were 
considered to display diurnal rhythmicity if a significant fit to a 24-hour period (as 
indicated by the p-value) was determined by the cosinor analysis performed by the 
program. For microRNAs that were shown to display diurnal rhythmicity the acrophase 
(time of peak expression) was determined by the program. The mean relative 
expression for each microRNA at each timepoint and the standard error of the mean 
was calculated and is displayed graphically in Figure 5.2A-C, and the significance of fit to 
a 24-hour period and the acrophase for each microRNA are expressed in Table 5.1. One­
way ANOVA was also carried out to identify significant differences between expression 
levels at individual timepoints; p-values are also shown in Table 5.1
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Table 5.1: 24-hour periodicity of microRNAs validated by qPCR. Conserved microRNAs 
showing an intensity of expression of > 8 and a 2-fold change or greater between any 
two timepoints on microRNA in situ hybridization microarrays were profiled by qPCR. 
The expression of each microRNA was normalized to the expression of the 
housekeeping gene snoRNA for the same sample. The data were arranged as if a single 
animal was harvested at 3-hourly intervals over 6 days and cross-sectional pattern 
analysis was performed with the cosinor procedure[312]; freely available at 
www.circadian.org (accessed 23rd September 2008). This software was used to 
determine the significance of fit of the temporal expression of the data to a cosinor 
pattern with a 24-hour period. The acrophase (time of peak expression) was abstracted 
from the programme. A cosinor rhythm is necessary for the calculation of acrophase, 
hence no acrophase can be calculated for microRNAs that do not display a significant fit 
a cosinor rhythm.
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Analysis of the expression of the 8 shortlisted microRNAs by qPCR showed that the 
expression of microRNAs mir-16, mir-141 and mir-20a in rat jejunum demonstrated a 
significant fit to a 24-hour period (p=0.001; 0.003 and 0.019 respectively, Table 5.1) as 
determined by the cosinor procedure, indicating that these microRNAs display diurnal 
rhythmicity in the intestine of rats. Peak expression of these three microRNAs occurred 
between ZT 4 and 6, corresponding to the lights-on fasting period (Table 5.1, Figure 
5.2A-C). The expression profiles of the remaining five shortlisted microRNAs [mir-142, 
mir-21, mir-503, mir-17 and mir-26a) did not display a significant fit to a 24-hour period 
and hence these microRNAs were not considered to display diurnal rhythmicity in rat 
intestine.
Two of the three microRNAs exhibiting diurnal rhythmicity in the intestine have been 
reported to play a role in proliferation: mir-20a is pro-proliferative[22-24] and mir-16 is 
anti-proliferative[18-21]. Intestinal villus height and cell number have been shown to 
peak in anticipation of maximal nutrient intake in previous studies[369]. Because anti­
proliferative mir-16 began to wane late in the light phase, when intestinal proliferation 
has been shown to increase, I selected this microRNA for further study. As the qPCR had 
been performed on total mucosal scrapings, which included all three fractions of crypt, 
villus and smooth muscle, my next aim was to determine the exact intestinal fraction 
which demonstrated diurnal rhythmicity in mir-16 expression.
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5.2.2. mir-16 rhythmicity is restricted to the crypt fraction of the intestine
To compare mir-16 expression levels in crypt, villus and smooth muscle, rats (3 per 
timepoint) were culled at ZT 6 and ZT 18, the respective mir-16 peak and nadir. Fresh 
frozen sections were cut at 9|im thickness, stained and crypts (lower half), villi (top half) 
or smooth muscle isolated by laser capture microdissection. 20 crypts or villi were 
captured from each section and 10 sections used per animal. Smooth muscle was 
captured from the circumference of each section. Extracted total RNA was subjected to 
microRNA reverse transcription and qPCR. Purity of isolation was confirmed by 
measuring PCNA [proliferating cell nuclear antigen, denoting isolation of the crypt 
fraction), SMA [smooth muscle actin, denoting isolation of the smooth muscle fraction) 
and IFABP [intestinal fatty acid binding protein, denoting isolation of the differentiated 
cells of the villi) expression via qPCR. mir-16 expression for each sample was expressed 
as a ratio to the expression of the housekeeping gene snoRNA for the same sample and 
mean relative mir-16 expression for each fraction at each timepoint calculated. ANOVA 
(analysis of variance) was used to identify the presence of a significant difference in mir- 
16 expression across the 3 intestinal fractions at each timepoint and post-hoc Tukey's 
multiple comparisons test was used to compare the relative expression of mir-16 
between individual fractions.
mir-16 expression was not significantly different across crypt, villus or smooth muscle 
fractions at ZT 18 (Figure 5.3; p=0.97). However, mir-16 expression was 3.2-fold higher 
in crypts at ZT 6 vs. ZT 18 (Figure 5.3; p=0.003) while it was not detectably different
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between these two timepoints in villi or smooth muscle. Thus, mir-16 rhythmicity 
appears restricted to crypts, the proliferative compartment of the intestinal mucosa. My 
next aim was to determine the exact role of mir-16 in the proliferative function of the 
intestine.
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Figure 5.3: mir-16 expression in intestinal fractions. Rats were killed at ZT 6 or and ZT 
18, n= 3 per timepoint. Sections of jejunum were embedded in OCT over isopentane and 
dry ice, and subjected to cryosectioning. Laser capture microdissection was performed 
to isolate fractions of crypts, villi and smooth muscle. RNA was extracted from each 
section and subjected to reverse transcription and real-time PCR. mir-16 expression was 
expressed relative to the expression of snoRNA. Students t-test was used to identify a 
significant difference in mir-16 expression in each fraction between ZT 6 and ZT 18.
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S3.mir-16 suppresses cell proliferation in enterocytes
Having determined that the alteration in mir-16 expression at diurnal timepoints was 
confined to the crypt compartment I decided to use crypt-derived cells to investigate 
the effects of mir-16 in vivo. Although the use of a human-derived crypt cell line would 
have been preferable, there are no commercially available human intestinal crypt cell 
lines at present. Therefore the commercially available rat crypt-derived cell line IEC-6 
was chosen for further investigation of mir-16 effects on the intestine in vitro.
I decided to investigate the effects of mir-16 overexpression in IEC-6 cells to determine 
the effects on proliferation, an approach that has been previously adopted by Liu et 
al[20] to investigate the effects of mir-16 in hepatocytes. As microRNAs exert their 
effects at a post-transcriptional level, I believed that an induced decrease in target gene 
expression due to overexpression of mir-16 might be more accurately and consistently 
measured than an increase, which may be confounded by any changes in transcription 
of these targets.
The effects of mir-16 on enterocyte proliferation were assessed by tetracycline-induced 
overexpression of either mir-16 or the negative control {a commercially available 
scrambled microRNA sequence) in IEC-6 cells, mir-16 expression was 2.1-fold higher 
following overexpression vs. the negative control (p=0,03, Figure 5.4). Although this was 
a relatively small difference in expression of mir-16, it was comparable to the
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peak/trough difference observed in mir-16 expression on a diurnal basis. This modest 
difference in the level of mir-16 expression had a profound effect on cell proliferation.
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Figure 5.4: Overexpression of mir-16 in IEC-6 cells. The mir-16 sequence with the 
flanking 200bp was cloned from human genomic DNA and inserted into the pTRIPZ 
vector. IEC-6 cells were stably transfected with the mir-16 overexpressing pTRIPZ vector 
or the scrambled control, and mir-16 (or scrambled control) expression induced with 
doxycycline. Cells were harvested for RNA expression after 48 hours, and mir-16 
expression was quantified by reverse transcription and real-time PCR and normalized to 
the expression of the housekeeping gene snoRNA. Wells were plated in triplicate for the 
qPCR reaction and the experiment was performed a total of three separate times. 
Student's t-test was used to identify a significant difference in mir-16 expression in mir- 
16 overexpressing cells compared to the control.
The effects of mir-16 on enterocyte proliferation were determined using the MTS assay 
and cell counting. IEC-6 cells stably overexpressing mir-16 vs. scrambled negative 
control were seeded in triplicate in 96-well plates and proliferation indices measured 48 
hours later using the MTS assay as per section 2.12.1. The experiment was performed a 
total of three separate times and the mean level of proliferation for mir-16
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overexpressing cells and control cells calculated. Students t-test was used to identify a 
significant difference in proliferation between the two stable cell lines. At 48 hours after 
plating, the proliferation rate was decreased by 76% vs. control cells as measured by the 
MTS assay (4.2-fold difference; p=0.006, Figure 5.5A).
Cell growth rates were also confirmed by manual cell counting. IEC-6 cells stably 
overexpressing either m/r-16 or the scrambled control were seeded in triplicate in 6-well 
dishes and after 48 hours, were trypsinized and counted. The experiment was 
performed a total of three separate times and the mean cell count for mir-16 
overexpressing cells and control cells calculated. Students t-test was used to identify a 
significant difference in cell counts between the two stable cell lines. Cell counts were 
5.2-fold higher in the control cells compared to the mir-16 overexpressing cells (p=0.02, 
Figure 5.5B). Together these findings show that mir-16 has a significant effect on the 
regulation of cell number. I next set out to identify the mechanism by which mir-16 
exerted this effect. Changes in cell number can be effected either by changing the level 
of cellular proliferation or by changing the rate of apoptosis and it was therefore 
necessary to determine the effects of mir-16 on cell cycle and apoptosis in enterocytes.
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5A.mir-16 induces cell cycle arrest in enterocytes
To determine the mechanism by which mir-16 exerted its anti-proliferative effects on 
enterocytes, I examined the effect of mir-16 overexpression on the cell cycle of IEC-6 
cells. IEC-6 cells stably overexpressing either mir-16 or the scrambled negative control 
were grown in triplicate in 10cm tissue-culture treated dishes in the presence of 
doxycycline to induce mir-16 (or scrambled control) expression. After 48 hours, ceils 
were trypsinized and resuspended in 70% ethanol and incubated overnight at -20°C. The 
next day ceils were centrifuged, the ethanol aspirated off and the cell pellet 
resuspended in propidium iodide. Resuspended cells were incubated for SOmins at 37°C 
in darkness and analyzed at 10,000 events per sample by Ashley Lansing, a technician at 
the Dana Farber Cancer Institute Flow Cytometry Core Facility on a BD FACScan flow 
cytometer (BD). The percentage of cells in each of the cell cycle stages (Gl, S, G2 and M) 
was determined by Ashley Lansing using the software ModFit (Verity, Topsham, ME) and 
the results provided to me for further analysis.
Overexpression of mir-16 led to a significantly larger fraction of cells in Gl compared to 
control (65% vs. 25%, p=0.001, Figure 5.6). The fraction of mir-16 overexpressing cells 
was much smaller in G2 (13% vs. 31% in controls, p=0.018) and S (21% vs. 43% in 
controls, p=0.001), suggesting that mir-16 overexpression was able to arrest cells in the 
Gl stage of the cell cycle, preventing progression to the S and G2 stages and thereby 
arresting proliferation.
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p=0.001
control mir-16
Figure 5.6: Effect of mir-16 on G1 of the cell cycle in IEC-6 cells. IEC-6 cells stably 
overexpressing either mir-16 or the scrambled negative control were grown in the 
presence of doxycycline for 48 hours then trypsinized and resuspended in 70% ethanol 
and incubated overnight at -20°C. The next day cells were resuspended in propidium 
iodide then incubated for BOmins at 37°C in darkness. Cells were analyzed at 10,000 
events per sample and the percentage of cells in each of the cell cycle stages (Gl, S, G2 
and M) determined using the software ModFit. The experiment was performed a total 
of three separate times and the mean percentage of cells in each of the cell cycle stages 
for mir-16 overexpressing cells and control cells calculated. Students t-test was used to 
identify a significant difference in the percentage of cells in each cell cycle stage 
between the two stable cell lines.
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Because mir-16 has previously been shown to regulate apoptosis, I also investigated 
whether mir-16 was also able to exert an effect on apoptosis in enterocytes. Apoptosis 
in mir-16 overexpressing IEC-6 cells was quantified using the measurement of Annexin- 
V, a protein that binds to the phospholipid phosphotidylserine that translocates from 
the inner to the outer leaflet of the plasma membrane during apoptosis and is hence 
exposed in apoptotic cells. The nucleic acid stain Sytox Blue was used as a counter stain 
to specifically identify dead or necrotic cells which also stain Annexin-V positive. IEC-6 
cells stably overexpressing either mir-16 or the scrambled negative control were grown 
in 10cm tissue-culture treated dishes. After 48 hours, cells were trypsinized and counted 
and stained with Annexin V-FITC and Sytox Blue then analyzed at 10,000 events per 
sample by Miss Ashley Lansing, a technician at the Dana Farber Cancer Institute Flow 
Cytometry Core Facility on an LSR1I flow cytometer (BD). The percentage of live, 
apoptotic and dead ceils was determined by Ashley Lansing using the software Diva (BD) 
and the results provided to me for further analysis.
The average rate of apoptosis was similar in both groups of cells (3.8% in mir-16 
overexpressing cells vs. 3.3% in control cells, p=0.32, Figure 5.7), suggesting that the 
effect of mir-16 on proliferation is due to the arrest of enterocytes in G1 as shown in 
Figure 5.6, rather than an effect on apoptosis[18, 370]. These results point to an effect 
of mir-16 on the cell cycle in enterocytes, specifically genes involved in the regulation of 
the Gl/S transition.
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Figure 5.7: Effect of mir-16 on apoptosis in IEC-6 cells. IEC-6 cells stably overexpressing 
either mir-16 or the scrambled control were trypsinized and counted after 48 hours 
growth and stained with Annexin V-FITC and Sytox Blue. Cells were analyzed at 10,000 
events per sample. The experiment was performed a total of three separate times and 
the mean percentage of live, apoptotic and dead cells calculated. The mean and 
standard error of the mean of the percentage of mir-16 overexpressing and control cells 
exhibiting apoptosis is shown in the figure. Students t-test was used to identify a 
significant difference between apoptosis levels in the two stable cell lines.
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5.5. mir-16 suppresses key Gl/S regulators in enterocytes
To identify specific mir-16 targets involved in inducing G1 arrest, the B'UTRs of Gl/S 
regulatory genes were interrogated for the presence of mir-16 binding sequences using 
the microRNA target prediction algorithm Targetscan[248, 371]. Cyclin D1 [Ccndl), cyclin 
D2 {Ccnd2), cyclin D3 {Ccnd3)t cyclin E (Ccnel) and cyclin-dependent kinase 6 {Cdk6} 
were identified as targets of mir-16. These are all known to regulate the Gl/S transition 
and were therefore examined using in vitro experiments for responsiveness to mir-16 in 
enterocytes. As a negative control, the effect of mir-16 on cyclin-dependent kinase 4 
(Cdk4), a Gl/S regulator lacking a mir-16 target site in its mRNA 3'UTR, was also 
examined.
I EC-6 cells stably overexpressing mir-16 or the scrambled control were grown in 10cm 
tissue-culture treated dishes and harvested after 48 hours for determination of the 
expression of CCND1, CCND2, CCND3, CCNE1, CDK4 and CDK6. Protein expression of 
these genes was measured using Western blotting using the protocol described in 
section 2.5, Western blot images were quantified by densitometry and protein 
expression for each gene expressed as a ratio to the expression of the housekeeping 
gene P-actin for the same sample. The experiment was performed a total of three 
separate times and the mean expression of CCND1, CCND2, CCND3, CCNE1, CDK4 and 
CDK6 in mir-16 overexpressing cells and control cells calculated. Students t-test was 
used to identify a significant difference in the expression of these genes between the 
two stable cell lines.
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Figure 5.8 shows the representative blots for each of the six genes examined along with 
the corresponding blot of the housekeeping gene p-ACTIN, as well as a graphical 
presentation of the densitometry results from these blots. Overexpression of mir-16 
significantly decreased protein levels of all five mir-16 targets, CCNDl, CCND2, CCND3, 
CCNE1 and CDK6, in IEC-6 cells compared to the non-silencing control (p=0.030to 0.039, 
Figure 5.8A-E, Table 5.2). Interestingly the degree of suppression of protein expression 
was very similar across all five targets, with levels in mir-16 overexpressing cells 
suppressed to 0.3-0.5 that of controls. CDK4, a cell cycle regulator that is not a predicted 
target of mir-16, did not demonstrate any change in expression following mir-16 
overexpression (p=0.223, Figure 5.8F, Table 5.2), confirming that mir-16 did not exert 
any non-specific effect on cellular protein expression.
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Protein expression of Gl/S regulators
Target Fold-change vscontrol p-value
Ccndl 0.4 0.030
Ccnd2 0.4 0.037
Ccnd3 0.3 0.030
Ccnel 0.5 0.030
Cdk6 0.4 0.039
Cdk4 1.2 0.223
Table 5.2: Effect of mir-16 overexpression on Gl/S regulator protein expression in IEC-6 
cells. Western blot images were quantified by densitometry and protein expression for 
each gene expressed as a ratio to the expression of fJ-ACTIN for the same sample. The 
experiment was performed a total of three separate times and the mean expression of 
CCND1, CCND2, CCND3, CCNE1, CDK4 and CDK6 in mir-16 overexpressing cells and 
control cells calculated. Students t-test was used to identify a significant difference in 
the expression of these genes between the two stable cell lines.
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For measurement of mRNA expression of Ccndl, Ccnd2, Ccnd3, Ccnel, Cdk4 and Cdk6,
IEC-6 cells stably overexpressing mir-16 or the scrambled control were grown in 10cm 
tissue-culture treated dishes and harvested after 48 hours. RNA was extracted and 
reverse transcribed and qPCR performed according to protocols described in section 2,2. 
The expression of individual genes quantified by qPCR was expressed as a ratio to the 
expression of the housekeeping gene fi-actin for the same sample.
The expression of Ccnd2 and Cdk6 mRNA was reduced by 75% (p=0.002) and 58% 
(p=0.001) respectively following mir-16 overexpression (Table 5.3, Figure 5.9), 
suggesting that mir-16 may regulate these genes via effects on mRNA cleavage, mir-16 
overexpression did not change the mRNA expression of Ccndl, Ccnd3 and Ccnel 
(p=0.660, 0.151 and 0.181 respectively, Table 5.3, Figure 5.9) despite suppression at a 
protein level (Figure 5.8A,C and D, Table 5.2) suggesting that these specific genes may 
be regulated by mir-16 at a translational level rather than mRNA cleavage. Cdk4, a Gl/S 
regulator which is not a target of mir-16 but measured as a negative control, was 
unaltered at both the mRNA and protein level following mir-16 overexpression (p=0.223 
and 0.591 respectively, Tables 5.2 and 5.3) These results confirm that CDK4 is not a mir- 
16 target and indicate that mir-16 overexpression does not exert non-specific effects on 
cell cycle proteins.
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Figure 5.9: Effect of mir-16 on the mRNA expression of Gl/S regulators in IEC-6 cells. 
IEC-6 cells stably overexpressing mir-16 or the scrambled control were grown in 10cm 
tissue-culture treated dishes and harvested after 48 hours. RNA was extracted and 
reverse transcribed and qPCR performed. The expression of individual genes was 
expressed as a ratio to the expression of the housekeeping gene fi-actin for the same 
sample. Each well was plated in triplicate and the qPCR reaction performed twice for 
each experiment. The experiment was performed a total of three separate times and 
the mean expression and standard error of Ccndl, Ccnd2, CcndS, Ccnel, Cdk4 and Cdk6 
in mir-16 overexpressing cells and control cells calculated. The expression of these 
genes in mir-16 overexpressing cells has been presented as a ratio of the expression in 
control cells in the graph for ease of interpretation. Students t-test was used to identify 
a significant difference in the expression of these genes between the two stable cell 
lines.
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mRNA expression of Gl/S regulators
Target Fold-change vs control p-vaiue
Ccndl 0.9 0.660
Ccnd2 0.2 0.002
Ccnd3 1.2 0.151
Ccnel 0.8 0.181
Cdk6 0.4 0.001
Cdk4 1.0 0.591
Table 5.3: Effect of mir-16 overexpression Gl/S regulator mRNA expression in IEC-6 
cells. mRNA expression was determined by qPCR. The expression of individual genes 
was expressed as a ratio to the expression of the housekeeping gene fl-actin for the 
same sample. The experiment was performed a total of three separate times and the 
mean mRNA expression of Ccndl, Ccnd2, Ccnd3, Ccnel, Cdk4 and Cdk6 in mir-16 
overexpressing cells and control cells calculated. Students t-test was used to identify a 
significant difference in the expression of these genes between the two stable cell lines.
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My data suggest that the effects of mir-16 on G1 arrest of cell cycle progression in
enterocytes may be mediated by one or more of these Gl/S proteins, i therefore 
proposed that the rhythmic expression of mir-16 in vivo would therefore be expected to 
induce rhythmicity in its target genes in vivo and sought to confirm rhythmicity of 
Ccndl, Ccnd2, Ccnd3, Ccnel and Cdk6 in the jejunum of diurnally harvested rats.
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5.6.G1/S regulatory proteins targeted by mir-16 peak in antiphase to mir-16
expression in jejunum
Cell cycle proteins are able to regulate cellular proliferation[123-125] and may therefore 
be mediators of the known diurnal rhythmicity in intestinal proliferation[112; 307]. My 
data so far has shown that these proteins may be regulated in vitro by the diurnally 
rhythmic microRNA mir-16. involvement of mir-16 in the cell cycle of enterocytes in the 
jejunal mucosa via suppression of these proteins as suggested by the I EC-6 studies 
would likely be evidenced by a corresponding temporal displacement of their rhythms 
from that of mir-16 in vivo. However to date the rhythms of cell cycle proteins in the 
small intestine have not been sufficiently characterized. I therefore examined the 
temporal protein expression patterns for the 5 mir-16 targets {Ccndl, Ccnd2, Ccnd3, 
Ccnel, and Cdk6) as well as the r\or\-mir-16 target Cdk4 in the jejunum of rats harvested 
at 3-hourly diurnal timepoints.
To do this, rats fed ad lib were culled at 3 hourly intervals (6-7 rats per timepoint) and 
jejunum harvested for subsequent analysis of protein and mRNA expression. Protein 
was extracted from jejunal mucosal scrapings of these rats and Western blotting 
performed as described in section 2.5.
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Circadian rhythmicity of protein expression of CCND1, CCND2, CCND3, CCNE1, CDK6 and 
CDK4 was determined using the Cosinor procedure assuming a 24-h period[312]. 
Specifically, cross-sectional pattern analysis was performed on data arranged as if a 
single animal was harvested at 3-hourly intervals over 6 days. The significance of fit to a 
24-hour period and acrophase of rhythmic genes were determined by the programme 
and are expressed in Table 5.4. In addition, one-way ANOVA was used to identify 
significant differences in expression between timepoints.
All five mir-16 targets (CCND1, CCND2, CCND3, CCNE1 and CDK6,) exhibited diurnal 
rhythmicity at the protein level with a 24-hour period, with acrophases (expression 
peaks) mostly falling during the nocturnal feeding period between ZT 12 and ZT 18 
(p<0.05. Figure 5.10 A-E; Table 5.4) and nadirs during the lights-on period between ZT 0 
and 6. Peak expression of mir-16 at ZT 6 coincided with low levels of protein expression 
for all five targets, providing further evidence that mir-16 may act to suppress these 
proteins and contribute to their rhythmicity in vivo.
Page 213 of 272
iMissajdits trMOT ** li|9y
*
m
R
o
uofistidxvsxD »A]W|»B
00c
'cc
ooai
_Q
c
o
Q.QJ
E
QJ
Q.
rv
iS.
in
fO
>
<u
4->c
3O
T3
_QJ
3u
QJi_
QJ
$
JD
■a
-a
QJ
fOCd
E3
C
3
'aT
Q.
X
QJ
C
'qj
*->
o
Q.
H—
o
o
E
-C
QC
6
in
QJ
00
at
 Z
T 
0 (
7a
m
) a
nd
 je
ju
nu
m
 ha
rv
es
te
d 
fo
r a
na
ly
si
s 
of
 p
ro
te
in
 ex
pr
es
si
on
 o
f m
ir-
16
 ta
rg
et
s C
C
N
D
1 (
A
), C
C
N
D
2 (
B)
, C
C
N
D
3 (
C)
, C
C
N
E1
 (D
), C
D
K6
 (E
) 
an
d  t
he
 no
n m
ir-
16
 ta
rg
et
 C
D
K4
 (F
) b
y W
es
te
rn
 bl
ot
tin
g.
 Pr
ot
ei
n e
xp
re
ss
io
n f
or
 ea
ch
 ge
ne
 ex
pr
es
se
d a
s a
 ra
tio
 to
 th
e h
ou
se
ke
ep
in
g g
en
e (
3-
 
AC
TI
N
 fo
r t
he
 sa
m
e s
am
pl
e.
 V
al
ue
s r
ep
re
se
nt
 th
e m
ea
n 
an
d s
ta
nd
ar
d e
rro
r f
or
 ea
ch
 ge
ne
 at
 ea
ch
 tim
ep
oi
nt
. In
 ad
di
tio
n,
 on
e-
w
ay
 A
N
O
VA
 w
as
 
us
ed
 to
 id
en
tif
y 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
in
 e
xp
re
ss
io
n 
be
tw
ee
n 
tim
ep
oi
nt
s.
Rhythmicity of protein expression
Target
p value on
cosinor
Acrophase
(ZT, h)
Fold-change
peak/trough
p value on
ANOVA
CCND1 0.009 12 2.3 0.047
CCND2 0.001 14 4.4 0.009
CCND3 0.004 17 2.8 0.034
CCNE1 0.013 11 2.8 0.008
CDK6 0.004 16 2.5 0.039
CDK4 0.000 15 2.8 <0.0001
Table 5.4: Rhythms in Gl/S regulator protein expression in diurnally harvested rat 
jejunum. Protein was extracted from jejunal mucosal scrapings and Western blotting 
performed. Blot images were quantified by densitometry and protein expression for 
each gene expressed as a ratio to the expression of the housekeeping gene (3-ACTIN for 
the same sample. Cross-sectional pattern analysis was performed with the cosinor 
procedure[312], used to determine the significance of fit of the temporal expression of 
the data to a 24-hour cosinor pattern and to calculate the acrophase (peak expression) 
for each protein. One-way ANOVA was used to identify significant differences in 
expression between individual timepoints
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I next determined whether these genes were rhythmic at the mRNA level. Total RNA
was extracted from jejunal mucosal scrapings from these rats and subject to reverse 
transcription and qPCR as described in section 2.2, The non-circadian gene fi-actin was 
used as a housekeeping gene to normalize for RNA loading. The level of each gene was 
expressed as a ratio to the level of fi-actin in the same sample.
Circadian rhythmicity of mRNA expression of Ccndl, Ccnd2, Ccnd3, Ccnel, Cdk6 and 
Cdk4 was determined using the Cosinor procedure assuming a 24-h period [312] as 
described above. The significance of fit to a 24-hour period and the acrophase of 
rhythmic genes were determined by the Cosinor programme and are expressed in Table 
5.5. In addition, one-way ANOVA was used to identify significant differences in 
expression between timepoints.
Ccnd2 and Ccnd3 displayed rhythmicity at the transcriptional level (p<0.05 on both 
cosinor analysis and ANOVA; Figures 5.11 B and C, Table 5.5). The temporal expression 
of Ccndl, Ccnel and Cdk6 did not fit a 24-hour period and hence did not qualify as a 
diurnal rhythm {p>0.1 on both cosinor analysis and ANOVA, Figures 5.11 A, D and E). 
CDK4, which demonstrated no response to mir-16 overexpression in vitro, displayed 
significant rhythmicity at both the transcriptional and post-transcriptional level in vivo 
(p=0.005 and <0.001 on cosinor analysis and 0.021 and <0.0001 on ANOVA, Figures 5.11 
F and 5.10 F), suggesting that other mechanisms besides mir-16 are likely to play a role 
in governing diurnal rhythmicity of cell cycle proteins, as will be discussed later.
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Rhythmicity of mRNA expression
p value on Acrophase Fold-change p value on
Target cosinor (ZT,h) peak/trough ANOVA
Ccndl 0.120 0.258
Ccnd2
Ccnd3
Ccnel
Cdk6
Cdk4
0.039
0.000
0.330
0.770
0.005
0.001
<0.0001
0.112
0.847
0.021
Table 5.5: Rhythms in Gl/S regulator mRNA expression in diurnally harvested rat 
jejunum. RNA was extracted from jejunal mucosal scrapings and qPCR performed. 
mRNA expression for each gene was expressed as a ratio to the expression of the 
housekeeping gene fi-actin for the same sample. The cosinor procedure[312] was used 
to determine the significance of fit of the temporal expression of the data to a 24-hour 
cosinor pattern and the acrophase (peak expression) for each gene displaying a 
significant 24-hour rhythm was abstracted from the program. The acrophase cannot be 
calculated for genes that do not display a significant fit to a 24-hour cosinor pattern. 
One-way ANOVA was used to identify significant differences in expression between 
individual timepoints.
Cell cycle proteins regulate the transitions between the various stages of the cell 
cycle[123-125] and thereby contribute to the proliferative activity of the cell. I therefore 
proposed that these rhythms in cell cycle proteins were likely to correlate with rhythms 
in jejunal enterocyte morphology and proliferation.
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5.7. Diurnal rhythmicity in DNA synthesis and morphology in rat jejunum
To assess rhythmicity in enterocyte morphology and proliferation, rats fed ad lib were 
culled at 3 hourly intervals {6-7 rats per time point) and sections of jejunum harvested 
and fixed overnight in 10% buffered formalin. These sections were processed by 
technicians at the Brigham and Women's Histopathology Core Facility. For 
determination of cells in S-phase, sections were stained with anti-BrdU primary 
antibody and counterstained with haematoxylin and eosin to facilitate counting of BrdU- 
negative nuclei. Stained sections on microscope slides were returned to the author for 
analysis. I trained Miss Britta Thompson, a medical student in our laboratory, to perform 
measurements of crypt and villus morphology. The following crypt- villus axis 
parameters were measured: crypt depth, villus height, villus width (at the midpoint of 
the villus), crypt enterocyte width and villus enterocyte width (as measured by number 
of nuclei over 125 pm) and number of enterocytes per crypt. I performed the BrdU 
staining measurements by counting the number of BrdU-stained nuclei per crypt.
Circadian rhythmicity of DNA synthesis and morphologic parameters was determined 
using the Cosinor procedure assuming a 24-h period[312j. The significance of fit to a 24- 
hour period (as indicated by the p-value) and acrophase of rhythmicity for each 
parameter were determined by the program and are expressed in Table 5.6. One-way 
ANOVA was used to identify significant differences in expression between timepoints.
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The number of cells per crypt labelled with BrdU peaked at ZT 3 (p=0.005 on cosinor 
analysis and 0.003 on ANOVA, Figure 5.11A). The total number of cells per crypt peaked 
several hours later at ZT 12 (p=0.001 on cosinor analysis and 0.014 on ANOVA, Figure 
5.11B). Peak crypt depth occurred at ZT 13 on cosinor analysis and ZT15 on ANOVA 
(Figure 5.11C). Villus height shown significant rhythmicity on cosinor analysis with a 
peak at ZT14 (p=0.043) but not on ANOVA (p=0.480, Figure 5.11 D). There was no 
diurnal rhythmicity in cell width of villi crypts (p>0.1 on both cosinor analysis and 
ANOVA, Figure 5.HE and F). Similarly crypt and villus width both showed no rhythmicity 
over the diurnal period (p>0.05 on both cosinor analysis and ANOVA, Figure 5.11G and 
H). Overall these data demonstrate that cell proliferation in the crypt is the main factor 
contributing to the observed rhythmicity in crypt and villus morphology (Table 5.6).
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Parameter p value
Acrophase 
(ZT, h)
Fold change 
(peak/trough)
p value 
on
ANOVA
BrdU 0.005 1.6 0.003
Enterocytes per crypt 0.001 12 1.2 0.014
Crypt depth 0.005 13 1.3 0.049
Villus height 0.043
Villus enterocyte width 0.217
Crypt enterocyte width 0.8
Crypt width 0.080
Villus width 0.610
14 1.1 0.480
Table 5.6: Rhythmicity in morphological parameters in diurnally harvested rat jejunum. 
The cosinor procedure[312] was used to determine the fit of the data to a cosinor curve 
with 24-hour periodicity and the acrophase (peak expression) for each gene displaying a 
significant 24-hour periodicity. The acrophase cannot be calculated for genes that do 
not display a significant fit to a 24-hour cosinor pattern. One-way ANOVA was used to 
identify significant differences between timepoints.
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5.8. Discussion
Intestinal proliferation is known to exhibit a circadian rhythm, but the mechanisms 
underlying this have not been investigated. MicroRNAs are known to regulate 
proliferation in other tissues[18-24]. I hypothesized that microRNAs may therefore 
contribute to the regulation of circadian rhythms in intestinal proliferation. Prior to this 
study the temporal profile of microRNAs in the intestine and their role in the regulation 
of intestinal proliferation was unknown. To investigate this, I profiled microRNAs in the 
intestine of ad libitum fed rats using oligonucleotide arrays and identified a candidate 
microRNA that may regulate diurnal rhythmicity in intestinal proliferation from three 
microRNAs exhibiting diurnal rhythmicity. I further examined the effects of this 
microRNA on proliferation in an enterocyte cell line in vitro and identified the genes 
targeted by this microRNA in cultured enterocytes. Finally, I correlated rhythmicity in 
microRNA expression in vivo with rhythms in intestinal morphology and proliferation.
The data shown in this chapter have a number of novel key findings. Firstly, that the 
anti-proliferative microRNA mir-16 is expressed in both crypt and villus enterocytes but 
exhibits diurnal rhythmicity only in the crypts. Secondly, that the cell cycle regulators 
CCND1, CCND2, CCND3, CCNE1 and CDK6 exhibit diurnal rhythmicity with a peak in 
expression which occurs in antiphase to mir-16. Thirdly, that mir-16 has an anti­
proliferative role in cultured enterocytes, as shown by its ability to inhibit proliferation 
and decrease the expression of genes involved in cell cycle regulation when over-
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expressed in rat I EC-6 cells. My data therefore identifies mir-16 as a potentially
important microRNA in regulating diurnal rhythms in the intestine.
This study is the first to profile microRNA expression in rat jejunum as well as to 
establish rhythmic expression of specific microRNAs. Three microRNAs, mir-16, mir-141 
and mir-20a were found to exhibit 24-hour periodicity of expression in rat jejunum. All 
three microRNAs peaked at 4 to 6 hours after light onset, during the fasting period in ad 
libitum fed rats and reached their lowest levels of expression 18 hours after light onset 
during the lights off feeding period (Figure 5.2, Table 5.1}. This suggests the possibility of 
regulation of the rhythmicity of microRNA expression by either light or nutrient 
availability, both factors which exhibit diurnal periodicity. Further studies dissecting the 
relationship between microRNAs and light and nutrient exposure, for instance with 
restricted feeding regimens, are necessary to adequately determine which of these 
factors influences microRNA rhythmicity in the intestine.
Previous studies have attempted to investigate the effect of circadian rhythmicity in 
microRNA expression, although not in the intestine. Circadian rhythmicity of microRNA 
expression has been shown by other groups to regulate cell behaviour and gene 
expression in tissues with known rhythmicity of function, such as the retina[203], the 
SCN[229] and the liver[17j. In the retina, 12 microRNAs display circadian rhythmicity, of 
which two - mir-96 and mir-182 - were shown to mediate rhythmic expression of the 
Adcy6 {adenylate cyclase type 6) gene, which exhibited rhythmicity in antiphase to mir-
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96 and mir-182[2Q3]. Interestingly, the 1.8- to 3.2-fold amplitude changes observed in 
intestinal microRNAs in this study (Figure 5.2A-C) are consistent with the 1.25- to 3-fold 
changes observed in the retina[203, 229, 261]. Another microRNA shown to 
demonstrated transcriptional rhythmicity is mir-122) depletion of this microRNA in the 
liver disrupted the circadian rhythmicity of numerous transcripts regulating lipid 
metabolism[17, 372].
In mouse SCN, rhythmic expression of mir-219 and mir-132 mediates photic 
entrainment of circadian clock activity[229]. These microRNAs exhibited a 2-3 fold 
change in expression between peak and trough levels and displayed rhythmicity 
restricted to the SCN, with no rhythms observed in the adjacent cortex. The authors 
demonstrated further that these microRNAs were differentially regulated. A light pulse 
in the middle of the subjective night was able to reproduce the peak in expression of 
mir-132, but had no effect on mir-219. Inhibition of mir-219 levels with antagomirs 
(microRNA inhibitors) resulted in lengthening of the circadian period as measured by 
wheel running activity[229]. Inhibition of mir-132 levels with antagomirs had a different 
effect, producing inhibition of light-induced phase shifts in wheel running behaviour. 
These data suggest that mir-219 regulates the length of the circadian period while mir- 
132 acts as a negative regulator of light-induced resetting of the circadian clock. In the 
same study, mir-132 or mir-219 were each able to induce transcription of the clock gene 
PERI. The authors further demonstrated that co-expression of either mir-132 or mir-219 
with known PERI regulators CLOCK and BMAL1 resulted in a greater induction of Perl 
transcription than CLOCK and BMAL1 alone.
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The above microRNAs which were found to exhibit circadian rhythmicity in other tissues
were expressed in the intestine on our arrays, however none of these microRNAs met 
our criteria for qPCR validation from our array data and hence identification of 
rhythmicity of these microRNAs in the intestine was not attempted. Moreover, none of 
these previous studies had identified rhythmicity in mir-16. My data presented in this 
chapter is to date the first description of diurnal rhythmicity of mir-16 expression and 
the first identification of a potential role for microRNAs in regulating the rhythmicity of 
intestinal proliferation.
Rhythmicity of mir-16 expression was shown to be restricted to the crypts, the 
proliferative fraction in the intestine (Figure 5.3) and is consistent with my data showing 
that mir-16 suppresses proliferation of intestinal crypt-derived cells in vitro (Figure 5.5). 
Of particular note, the level of mir-16 in IEC-6 cells following mir-16 overexpression 
produced a difference in expression similar to the degree of change observed on a 
diurnal basis in jejunum. This modest increase almost completely arrested growth in 
mir-16 overexpressing IEC-6 cells (Figure 5.5) making this the first study to investigate 
and identify an anti-proliferative role for mir-16 in untransformed cells and specifically 
in the small intestine. Previous studies have identified an anti-proliferative role for mir- 
16 in other cell types[18-21, 373]. Bonci et al[373] identified a role for mir-16 as a 
tumour suppressor gene in the prostate: mir-16 is frequently downregulated in 
advanced prostate cancer and mir-16 knockdown in prostate cancer cells promotes
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proliferation and invasiveness. Similarly, mir-16 expression is reduced in squamous cell 
carcinomas and adenocarcinomas of the lung[21] and mir-16 overexpression in lung 
cancer cell lines induces cell cycle arrest[21], Linsley et al[19] found a similar effect of 
mir-16 in colorectal carcinoma cell lines (HCT116 and DLD-1 cells). All these cell types 
are cell lines derived from malignant tissues and hence each bears various mutations 
(such as the mutation of the Ras proto-oncogene in HCT 116 ceils[19] and the mutation 
of p53 in DLD-1 cells[19]) which contribute to a pre-existing tumorigenic phenotype in 
these cells, making them different from untransformed cells. Previous characterization 
of IEC-6 has confirmed that these cells do not express any of the features of 
transformed cells[374] hence my data on the anti-proliferative function of mir-16 in IEC- 
6 cells shows that mir-16 serves an important physiological role in untransformed cells 
and may have a key regulatory role in enterocytes in vivo.
My studies do not show an effect of mir-16 on apoptosis in IEC-6 cells (Figure 5.7). 
However, mir-16 has been shown to increase apoptosis in leukaemic cell lines, gastric 
cancer cells and prostate cancer via downregulation of pro-survival protein BCL2 (B-cell 
lymphoma 2)[18, 370, 373, 375]. This apparent discrepancy between my observations 
and those of others may in fact be due to different properties of BCL2 pathways in the 
small intestine; although BCL2 is expressed in enterocytes, it may perform different 
functions in this tissue. Indeed, ablation of Bcl2 in mice increases the apoptosis rate in 
the colon but not the small intestine[110, 111, 376].
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The reduction in proliferation induced by mir-16 overexpression in vitro was associated
with suppressed expression of five key Gl/S regulators—CCND1, CCND2, CCND3, CCNE1
and CDK6 (Figure 5.8; Table 5.2). In normal cell cycle progression, D-type cyclins (CCND1,
CCND2 and CCND3) are synthesized during Gl, in response to proliferative signals and
complex with cyciin-dependent kinases (CDK4 and CDK6) [123, 124]. This results in the
phosphorylation and inactivation of the retinoblastoma protein pRb, Loss of pRb
function results in dissolution of complexes of pRb with members of the E2F
transcription factor family and chromatin-modifying enzymes. This in turn activates cell
cycle proteins vital for entering S-phase (including CCNE1 and the protein with which it
forms a complex, CDK2) [123, 124]. The effects of the D cyc!in/Cdk4/6 complexes is
countered by INK4 CDK inhibitors, such as pl6INK4a which, in conditions of cellular
stress, blocks CDK4/6 activity, locking pRb in its active, antiproliferative state. The G2/M
transition is regulated by levels of cyclins A and B (CCNA and CCNB) and cyciin-
dependent kinase 1 (CDK1). CCNA and CCNB show progressive accumulation during the
cell cycle, allowing entry into mitosis and then are abruptly degraded at the end of
anaphase, resulting in exit of the cells from the stage of mitosis[125]. mir-16 increased
the proportion of cells in Gl but did not affect the G2/M transition in my studies (Figure
5.6). Similarly mir-16 did not appear to play a role in the G2/M transition in the non-
intestinal tissues studied by others[19, 21, 373] and in addition is not predicted to target
either cyclins A or B or CDK1[371]. Together, this suggests that its effects on cell
proliferation are specific to the Gl/S stage of the cell cycle. In my studies, upregulation
of mir-16 expression suppressed expression of CCND1, CCND2, CCND3, CCNE1 and CDK6
in vitro, but downregulated the expression of each protein by only 50 to 70% (Figure 5.8,
Table 5.2), thereby corroborating existing evidence that small changes in microRNA
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expression alter cellular phenotypes by downregulating multiple components of single
pathways[209; 366, 377],
Protein abundances of all five Gl/S regulators presumably targeted by mir-16 were 
found to exhibit diurnal rhythmicity in rat jejunum in antiphase to mir-16 as shown in 
Figure 5.10 and summarized in Table 4.4. G1 proteins CCND1 and CCND2 peaked at ZT 
12, at the same time as CCNE1, while the remaining D-type cyclin family member CCND3 
peaked later at ZT 18 (Figure 5.10, Table 5.4). While this would appear to deviate from 
the traditionally described linear sequence of events in the cell cycle in which D cyclins 
would be expected to peak before CCNE1[123, 124j, increasing evidence suggests that 
this linear sequence may not hold true in all tissues[122, 378, 379], CCNE1 has been 
shown to substitute for deficiencies in D cyclin expression in vivo[378]. Mice deficient in 
all three D cyclins demonstrate normal intestinal development and normal development 
of all but the cardiovascular and haematopoietic system, suggesting that tissues can be 
divided into those dependent on or independent of D cyclin activity[379j. The 
simultaneous peak in both CCND1 and CCNE1 in my data is corroborated by a previous 
study investigating circadian expression of cyclin D1 and E in the human colon, showing 
a similar simultaneous peak in both cyclins[122j. To date, no studies have examined the 
temporal profile of cyclins in human small intestine; however as these sites undergo 
similar developmental and physiological processes, the pattern of cell cycle protein 
changes would be expected to be similar. Other studies have reported differences in the 
relative timing of D cyclins in various non-intestinal cell types, hence the different peaks
in protein expression of cyclins D1 and D2 to that of cyclin D3 in this study (as shown in
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Figure 5.10 and Table 5.4) may be a result of differential regulation and a degree of
functional redundancy[380, 381]. Lack of transcriptional rhythmicity in vivo (Figure 5.11, 
Table 5.5) corroborated the lack of response of Ccndl and Ccnel at an mRNA level to 
mir-16 overexpression in vitro. Ccnd3 exhibited strong rhythmicity at a transcriptional 
level in vivo (Figure 5.11C) despite a lack of transcriptional responsiveness to mir-16 
overexpression in IEC-6 cells (Figure 5.8C) while in complete contrast, CDK6 did not 
display diurnal rhythmicity of transcription in vivo (Figure 5.11F) despite its 
transcriptional responsiveness to mir-16 overexpression in IEC-6 cells (Figure 5.9F). The 
lack of significant transcriptional rhythmicity in Ccndl and Ccnel expression (Figure 
5.11) but the presence of significant rhythmicity of Ccnd2 and Ccnd3 expression (Figure 
5.11) further highlights the possibility of differential regulation of the D cyclins in the 
intestine.
The acrophase of mir-16 occurs at ZT 6, as indicated in Figure 5.2A and Table 5.1 and is 
coincident with the troughs in enterocyte number and crypt depth, as shown in Figure 
5.12B-D. These coordinated responses point to mir-16 as an important regulator of 
proliferation in jejunal crypts. This function may be essential to coordinate intestinal 
circadian rhythms, serving to optimally match proliferation and absorptive capacity with 
nutrient availability. My data showed peak S-phase to occur at ZT 3 (Figure 5.12A, Table 
5.6), indicating a Gl/S duration of approximately 10 to 15 hours, in agreement with 
previous studies showing a long Gl/S and short G2/M period in the small intestine[382- 
384]. The degree of change in cell labelling observed at ZT 3 vs. ZT 15 (63%, Figure
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5.12A) is also similar to the 30-60% increase at ZT 3 in murine jejunum reported by
Scheving etal[112,117].
My data show that mir-16 is able to affect translation of CCND1, CCND3 and CCNE1 
without affecting mRNA expression, as demonstrated in Figures 5.8 and 5.9, 
corroborating previous data showing microRNAs are able to suppress protein levels 
independent of mRNA expression[209]. This was also demonstrated by my findings in 
vivo; CCND1 and CCNE1 showed rhythmicity only at the protein level (Figure 5.10). This 
is in keeping with previous data by Reddy et al[260] showing that almost half of the 
proteins demonstrating circadian rhythmicity in the mouse liver lack a corresponding 
cycling transcript. The rhythmicity in CCND1 and CCNE1 does not appear to be initiated 
at the transcriptional level in rat jejunum (Figure 5.11) and my findings suggest the 
possibility that the rhythmic protein expression of these two genes in the jejunum in my 
study as noted in Figure 5.8 may be produced solely by miRNAs, whether by mir-16 
alone or in combination with others. Cell-type specificity of the rhythmicity of mir-16 
itself, such as seen in the intestinal crypts in my study (Figure 5.3), would then lead to 
consequent rhythmicity of target proteins.
The amplitude of change in protein and mRNA expression of each these genes in my 
diurnal studies is rather modest, ranging from a 2.3 to 4.4 fold diurnal change in protein 
expression and a 2.3 to 2.8 fold change (where present) in mRNA expression (Figures 
5.10 and 5.11 respectively). Similarly the reduction in protein and mRNA expression
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following microRNA overexpression was equally modest, ranging from a 2 to 3-fold 
reduction in protein expression compared to controls and for some genes, 2.5 to 5 fold 
reduction in mRNA expression compared to controls (Figures 5.8 and 5.9 respectively}. 
These findings are in keeping with data from Baek et al[209], who demonstrated that 
proteins were only repressed to 0.8 fold of the levels of controls by each microRNA in 
vitro. mRNA expression was even less repressed, with a mean decrease in expression to 
0.9 fold of the level of controls. Similar effects were demonstrated on deleting a single 
microRNA in vivo - target protein expression was increased by 1.2 fold and target mRNA 
expression by 1.1 fold[209]. In the abovementioned study each microRNA was able to 
repress hundreds of target genes, with consistently greater effects on protein 
expression compared to mRNA expression. The authors further noted that the more 
highly repressed proteins were more likely to exhibit repression at the transcriptional 
level[209]. This is in keeping with the data from my study; 3 of the 4 proteins exhibiting 
the greatest peak-trough fold-change in rat jejunum exhibited rhythmicity at the mRNA 
level as well. Such a correlation was not as clear in vitro in the effects of mir-16 on 
protein and mRNA expression in IEC-6 cells. Only 2 of the 5 proteins repressed at a 
protein level exhibited repression at the mRNA level in vitro. This discrepancy may be a 
reflection of the presence of additional factors in vivo that may also play a role in the 
regulation of rhythmicity. One example is humoral regulation of the cell cycle[128, 385, 
386], for instance by corticosteroids. Cortisol has been previously described to suppress 
enterocyte proliferation in vivo as well as in vitro and cortisol levels are known to exhibit 
diurnal rhythmicity in vivo[128, 385, 386]. The superimposition of rhythmicity in cortisol 
expression on to the rhythmicity of mir-16 in vivo but lack of rhythmicity in cortisol in
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vitro may be one cause of the discrepancy in findings between my in vivo and in vitro
data.
Other factors may also be mediating this discrepancy between protein and mRNA 
rhythmicity in vivo. Regulation of gene expression by microRNAs is a complex process, 
with the potential for each to target many related or unrelated genes and for responsive 
genes to be regulated by multiple microRNAs. As such, mir-16 may not be the only 
potential microRNA regulating diurnal rhythms in cell cycle genes. Several other 
microRNAs are known to affect target proteins involved in the cell cycle. Overexpression 
of mir-34a suppresses E2F1 and E2F3, members of the E2F signalling pathway, in colon 
cancer cell lines, arresting ceil proliferation[387]. mir-192 and mir-215 also had a 
negative effect on proliferation, arresting colon cancer cells in Gl[388], In contrast, mir- 
106b and mir-221 accelerate Gl/S progression by suppressing the cyclin-dependent 
kinase inhibitors p21 and p27, respectively[389, 390]. As none of these microRNAs met 
the criteria for PCR validation (sequence conservation and a two-fold change or greater 
between timepoints on microarrays), they were not investigated further in my studies. 
There is therefore insufficient evidence to speculate as to whether these microRNAs 
might play a roie in regulating the circadian rhythmicity in proliferation in the rat 
jejunum, however the possibility that they might act to regulate proliferation along with 
mir-16 despite a presumed lack of rhythmicity cannot be excluded.
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Factors other than microRNAs are also clearly important in cuing the intestinal 
proliferation rhythm. Members of the clock gene family have been shown to regulate 
rhythmicity of genes involved in proliferation[391-393]. For instance, mPerl deficient 
mice exhibit deregulation of the temporal expression of cell cycle genes c-Myc, Cyclin A, 
Mdm-2 and Gadd45a[391]. Both PER and CRY have been found to indirectly regulate 
cyclin D1 expression in vivo[342, 393] - this is likely to occur via transcriptional 
regulation of the clock-controlled gene c-myc, which is a regulator of cyclin Dl, but to 
date has not been found to affect expression of the other Gl/S regulators examined in 
this study.
Although microRNAs are particularly well known for their ability to dissociate protein 
expression from mRNA expression, other genes may also be responsible for the 
regulation of post-transcriptional rhythmicity of gene expression. In this study cyclin Dl 
exhibited rhythmicity at the protein level but not at the transcriptional level. The protein 
SNIP1 has been found to play a role specifically in the post-transcriptional regulation of 
cyclin Dl via regulation of mRNA stability as the absence of SNIP1 destabilizes cyclin Dl 
mRNA and results in its premature degradation [394], making SNIP1 a potential 
candidate for non-microRNA mediated regulation of post-transcriptional rhythmicity. A 
further candidate for the post-transcriptionai regulation of cell cycle gene rhythmicity is 
Skpl-Cdc53/Cull-F-box (SCF) protein SCFhCDC4 which mediates the ubiquitination and 
degradation of cyclin El[395], another mir-16 target which, as shown in Figure 5.10 and 
5.11, demonstrates post-transcriptional but not transcriptional rhythmicity on a 
circadian basis. To date the presence of any circadian rhythmicity in SNIP1 or SCFhCDC4
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expression in the intestine that might contribute to the observed post-transcriptional
circadian rhythmicity of cell cycle gene expression is unknown.
Ultimately, proliferation and cell cycle rhythms may be a result of combined inputs of 
circadian clock components, post-transcriptional regulators, other transcription factors 
and rhythmic microRNAs. This potentially multifactorial regulation of circadian 
rhythmicity may explain, amongst the other observations described above, rhythmicity 
in CDK4 (Figure 5.10), a ceil cycle gene shown not to be regulated by mir-16 in vitro 
(Figure 5.8 and 5.9) and the lack of transcriptional rhythmicity in Cdk6 in vivo (Figure 
5.11) despite responsiveness to mir-16 overexpression in vitro (Figure 5.8 and 5.9). 
Generation of knockout mice lacking mir-16 will be invaluable in defining its functions 
and dissecting these regulatory pathways.
Finally, a broader implication can be drawn from these findings. The temporal 
expression profile of mir-16 in vivo and its suppression of ceil proliferation in vitro 
highlight microRNA-mediated gene silencing as another potential route for linking 
proliferation to nutrient availability, which cues the intestinal rhythms. Rhythmic mir-16 
expression in crypt cells could be initiated by luminal nutrients directly or via neuro- 
hormonal pathways. In either case, proliferation may be a key early component to 
expand the mucosal surface area in the anticipatory diurnal increases in absorptive 
capacities for glucose, peptides and other nutrients[69, 70].
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In summary, the studies in this chapter show for the first time rhythmicity of microRNA
expression in the intestine and anti-proliferative effects of the diurnally expressed mir- 
16 in untransformed enterocytes in vitro. My findings here lead me to hypothesize that 
rhythmicity of mir-16 in jejunum may act to mediate the rhythmicity in intestinal 
proliferation and coordinate the proliferative response with nutrient availability to 
optimize intestinal absorption and function.
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Chapter 6: Conclusions
Short bowel syndrome is a clinical condition that results from the loss of a large 
proportion of functioning intestine[2, 396]. The absorptive capacity of the remnant 
intestine fails to meet the individual's nutritional needs, requiring supplementation of 
nutrients by the parenteral route[2, 396]. This condition therefore remains one of high 
morbidity and mortality[2]. Current treatments involve lifelong intravenous 
feeding[396] or intestinal transplantation[397], management options which are 
associated with significant side-effects including the risk of death. There is therefore a 
great need for alternative therapies for short bowel syndrome and the work from our 
laboratory aims to address this. To identify better management options for short bowel 
syndrome we chose to investigate the molecular pathways governing the important 
physiological phenomenon of diurnal rhythmicity in intestinal absorption, which allows 
upregulation of intestinal absorptive capacity to match nutrient availability.
Rhythmicity in nutrient absorption by the rat intestine occurs with a 24-hour periodicity,
with peak absorption occurring at the time of maximal nutrient delivery[12]. This is
facilitated by rhythmicity of intestinal proliferation and various morphological
parameters such as crypt depth and enterocyte number [112, 307], thereby increasing
the intestinal surface area available for absorption of vital nutrients and matching
nutrient availability to absorptive capacity. Superimposed on this background of
rhythms in intestinal proliferation is the specific rhythmicity of expression of selected
intestinal genes; work by our group[13, 63, 69] and others[398, 399] have shown diurnal
rhythmicity in the expression of specific key nutrient transporters, specifically SGLT1,
Page 237 of 272
but a lack of rhythmicity in the expression of certain other genes[71]. This suggests that 
separate moiecular pathways may mediate the rhythms in intestinal proliferation and 
the specific rhythmicity of individual gene expression. Analysis of the current literature 
suggested the possible existence of distinct regulatory mechanisms mediating the 
rhythmicity of intestinal absorption. microRNAs, a newly discovered class of 
endogenous gene silencers, have been shown to play a role in the simultaneous 
silencing of many genes. These molecules have been shown to regulate rhythmicity of 
hepatic genes[17] and mediate the proliferative response in other tissues[19, 21, 373, 
387-390]. On the other hand, clock genes, circadian molecular feedback loops, have 
been shown to regulate the expression of individual transporters such as MDR1 and 
PEPT1 in the intestine[15, 16] and of NHE3 in the kidney[14]. I therefore hypothesized 
that rhythmicity in intestinal absorption may be a result of clock-gene mediated 
regulation of rhythmicity of SGLT1 expression superimposed on a background of 
microRNA-mediated regulation of circadian rhythmicity of intestinal proliferation.
A major aim of this thesis was to correlate rhythms in Sgltl expression with rhythms in 
clock gene expression and identify clock genes that might act as potential transcriptional 
regulators of Sgltl using in vitro studies. My studies show diurnal rhythmicity of the 
expression of clock genes Clock, Small, Perl, Per2, Cryl, Cry2, ReverbA and ReverbB as 
well as Sgltl in the jejunum of rats harvested at diurnal timepoints (Figure 3.2, Table 
3.1). The shift in the temporal expression of the clock genes (Figure 3.6, Table 3.2) as 
well as SGLT1 (Figure 3.7, Tables 3.2) in the jejunum of rats with nutrient availability 
restricted to only the lights-on period shows nutrients to be a strong cue of rhythmicity
in the intestine. PERI in particular was found to shift in phase with Sgltl expression in
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these rats (Figure 3.11, Table 3,3). I therefore postulated that PERI might act as a 
transcriptional regulator of Sgltl and chose PERI for further in vitro studies to 
investigate this.
My subsequent studies using knockdown of PERI in Caco-2 enterocytes showed that 
PERI downregulates SGLT1 in vitro (Figure 4.3, Table 4.2) without altering the 
expression of Clock, Bmoll, Per2, Cryl, Cry2 ReverbA or ReverbB (Figure 4.5, Table 4.3). 
Promoter studies using the human SGLT1 promoter and PERI overexpression vectors in 
the non-enterocytic CHO cell line showed that PERI acted via the proximal Ikb of the 
SGLT1 promoter (Figure 4.9, Table 4.5). E-boxes are consensus binding sites for various 
transcription factors including clock genes; 4 E-box sites were found on the proximal Ikb 
of the SGLT1 promoter (Figure 4.6). Mutation of these E-box sites on the SGLT1 
promoter increased SGLT1 promoter activity, suggesting that E-box sites mediated a 
suppressive effect on the SGLT1 promoter (Figure 4.10, Table 4.6). Introduction of the 
PERI overexpression vector suppressed SGLT1 promoter activity despite mutation of E- 
boxes, indicating that the actions of PERI on SGLT1 are independent of E-boxes (Figure 
4.11, Table 4.8) and likely to occur via other binding sites on the SGLT1 promoter. 
Moreover E-boxes themselves are likely to mediate rhythmicity in SGLT1 promoter 
activity via other rhythmic genes such as clock-controlled genes, known to mediate 
rhythmicity of other intestinal genes[16]. The above findings, detailed in Chapters 3 and 
4, are shown as a schematic in Figure 6.1. These new insights into the regulation of 
SGLT1 by clock genes suggest that manipulation of clock gene expression may facilitate 
modulation of SGLTl-mediated glucose absorption for the management of short bowel 
syndrome.
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Figure 6.1: Interaction of clock genes and SGLT1.A schematic of my data (detailed in 
Chapters 3 and 4) demonstrating rhythmicity of clock gene and Sgltl expression in vivo 
and suppression of SGLT1 by PERI in vitro. TF=transcription factor, CCG=clock-controlled 
gene.
Another major aim of this thesis was to identify microRNAs exhibiting diurnal
rhythmicity in expression in the intestine and correlate rhythmicity in microRNA
expression with rhythms in morphology and proliferation in vivo. In my studies, levels of
mir-16, mir-20a and mir-141 were found to oscillate with a 24-hour periodicity in the
jejunum of ad libitum fed rats (Figure 5.2, Table 5.1.), identifying for the first time
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diurnal rhythmicity in intestinal microRNA expression. The decrease in expression of 
mir-16 during the late light phase (Figure 5.2A, Table 5.1), coinciding with the peak in 
morphological parameters such as crypt depth, number of enterocytes per crypt and the 
proliferation marker BrDU in the intestine (Figure 5.12, Table 5.6) and in keeping with its 
known anti-proliferative function in other tissues[18-21], meant that mir-16 was chosen 
for further investigation.
A further aim of this thesis was to subsequently determine the effects of these 
microRNAs on enterocyte proliferation in vitro. My proposal that mir-16 might regulate 
intestinal proliferation is supported by my data showing significantly higher levels of 
mir-16 in LCM-captured crypts of rats harvested at ZT 6 compared to ZT 18 (Figure 5,3), 
indicating diurnal rhythmicity of mir-16 in the crypt fraction, the site of proliferation in 
the intestine. Loss of mir-16 was found to suppress expression of the cell cycle 
regulators CCND1, CCND2, CCND3, CCNE1 and CDK6 in crypt-derived IEC-6 cells (Figure 
5.8, Table 5.2), thereby inhibiting proliferation and inducing G1 arrest (Figures 5.6 and 
5.5). Measurement of the temporal profile of morphological parameters in rat jejunum 
showed diurnal rhythmicity of crypt depth, villus height and number of enterocytes per 
crypt (Figure 5.10, Table 5.4), all of which oscillated in antiphase to the temporal 
expression of mir-16 (Figure 5.2, Table 5.1). My data therefore identifies mir-16 as a 
potentially important microRNA in regulating diurnal rhythms in intestinal proliferation. 
The findings of Chapter 5 are summarised in the schematic shown in Figure 6.2, 
highlighting microRNAs as potential targets in the modulation of intestinal proliferation 
and thereby the development of new treatments for short bowel syndrome.
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Figure 6.2: Effects of mir-16 on intestinal proliferation. A schematic of my data (detailed 
in Chapter 5) highlighting the postulated role of mir-16 in regulation of intestinal 
proliferation.
My findings therefore support my hypothesis that several independent molecular 
regulatory pathways may contribute to the known rhythmicity in intestinal absorption 
(Figure 6.3). MicroRNAs, such as mir-16, may have a role in regulating the rhythmicity in 
intestinal proliferation, thereby increasing intestinal surface area to match absorptive
capacity to the times of peak nutrient delivery. In contrast clock genes, such as PERI,
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may act on individual genes, upregulating the expression of key transporters during 
maximal nutrient availability to further increase the absorptive capabilities of the 
intestine.
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Figure 6.3: Schematic showing the proposed regulatory mechanisms contributing to the 
rhythmicity in intestinal absorption. The filled arrows show the regulatory pathways that 
have been investigated in my studies and proposed as potential regulatory mechanisms 
behind rhythms in intestinal absorption. The dashed arrows suggest possible alternative 
or additional regulatory pathways that have not been investigated in these studies.
The existence of separate molecular pathways regulating rhythmicity of intestinal 
proliferation and regulating rhythmicity of individual transporters may represent a
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means of conservation of energy by the organism. While rhythmicity in intestinal 
proliferation contributes to an overall increase in absorptive capacity, regulation of 
individual transporters on the other hand allows additional specific upregulation of 
transporters required for nutrient absorption, minimizing the energy wastage that 
would accompany simultaneous upregulation of all transporters regardless of function. 
The existence of distinct regulatory pathways allows unique peaks in transporter 
expression, temporally distinct from the peak in global increase in absorptive capacity 
that would be expected to accompany the peak in morphological parameters. One 
example of this can be found in the rhythmicity exhibited by intestinal drug 
transporters, shown in previous studies from our laboratory[71]. A select number of 
drug transporters in the jejunum (Mdrl, monocarboxylate transporter Mctl, multidrug 
resistance protein Mrp2 and breast cancer resistance protein Bcrp) were found to show 
peak expressions occurring out of sync with the time of peak morphological parameters. 
This difference is likely related to the role of drug transporters which control drug 
efflux[73, 400] rather than nutrient absorption. Clock genes have been shown to play a 
role in the regulation of the rhythmicity of at least one of these drug transporters, 
MDR1[15], The separate regulation of the rhythmicity of these drug transporters by 
clock genes allows modulation of the time of peak expression and matches the time of 
peak expression to the more relevant parameter of peak drug metabolite concentration 
in the intestine.
Although the proposal that rhythmicity of intestinal proliferation is regulated by a
pathway distinct and separate to that regulating rhythmicity in transporter expression is
attractive, to date there are insufficient data to completely exclude overlapping roles of
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each of these molecular regulatory pathways; for instance clock genes may also play a 
role in the regulation of intestinal proliferation and similarly microRNAs may regulate 
the expression of individual transporters. Deciphering the interactions of these 
regulatory mechanisms may allow new insights into the understanding of physiological 
rhythmicity of intestinal absorption and therapies targeting one or both of these 
pathways and may hence contribute to developing new treatments to upregulate 
intestinal absorption in short bowel syndrome.
While the role of clock genes in regulation of rhythmicity of intestinal proliferation has 
not previously been studied, recent data has identified a role for clock genes in the 
regulation of tumorigenesis in the small intestine and colon[401], Downregulation of 
PER2 was found to increase cell proliferation in colon cancer cell lines via upregulation 
of cyclin D1 and (3-catenin[401]. Similarly, expression of P-catenin and cyclin D1 was 
increased in the small intestine and colon of Per2-/~ mice. Loss of PER2 also accelerated 
tumorigenesis as measured by the rate of polyp formation in the small intestine of 
ApcMm/+ mice[401]. Clock genes have been found to regulate proliferation in other 
tissues besides the intestine; for instance the circadian clock mediates tumorigenesis in 
a breast cancer model in vitro[402]. Depletion of PERI and PER2 enhanced tumour 
growth in implanted breast cancer cells in a circadian manner, with the greatest 
enhancement noted at the time of physiological peak in PERI and PER2 expression[402]. 
BMAL1 has been shown to indirectly suppress expression of the cell cycle inhibitor p21 
via ROR response elements on the p21 promoter[403]. Consistent with these in vitro 
findings, hepatocyte proliferation was impaired in Bmall-/- mice[403]. Clock has been
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shown to be pro-proliferative; cell-cycle inhibitory genes (e.g., p21, p27, Chkl, Chk2 and 
Atrl) were up-regulated while proproliferative genes (e.g., Jak2, ERa, Pbef, Aktl, Cdk2, 
cyclins D3 and El) were down-regulated in the liver of Clock-/- mice, concomitant with a 
lack of proliferation of cultured fibroblasts from Clock-/- mutant mice [404]. These 
studies suggest that the possibility that clock genes may also contribute at least in part 
to the regulation of proliferation in the intestine cannot be discounted.
To determine whether microRNAs may play a role in the specific regulation of SGLT1 in 
addition to regulating intestinal proliferation, I analysed the 3'UTR of SGLT1 for the 
presence of complimentary binding sites to any of the three validated rhythmically 
expressed microRNAs - mir-16, mir-20a and mir-141 - using the microRNA target 
prediction algorithm Targetscan, freely available at www.targetscan.org (accessed on 
29th August 2008)[206]. There were no complementary sites for any of the three 
rhythmic microRNAs on the SGLT1 3JUTR. Furthermore there were no microRNA binding 
sites conserved across mammalian species for any microRNA on the 3'UTR of SGLT1. 
While a number of non-conserved sites were identified, these have been suggested to 
represent sites of reduced evolutionary significance and are considered therefore to be 
of reduced biological importance[405], making it less likely that microRNAs might play a 
role in the regulation of the rhythmicity of SGLT1.
While the data in Chapters 3-5 suggest that both clock genes and microRNAs may 
contribute to the regulation of rhythmicity of intestinal absorption, the relationship 
between intestinal clock genes and intestinal microRNAs has not been explored in my
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studies. However several examples of microRNA-clock gene interactions exist in the 
literature[17; 229, 406, 407]. miR-132 and miR-219 display circadian rhythmicity in 
murine brain[229], with up to a 3-foid difference in microRNA levels between subjective 
day and night. Two other miRNAs examined in this study, miR-16 and miR-128a, 
exhibited no significant change in expression over a diurnal cycle, suggesting that the 
rhythmicity noted in miR-219 and miR-132 expression was unique to these microRNAs 
and not a simple reflection of oscillation in the microRNA-processing machinery, mir-132 
or mir-219 indirectly stimulated Perl promoter activity in vitro, acting synergistically 
with each other and with increased effect in the presence of CLOCK and BMALI[229]. 
Circadian rhythmicity of mir-219 was obliterated upon genetic deletion of the clock 
components Cryl and Cry2, indicating that the circadian rhythmicity of these microRNAs 
is dependent on the molecular clock[229]. Functional experiments using wheel-running 
activity revealed a role for miR-219 in modulating circadian period length, as reduction 
of miR-219 levels using antisense microRNA increased period length in mice[229]. miR- 
132 expression was stimulated by light and in turn was found to mediate the phase- 
shifting capacity of light[229]. Subsequent analysis of miR-219 and miR-132 targets 
revealed circadian oscillation of these transcripts in mouse brain, in vitro experiments 
showed that miR-219 and miR-132 acted synergistically to increase Perl transcription, 
further confirming a role for these microRNAs in modulation of the circadian clock[229].
Recently the primary transcript of miR-122, the most abundant microRNA in the liver, 
was shown to exhibit circadian rhythmicity in wild-type mice; this was lost in ReverbA
null mice[17]. The authors further demonstrated that depletion of miR-122 levels with
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antisense oligonucleotides selectively dysregulated the expression of transcripts known
to exhibit circadian rhythmicity[17].
The mir-192/194 cluster in turn suppresses PERI-3 expression[406] in colon cancer cell 
lines. The known high expression of miR-192 and miR-194 in the liver and kidney[408; 
409], tissues capable of rhythmicity in clock gene expression independent of the SCN, 
suggests that these microRNAs may play a role in maintaining tissue-autonomous clock 
gene expression. At present the pattern of expression of these microRNAs in these 
tissues remains unknown. In recent studies Kadener et al[407] identified a role for the 
Drosophila microRNA bantam as a regulator of the clock gene elk. Bantam is highly 
expressed in circadian cells in Drosophila and suppresses c/k via evolutionarily conserved 
sites on the 3'UTR of the elk gene, which are essential for maintenance of circadian 
rhythmicity of elk. Both bantam and elk exhibited circadian rhythmicity, and 
overexpression of bantam delayed the circadian clock by 3 hours at both a molecular 
and behavioural level[407].
The relationship between mir-16 and clock genes has yet to be explored. This is in great 
part due to the difficulty in accurately establishing the site of the promoter, which has 
been found in microRNAs to range from a few kb to up to 50kb upstream of the 
microRNA sequence[410], hence requiring further studies to define the mir-16 promoter 
before the use of conventional promoter assays to assess the role of clock genes as 
transcriptional regulators of mir-16.
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Although my data suggest a role for clock genes and microRNAs in regulating the 
rhythmicity of intestinal absorption, accurately identifying the contribution of each of 
these molecular pathways and delineating any areas of overlap of their suggested 
functions would require the use of knockout mice. Loss of mir-16 in vivo would be 
expected to blunt the rhythmicity of intestinal proliferation, but may also reveal 
unexpected effects on individual intestinal transporters and on the rhythmicity of clock 
genes themselves. Similarly loss of PERI in vivo would be expected to blunt rhythmicity 
in SGLT1 expression, but may unexpectedly reveal blunting of microRNA rhythmicity or 
intestinal proliferation. Both mir-16 and PERI are expressed ubiquitously in both 
rodents and humans, necessitating the creation of mice bearing intestine-specific 
deletion of these genes to exclude confounding effects of loss of expression in other 
tissues. At present such mice do not exist, hence these remain aims for future studies.
My data suggest that rhythmicity in intestinal absorption may be mediated by at least 
two molecuiar pathways, circadian clock genes and microRNAs (Figure 6.1). These 
studies add new insights into our understanding of the factors mediating these 
physiological rhythms in absorption. The interaction between the microRNA and clock- 
gene mediated gene regulatory pathways remains an important subject for future 
studies, however my findings are an essential first step in attempts to develop new 
therapies for conditions of insufficient absorption such as short bowel syndrome.
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Abstract
The intestine exhibits striking diurnal rhythmicity in glucose uptake, mediated by the sodium glucose cotransporter 
(SGLT1); however, regulatory pathways for these rhythms remain incompletely characterized. We hypothesized that 
SGLT1 rhythmicity is linked to the circadian clock. To investigate this, we examined rhythmicity of Sgltl and individual 
clock genes in rats that consumed food ad libitum (AL). We further compared phase shifts of Sgltl and clock genes in a 
second group of rats following restricted feeding to either the dark (DF) or light (LF) phase. Rats fed during the DF were 
pair-fed to rats fed during the LF. Jejunal mucosa was harvested across the diurnal period to generate expression profiles 
of Sgltl and clock genes Clock, Bmall (brain-muscle Amt-like 1), ReverbA/B, Per (Period) 1/2, and Cry (Cryptochrome) 1/2. 
All clock genes were rhythmic in AL rats (P < 0.05). Sgltl also exhibited diurnal rhythmicity, with peak expression 
preceding nutrient arrival (P< 0.05). Light-restricted feeding shifted the expression rhythms of Sgltl and most clock genes 
(Small, ReverbA and B, Perl, Per2, and Cryl) compared with dark-restricted feeding (P< 0.05). The Sgltl rhythm shifted 
in parallel with rhythms of Perl and ReverbB. These effects of restricted feeding highlight luminal nutrients as a key 
Zeitgeber in the intestine, capable of simultaneously shifting the phases of transporter and clock gene expression, and 
suggest a role for clock genes in regulating Sgltl and therefore glucose uptake. Understanding the regulatory cues 
governing rhythms in intestinal function may allow new therapeutic options for conditions of dysregulated absorption such 
as diabetes and obesity. J. Nutr. 140: 908-914, 2010.
Introduction
Circadian rhythmicity in gene and protein expression has been 
demonstrated in numerous mammalian organs and tissues. 
These rhythms serve a major physiological role by matching 
many visceral functions to anticipated environmental demands 
(1). We and others have documented circadian rhythmicity in 
intestinal expression of digestive enzymes and transporters for 
both nutrients and nonnutrients (2-5). Our studies on the
1 Supported by the NIH grant 5 R01 DK047326 (S.W.A.), ADA grant 7-05-RA-121 
(D.B.R.), the Harvard Clinical Nutrition Research Center grant (AT.) 
P30-DK040561, the Nutricia Research Foundation (A.B.), and the Berkeley 
Fellowship (A T S.).
2 Author disclosures: A. Balakrishnan, A. T. Stearns, S. W. Ashley, A. 
Tavakkolizadeh, and D. B. Rhoads, no conflicts of interest.
3 Supplemental Figures 1 and 2 and Supplemental Table 1 are available with the 
online posting of this paper at jn.nutrition.org.
4 This manuscript was presented in poster form at Digestive Diseases Week 
2007 and 2008, and published in abstract form only in the supplementary issue of 
Gastroenterology (less than 400 words).
* To whom correspondence should be addressed. E-mail: anita.balakrishnan® 
doctors.org.uk and rhoads@helix.mgh.harvard.edu.
intestinal sodium-glucose cotransporter (SGLT1),1 2 3 4 which is 
responsible for all active intestinal glucose uptake, demonstrate 
that rhythmicity in intestinal glucose uptake is conferred entirely 
by rhythmicity in transcription, translation, and function of 
SGLT1 (3). However, the molecular cues triggering rhythmicity 
in the Sgltl gene (SlcSal) and protein expression remain 
unknown.
Previous studies have identified a set of genes, referred to as 
clock genes, involved in the regulation of circadian rhythms, 
such as hormone secretion, and autonomic functions, including 
body temperature and blood pressure (6,7). In mammals, the 
master clock resides in the suprachiasmatic nucleus (SCN) and 
maintains a 24-h periodicity entrained by light (8) and regulated 
via opposing positive and negative molecular feedback loops. 
Mammalian clock components include Perl, Per2, Clock, 
Bmall, ReverbA and B, and Cryl and Cry2. Heterodimers of 
Clock and Bmall positively regulate Per and Cry genes via
9 Abbreviations used: AL, ad libitum; DF, dark fed; HALO, hours after light onset; 
LF, light fed; SCN: suprachiasmatic nucleus.
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promoter E-boxes (CAnnTG). Nuclear accumulation of Per and 
Cry inhibits Clock/Bmall activity, which represses Per and Qy, 
thereby setting up an oscillation in their expression (9,10). 
Orphan nuclear receptors ReverbA and ReverbB have been 
identified as key regulators linking the positive and negative 
limbs of the circadian oscillator, with Reverb transcription 
driven by Bmall/Clock and suppressed by Per and Cry (11,12). 
In addition to the central SCN circadian pacemaker, clock genes 
are also expressed in many peripheral tissues, including the 
heart, retina, lung, kidney, peripheral blood cells, and liver (13- 
16). While several clock genes are known to oscillate in the 
intestine, the temporal expression patterns of Reverbs have not 
been characterized.
While light is the predominant Zeitgeber (“time giver” or 
entraining cue) for the central SCN clock, peripheral clocks can 
be dissociated from the central clock by various stimuli, 
including nutrient availability and glucocorticoid exposure 
(11,17,18; A. T. Stearns, A. Balakrishnan, K. Abolmaali, D. 
B. Rhoads, S. W. Ashley, A. Tavakkolizadeh, unpublished 
results). Feeding in particular is a strong Zeitgeber. Restricted 
feeding can reset the peripheral clocks in the liver, kidney, heart, 
and pancreas within 1 wk with no change in phase of the SCN 
clock (19-21) and is a sufficiently potent Zeitgeber to reinstate 
rhythmicity of the liver clock in otherwise arrhythmic SCN- 
lesioned mice (22).
We hypothesized that rhythmic expression of SGLT1 in the 
rat intestine is driven by peripheral circadian clocks to link 
function to nutrient availability. We surmised that Sgltl would 
have a similar phase to 1 or more clock genes and that clock 
genes and Sgltl would exhibit parallel phase shifts in response to 
restricted feeding. Our studies show that nutrient availability 
acts as a major Zeitgeber in rat intestine, independent of light 
cycle, and simultaneously phase shifts Sgltl and clock gene 
expression. These results provide evidence for regulation of 
SGLTl by the peripheral clock.
Materials and Methods
Animal studies. All animal study protocols were prospectively 
approved by the Harvard Medical Area Standing Committee on Rats.
Sprague-Dawley rats (50 males, 7 wk old) were purchased from 
Harlan World and acclimatized to a 12-h-light/-dark photoperiod for 5 d 
with ad libitum access to food (Picolab Rodent Diet 20, LabDiet, 
containing 21% protein, 9.9% fat, 4.4% fiber, and an energy value of 
3.42 kcal/g) and water. Time is designated as H After Light Onset 
(HALO), with HALO 0 at 0700 h (lights on). In the control arm, rats 
received food ad libitum (designated AL) and were killed at 3-h intervals 
beginning at HALO 0 (n ~ 6-7 per time; Supplemental Fig. 1A). A second 
group of 50 male rats were similarly acclimatized, then randomly 
assigned to be fed for 7 d either during only the dark phase (designated 
DF; HALO 12-24, Supplemental Fig. IB) or light phase (designated LF; 
HALO 0-12, Supplemental Fig. 1C). DF rats were pair-fed to LF rats to 
ensure equal food intake. Rats were housed in pairs in cages. LF animals 
were given 100 g of food per cage at 0700. The remaining food at 1900 
was weighed and subtracted from 100 g to calculate the amount 
consumed per pair of rats (we assumed that both rats consumed equal 
amounts of food). The mean daily consumption of LF rats was 
calculated, multiplied by 2, and provided to each pair of DF rats at 
1900. No food remained in the cages of DF rats at 0700 the next day. To 
minimize disruption during restricted feeding, rats were weighed only 3 
times (d 0, 3, and 7). On d 7, rats (» = 6-7) were killed at 6-h intervals 
beginning at HALO 3.
Tissue harvest. Rats were anesthetized with sodium pentobarbital (50 
mg/kg, Ovation Pharmaceuticals). The small intestine from 2 cm distal 
to the ligament of Treitz was harvested via midline laparotomy and
rinsed with ice-cold saline to remove luminal contents. The 10 cm of 
jejunum was divided along the antimesenteric border, mucosa scraped 
from the underlying muscle, snap-frozen in liquid nitrogen, and stored at 
-80°C for subsequent RNA or protein extraction.
RNA extraction, RT, and real-time PCR. Total RNA was extracted 
using the mirVana kit (Ambion). Samples were reverse transcribed 
simultaneously with Superscript III (Invitrogcn) and oligo-dT. Real-time 
PCR was performed as previously described (3). mRNA levels were 
expressed as ratios to the stably expressed B-actin. All primers were 
ordered as custom oligonucleotides from Invitrogen (Supplemental 
Table 1), except rat Per2, for which mRNA expression was measured 
using the Taqman primer-probe and gene expression Master mix 
(Applied Biosystems).
Protein extraction and Western blotting. SGLT1 protein expression 
was measured in total lysates from jejunal mucosal scrapings as 
previously described (3). Diurnal Perl protein expression in rat jejunum 
was measured in nuclear extracts of freshly collected mucosal scrapings 
(Nxtract nuclear extraction kit, Sigma). Western blotting was performed
TABLE 1 Rhythmicity, acrophase, mesor, and amplitude of
clock gene and Sgltl mRNA expression in AL rats fed 
either only during DF or LF periods1
Gene Group
Acrophase3 
(HALO, 
P-value2 hh:mm) Mesor4 Amplitude,5 %
Phase
difference6
Perl AL 0.0014 09:28 1.29 48
DF 0.0004 07:38 1.09 63 -01:50
LF 0.0015 01:38 0.96 57 -07:50
Per2 AL 0.0008 15:59 3.02 57
DF 0.0460 13:29 4.51 57 -02:30
LF 0.0470 05:32 3.22 59 -10:27
Small AL <0.0001 23:04 0.71 100
DF 0.0003 21:35 0.83 too -01:29
LF 0.0019 12:34 1.07 78 -10:30
Clock AL 0.0008 21:23 0.80 38
DF 0.5877
LF 0.5065
ReverbA AL <0.0001 06:21 0.57 76
DF 0.0001 04:34 0.37 120 -01:47
LF 0.0002 21:34 0.19 60 -08:47
ReverbB AL 0.0003 08:34 0.81 41
DF <0.0001 07:50 0.85 78 -00:44
LF <0.0001 01:29 0.71 67 -07:05
Cry! AL 0.0015 20:08 1.41 17
DF 0.0145 17:24 1.57 30 -02:44
LF 0.0033 08:50 1.41 33 -14:18
Cry2 AL 0.0097 18:41 1.47 36
DF 0.0790
LF 0.6250
Sgltl AL <0.0001 10:44 1.60 51
DF <0.0001 09:27 1.86 118 -01:17
LF <0,0001 02:27 1.96 88 -08:17
1 Cosinor analysis was used to determine rhythmicity, acrophase, mesor, and 
amplitude of clock gene mRNA expression in AL, DF, and LF rats.
2 The P-values indicate the fit of the data to a 24-h periodicity, with a P-vatue of 0.05 
indicating a 5% probability that the observed 24-h periodicity occurred by chance 
alone.
3 The acrophase is expressed as HALO (lights on is at 0700; hence, HALO 0 is 0700).
4 The mesor is the rhythm-adjusted mean.
5 The amplitude is expressed as a percentage of the mean to facilitate comparison 
across means.
6 The phase difference refers to the shift in peak expression of the gene (acrophase) in 
DF or LF animals compared with AL animals.
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as previously described (3). Nuclear or total protein extracts (75 /xg) 
were resolved on 4-12% Bis-Tris gels, transferred to polyvinylidene- 
fluoride membranes, blocked, then incubated with either rabbit anti- 
SGLT1 (1:4000; Chemicon International) or rabbit anti-Perl (1:200; 
Santa Cruz Biotechnology), respectively. Protein expression was nor­
malized to B-actin (mouse anti-B-actin, 1:1000, Labvision).
Statistical analysis. Data are presented as means ± SE. Graphical 
analysis was performed using Graphpad Prism. Circadian rhythmicity 
was determined as described previously by cross-sectional analysis using 
the Cosinor procedure, freely available online, and assuming a 24-h 
period (4,23,24). The acrophase (time of peak expression), mesor 
(rhythm-adjusted mean), amplitude of rhythmicity, and significance of fit 
to a 24-h period (as indicated by the P-value) for each gene was 
abstracted from the program. mRNA levels are expressed as ratios to 
mean expression of the respective gene at HALO 3 (DF group for all 
restricted-fed rats). The mesor is an arbitrary value, precluding compar­
isons between genes. However, amplitudes are independent of scaling 
and can thus be compared among genes and groups. Two-tailed t tests 
were used to compare weights of DF and LF groups. The acrophases for 
AL rats were subtracted from the acrophases of DF and LF rats to 
identify phase shifts relative to AL rats. A 1-sample t test was used to 
identify a significant difference in mean phase shift of DF or LF rats from 
the value 0 (complete absence of phase shift relative to AL). Differences 
were considered significant at P < 0.05.
Results
Rhythmicity of gene expression in jejunum of AL rats. All 
clock genes examined were expressed in intestinal jejunal 
mucosa. Cosinor analysis confirmed previously documented 
rhythmicity in expression of Clock, Email, Reverb A, Perl, 
Perl, and Cryl (Table 1; Fig. 1) and demonstrated that 
rhythmicity for all measured clock genes fit a 24-h periodicity 
(P < 0.05) (4,23). Periodicities of 24 h were also detected for
ReverbB, which exhibited an acrophase (peak) 2 h later than its 
paralog ReverbA, and for Cryl, which exhibited an acrophase 
2 h earlier than Cryl (Fig. 1C,£). In AL rats, amplitudes were 
greatest for Email, ReverbA, Perl, and Perl and more modest 
for Clock, Cryl, and Cry2. Positive clock regulators Email and 
Clock peaked at late dark phase (P < 0.0001; Table 1; Fig. 1A, 
B). In contrast, negative regulators Perl, ReverbA, and ReverbB 
peaked between HALO 6 and 10 and reached a trough at HALO 
0 during peak expression of Email and Clock (P < 0.005; Fig. 
1D,£). Perl expression peaked at HALO 16, a 6-h lag behind 
Perl (P < 0.005; Fig. ID). Sgltl mRNA exhibited robust 24-h 
rhythmicity as we have reported previously (3), with peak 
expression at HALO 11, close to that for Perl (HALO 9) as well 
as ReverbB (HALO 9, Table 1; Fig. ID-f).
Restricted feeding phase-shifts expression rhythms of 
both SGLT1 and clock genes. To identify regulatory cues 
triggering rhythmicity in Sgltl and clock genes, we sought to 
define their responses to imposed food availability, thus sepa­
rating nutrient cues from the light-dark cycle.
Food intake and body weight. Food consumption by LF rats 
on d 1 was 16 g (Supplemental Fig. 2A), -4 g less than the 20 g/d 
consumed by AL rats of similar weight (25) but had normalized 
by d 3. LF rats weighed less than DF rats on d 4 despite equal 
food intake (244 ± 1.4 g vs. 251 ± 1.4 g; Supplemental Fig. IB; 
P < 0.05). This was possibly a catabolic response to the stress of 
restricted feeding during daytime, or a relatively slower adap­
tation of intestinal nutrient absorption to the change in period of 
peak nutrient availability. Weights had equalized by harvest.
Rhythmicity of Sgltl and clock genes. DF rats would be 
expected to display rhythms similar to AL (Fig. 2). Although this 
was broadly true, we observed a consistent advance in acrophase
0 3 6 9 12151821 0 3 6 9 12151821
HALO
0 3 6 9 12151821 0 3 6 9 12151821
HALO
| Lights on
0 3 6 9 12151821 0 3 6 9 12151821 
HALO
Lights offLights off Lights on
D F
Reverb A 
Reverb B
0 3 6 9 12151821 0 3 6 9 121518210 3 6 9 12151821 0 3 6 9 12151821 
HALO
FIGURE 1 Circadian rhythmicity of Clock {A), Bmall {B), Cry1/Cry2 (Q, Perl/Per2 (D), ReverbA/ReverbB (E), and Sgltl (F) in AL rats. To 
facilitate comparisons of rhythmicity and amplitude, the x-axis was double-plotted and expression (y-axis) indexed to mean HALO 3 expression 
for each gene. Values are expressed as mean ± SEM, n = 6 or 7. P-values are shown in Table 1.
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FIGURE 2 Phase difference in acrophases of clock genes and Sgltl 
in DF and LF rats relative to AL rats showing a phase advance of 1.7 
and 9.6 h, respectively. Values are individual values (n = 6 or 7) and 
means ± 95% Cl. "Different from DF, P< 0.05.
for most clock genes and Sgltl in DF compared with AL rats 
(mean phase advance of 1.7 h; P = 0.0005) (Table 1; Fig. 2). 
Periodicity was retained in most clock genes and Sgltl in LF rats, 
with a mean phase advance of 9.6 and 7.9 h compared with the 
AL and DF group, respectively (P < 0.0001) (Table 1; Fig. 2). In 
contrast, amplitudes for Clock and Cry2 were lower in both 
restricted groups compared with AL, leading to a loss of 
rhythmicity (Fig. 3A,D).
The phase of the Sgltl mRNA rhythm was advanced in both 
DF and LF rats (1 and 8 h, respectively). Sgltl mRNA remained 
rhythmic in LF rats, but with a lower peak, blunted amplitude, 
and a 7-h phase difference from DF rats (Fig. 4£; P < 0.05). 
SGLT1 protein expression in DF rats peaked 4 h later than 
mRNA expression (HALO 14), 3-fold higher than the trough 
(Fig. 5A; P < 0.05). SGLT1 protein expression was highest 
during the day in LF rats, with levels 70% higher at HALO 9 
than HALO 21, but did not attain 24-h rhythmicity (Fig. 5A; P = 
0.24). We also observed higher trough SGLT1 protein expres­
sion in LF than in DF rats (P = 0.001 at HALO 21; Fig. 5A).
Clock genes Perl and ReverbB both displayed similar phase 
shifts to Sgltl under the 2 restricted-feeding regimens. The 
concordance between SGLT1 and Perl was also observed at the 
protein level in jejunal nuclear extracts (Fig. 5A,B). A 24-h 
periodicity was observed in both DF and LF rats, with 
acrophases of HALO 2 and HALO 22, respectively (Fig. SB). 
The period of increasing Perl protein coincided with the nadir of 
Sgltl mRNA and presumably its transcription (Figs. 4E and SB). 
Reverb A also exhibited similar phase shifts on restricted feeding, 
but peak ReverbA expression preceded Sgltl expression by 4- 
5 h in all 3 groups.
Discussion
All clock genes exhibited robust circadian rhythmicity in jejunal 
mucosa of AL rats. Restricting food to the LF dissociated these
DF B DF
DF DF
FIGURE 3 Circadian expression of Clock (A), Bmall (B), Cry! (Q, and Cry2 (D) in DF and LF rats. To facilitate comparisons of rhythmicity and 
amplitude, the x-axis was double-plotted and expression (y-axis) indexed to mean HALO 3 DF expression for each gene. Values are expressed as 
mean ± SEM, n = 6 or 7. P-values are shown in Table 1.
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DF DF
FIGURE 4 Circadian expression of ReverbA (A), ReverbB (B), Perl (Q, Per2 (D), and Sgltl (E) in DF and LF rats. To facilitate comparisons of 
rhythmicity and amplitude, the x-axis was double-plotted and expression (y-axis) indexed to mean HALO 3 DF expression for each gene. Values 
are expressed as mean ± SEM, n = 6 or 7. P-values are shown in Table 1.
rhythms from the light cycle. Notably, rhythmicity of both Sgltl 
mRNA and protein were shifted. Previous studies from our 
group and others have shown that rhythmicity of SGLT1 protein 
expression correlates with rhythmicity at a functional level in the 
intestine (2,3). These results establish nutrient availability as a 
key Zeitgeber for the peripheral intestinal clock(s) as well as the 
expression rhythm of the glucose transporter SGLTl.
Determining the relative shifts in glucose transporter and 
clock gene rhythms in response to restricted feeding was a major 
study aim. After 7 d of restricted feeding to either the light or 
dark period, phase differences of 6-11.5 h were observed for 
Sgltl and 5 of the 8 clock genes examined. The lack of a 
complete 12-h phase shift difference between dark- and light-fed 
rats may reflect the influence of other factors such as glucocor­
ticoids, which can also partially phase shift gene expression 
(18,19; A. T. Stearns, A. Balakrishnan, K. Abolmaali, D. B. 
Rhoads, S. W. Ashley, A. Tavakkolizadeh, unpublished results). 
The duration of nutrient availability may have also affected the 
degree of phase shift, because a shorter period of food 
availability in other studies (HALO 2-8) (26) produced a 
greater phase shift than we observed. Moreover, peripheral 
clocks adapt to restricted feeding at different rates; liver shifts 
much more quickly than lung (19). Although it is possible that 
the small intestine would achieve a complete phase shift 
following longer restricted feeding, the sufficiency of 4-d 
adaptation previously reported (27), the equal weights between 
rats in the 2 restricted groups, and the plateau in food intake in 
the LF rats (matching that expected for rats of that weight (25)] 
all suggest that the partial phase shift was due to factors other 
than incomplete adaptation. We note that the rapid adaptation 
observed in liver may result from more direct (i.e. local) 
stimulus-response pathways. Adaptation in the intestine, par­
ticularly for diurnally rhythmic functions, is indirect [as shown 
by isolated loops (28)] and may entail cephalic and other inputs.
The apparently longer period required for adaptation by intes­
tine compared with liver may reflect a tissue-specific feature 
necessary to stabilize the rhythms in intestinal functions despite 
moderately varying nutrient intake patterns. Possibly, linkage of 
phases of critical intestinal functions such as proliferation and 
absorption to extra-luminal inputs could serve to coordinate 
these rhythms, thereby assuring that DNA synthesis and peak 
absorption do not coincide.
In AL rats, Perl and ReverbB mRNA expression peaked in 
phase with Sgltl, slightly preceding Sgltl expression by 1-2 h. 
Restricted feeding produced similar phase shifts for Sgltl, Perl, 
and ReverbB; all 3 genes were phase shifted by 1-2 h in DF rats 
and 7-8 h in LF rats compared with AL rats. The presence of 4 
canonical E-boxes in the Sgltl promoter raises the possibility 
that the Perl transcription factor is involved in controlling Sgltl 
rhythmicity. If so, occurrence of the Sgltl mRNA nadir when the 
Perl protein level is rising suggests that Perl exerts a negative 
influence. Lack of Reverb response elements in the Sgltl 
promoter argues against ReverbB involvement but does not 
preclude indirect regulation or use of a noncanonical element.
We were surprised that nocturnal food restriction advanced 
the phases oi Sgltl and intestinal clock genes by 1-2 h compared 
with AL feeding. Although only a modest amount of food is 
usually consumed during the day (10-20% daily intake) (27), 
the restriction was apparently sufficient to shift gene expression 
phases. The daytime food deprivation in DF rats effectively 
prevented “early phase eating,” consumption of food in the late 
LF, and may have enhanced entrainment signals normally 
produced by hunger or hormonal responses, thereby sharpening 
the anticipatory intestinal gene induction and advancing the 
acrophases in DF rats. In either case, it is clear that restricting food 
access to 12 h led to detectable alterations in intestinal rhythms.
Overall SGLT1 protein expression was higher in LF rats 
compared with DF rats (P = 0.010), despite no significant
912 Balakrishnan et al.
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FIGURE 5 Protein expression of SGLT1 [A) and Perl (B) in DF and 
LF rats. Values are expressed as mean ± SEM, n = 6 or 7.
difference in mRNA levels (P = 0.946). This result is consistent 
with our previous finding that post-transcriptional events are 
also important in regulating intestinal SGLT1 expression (28). In 
light of reports that SGLT1 expression is increased in obesity and 
diabetes (29,30), it would be interesting to assess the functional 
consequences of our observation by comparing glucose homeo­
stasis in light- and dark-fed rats as well as measuring SGLT1 
expression in shift workers who are forced to eat off schedule 
and have increased risk of developing glucose intolerance (31).
Our findings lend support to the notion that clock genes cue 
intestinal rhythmicity in response to nutrient availability. Clock 
genes are clearly important transcriptional regulators (26,32, 
33). Clock and clock-controlled genes have been implicated in 
the regulation of other proteins such as the Na+/H+ exchanger 
Nhe3 in the kidney (32), the oligopeptide transporter Peptl 
(26), and the multidrug resistance 1 gene (33). Pan and Hussain 
(34), using Clock mutant mice, presented evidence for its in­
volvement in intestinal absorptive rhythms. Our studies add 
to the existing evidence implicating clock genes in absorptive 
rhythms and provide important information on the role of clock 
genes in regulating SGLT1 rhythmicity and thereby rhythmicity 
of glucose uptake in the intestine.
The glucose concentration generated from digestion may be a 
major stimulus in regulating the expression of clock and Sgltl 
genes in the intestine. In an intriguing study, glucose was shown 
to downregulate Perl and Perl mRNA expression in rat-1
fibroblasts (35). The authors hypothesized that glucose itself, 
which displays a modest circadian rhythm in rodents (36), 
provides a Zeitgeber for peripheral clocks, acting to down­
regulate Perl and Perl via other transcriptional regulators. This 
hypothesis is consistent with decreased Perl mRNA levels 
during the period of nutrient consumption in both AL and DF 
rats. Although plasma glucose levels are relatively constant, 
enterocytes (and probably also hepatocytes) are unique in 
experiencing abrupt increases in glucose supply and intracellular 
concentrations following feeding. Thus, glucose suppression of 
Per expression may be the molecular basis for resetting intestinal 
(and liver) clocks by nutrient availability. The ability of these 2 
“gateway” organs to respond rapidly to nutrient intake patterns 
via peripheral clocks would have great adaptive value by optimally 
coordinating absorptive functions with nutrient delivery.
In summary, we have shown that nutrients provide a major 
Zeitgeber for intestinal clock genes and that shifting the period 
of availability simultaneously phase shifts expression of clock 
genes and intestinal transporters. Further studies are required to 
define the molecular mechanism linking clock genes to Sgltl 
rhythmicity. The regulatory mechanisms governing circadian 
rhythmicity of intestinal function may have a considerable role 
in obesity and diabetes and a better understanding could lead to 
new therapies for these worsening epidemics.
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ARTICLE I N F0RMATI 0N ABSTRACT
Background and aims: The intestine exhibits profound diurnal rhythms in function and morphology, 
in part due to changes in enterocyte proliferation. The regulatory mechanisms behind these rhythms 
remain largely unknown. We hypothesized that microRNAs are involved in mediating these rhythms, 
and studied the role of microRNAs specifically in modulating intestinal proliferation.
Methods: Diurnal rhythmicity of microRNAs in rat jejunum was analyzed by microarrays and 
validated by qPCR. Temporal expression of diurnally rhythmic mir-16 was further quantified in 
intestinal crypts, villi, and smooth muscle using laser capture microdissection and qPCR. 
Morphological changes in rat jejunum were assessed by histology and proliferation by 
immunostaining for bromodeoxyuridine. In IEC-6 cells stably overexpressing mir-16, proliferation 
was assessed by cell counting and MTS assay, cell cycle progression and apoptosis by flow cytometry, 
and cell cycle gene expression by qPCR and immunoblotting.
Results: mir-16 peaked 6 hours after fight onset (HALO 6) with diurnal changes restricted to crypts. 
Crypt depth and villus height peaked at HALO 13-14 in antiphase to mir-16. Overexpression of mir-16 in 
IEC-6 cells suppressed specific Gl/S regulators (cydins Dl-3, cyclin El and cyclin-dependent kinase 6) 
and produced G1 arrest Protein expression of these genes exhibited diurnal rhythmicity in rat jejunum, 
peaking between HALO 11 and 17 in antiphase to mir-16.
Conclusions: This is the first report of circadian rhythmicity of specific microRNAs in rat jejunum. 
Our data provide a link between anti-proliferative mir-16 and the intestinal proliferation rhythm 
and point to mir-16 as an important regulator of proliferation in jejunal crypts. This function may 
be essential to match proliferation and absorptive capacity with nutrient availability.
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Introduction
Circadian rhythms (24-h oscillations) play a key role in the 
regulation of numerous physiological functions. Circadian rhyth- 
micity of up to 10% of gene transcripts and an even greater fraction 
of proteins indicate the involvement of both transcriptional and 
translational pathways [1-5]. Regulation at both the transcrip­
tional and post-transcriptional levels suggests a role for micro- 
RNAs in this process. MicroRNAs are non-coding RNAs able to 
silence numerous genes simultaneously. Bioinformatics analysis 
suggests that up to 30% of mammalian gene transcripts are 
regulated by microRNAs, short non-coding RNAs [6-9]. microRNAs 
suppress protein expression following recognition of complemen­
tary sequences on the 3'UTR (untranslated region) of target genes, 
either by inducing mRNA cleavage (which manifests as changes in 
mRNA levels) or inhibiting translation (manifesting as changes in 
protein levels) [10-12]. The presence of the target sequence for 
each microRNA on multiple genes permits simultaneous regula­
tion of protein expression from numerous genes by a single 
microRNA [6,13,14], The postulated role of microRNAs in “fine- 
tuning” gene expression suggests that they also contribute to 
coordinating the circadian rhythmicity of many genes and proteins 
[15-18].
The intestine displays profound rhythmicity of morphology, 
resulting in peak absorptive function (e.g. for glucose) coinciding 
with maximal nutrient delivery to the bowel [19,20]. The number 
of enterocytes per villus also exhibits a diurnal rhythmicity, with 
an increase about the time of maximal nutrient availability [21]. 
Similar rhythmicity has been reported in human gastrointestinal 
mucosa [22,23]. The exact pathways coordinating rhythmicity in 
proliferation are presently unknown.
We hypothesize that microRNAs are integral components for 
mediating circadian rhythms in intestinal proliferation, morphol­
ogy, and function. To investigate this, we profiled microRNAs in 
the intestine of ad libitum fed rats using oligonucleotide arrays. The 
anti-proliferative microRNA mir-16 was expressed in both crypt 
and villus enterocytes but exhibited circadian rhythmicity only in 
the crypts. The cell cycle regulators Ccndl, Ccnd2, Ccnd3, Ccnel, 
and Cdk6 also exhibited circadian rhythmicity but in antiphase to 
mir-16. An anti-proliferative role for mir-16 was supported by its 
ability to inhibit proliferation and decrease expression of genes 
involved in cell cycle regulation when overexpressed in rat IEC-6 
cells. These studies point to mir-16 as a potentially important 
microRNA in regulating circadian rhythms in the intestine.
Methods
Animal studies
All animal study protocols were prospectively approved by the 
Harvard Medical Area Standing Committee on Animals.
Sprague-Dawley rats (50 males, 7 weeks old) were purchased 
from Harlan World (Indianapolis. IN) and acclimatized to a 12:12- 
h light: dark photoperiod for 5 days with ad libitum access to food 
and water. Time is designated as hours after light onset (HALO), 
with HALO 0 at 7 am (lights on). Rats were injected with BrdU (5- 
bromo-2-deoxyuridine, 50 mg/kg; Sigma, St Louis, MO) 1 h before 
harvest to label DNA as an index of S-phase. Rats were killed at 3-
h intervals over 24 h (n = 6-7 per time) and jejunum harvested for 
microRNA microarrays, RNA and protein determination, and 
morphological analysis (harvest protocol detailed in Supplemen­
tary Material).
Microarrays and validation by real-time PCR
Total RNA from jejunum was extracted using the mirVana kit 
(Ambion; Austin, TX) and profiled on in situ hybridization arrays 
(Exiqon, Woburn, MA) against a reference sample consisting of 
RNA pooled from HALO 0 rats. Dye swaps were incorporated in the 
arrays to correct for any dye bias. Data were subjected to Lowess 
normalization and log transformed.
Expression profiles of selected microRNAs were confirmed by 
real-time PCR. Specific microRNAs were selected from total 
extracted RNA by reverse transcription using the stem-loop 
hybridization based microRNA reverse transcription kit and 
microRNA-specific primers (Taqman microRNA reverse transcrip­
tion kit and Taqman microRNA assays, Applied Biosystems, Foster 
City, CA). microRNA expression was quantified in triplicate using 
the Taqman microRNA PCR primers and Taqman gene expression 
mastermix (Applied Biosystems). Reverse transcription and PCR 
were performed simultaneously on all samples to minimize 
differences introduced by variable reaction efficiency.
mir-16 overexpression vector
The human mir-16 gene was amplified from human genomic DNA 
by PCR and inserted into the Mlul/Clal sites of the tetracycline- 
inducible TRIPZ shRNAmir expression vector (Open Biosystems, 
Huntsville, AL) using restriction sites incorporated into the 
primers (Supplementary Table 1). A non-silencing TRIPZ inducible 
shRNAmir vector was used as a control (Open Biosystems). Vectors 
were sequenced to ensure fidelity of the microRNA sequence and 
insertion. Details of cell transfection are available in Supplemen­
tary Material.
Proliferation and cell counting
IEC-6 cells were seeded in 96-well plates at a density of 1000 cells 
per well in triplicate. Proliferation indices were measured 48 h 
later using the CellTiter96 Aqueous One Solution Cell Proliferation 
Assay (MTS assay, Promega, Madison, WI). Cell growth rates were 
confirmed by cell counting in trypsinized, 48-h cultures seeded in 
triplicate at 104 cells/ml in 6-well dishes. All experiments were 
performed thrice.
Cell cycle changes and apoptosis
For cell cycle analysis, trypsinized cells were counted and fixed 
overnight in 70% ethanol at —20 °C. Fixed cells were collected by 
centrifugation at 1200 rpm for 10 min at 4°C, suspended in 
propidium iodide (BD Biosciences, San Jose, CA) for 30 min at 
37 °C in darkness, and analyzed by flow cytometry (BD FACScan, 
BD, Franklin Lakes, NJ). Data were analyzed by ModFit (Verity. 
Topsham, ME). To determine apoptosis and viability, trypsinized 
cells were counted and stained with Annexin V-FITC (BD) and 
Sytox Blue (Invitrogen), respectively, and analyzed by flow 
cytometry (10,000 events per sample). Data were analyzed using 
Diva (BD).
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RNA extraction, mRNA reverse transcription and real-time PCR
mRNA levels of Ccndl, Ccnd2, Ccnd3, Ccnel, Cdk4 and Cdk6 were 
quantified by real-time PCR as previously described [24] (detailed 
in Supplementary Material) and expressed relative to B-actin. All 
genes had Cts within the same range, between Ct 22 and 27. 
Primers were custom-ordered from Invitrogen (Supplementary 
Table 2), with the exception of Ccndl mRNA which was measured 
using the Taqman primer-probe and gene expression Master Mix 
(Applied Biosystems).
Protein extraction and Western blotting
Protein expression of Ccndl, Ccnd2, Ccnd3, Ccnel, Cdk4 and Cdk6 
was measured in total lysates from jejunal mucosal scrapings or 
IEC-6 cell lysates as previously described, and detailed in 
Supplementary Material [19].
Analysis of morphologic parameters and BrdU labeling
Sections of jejunum were fixed overnight in 10% formalin, then 
orientated and embedded in paraffin blocks, cut at 7 pm thickness, 
mounted and stained with haematoxylin and eosin. Crypt depth, 
villus height, villus width, crypt enterocyte width, villus enter- 
ocyte width, and number of enterocytes per crypt were measured 
by a blinded observer under light microscopy (Olympus BX50; 
Center Valley, PA) at lOOx or 400x magnification. Only samples 
displaying a single layer of enterocytes and villi with a visible 
central lacteal were included in the analysis (5-10 measurements 
per rat). For measurement of rhythmicity of proliferation, blocks of 
jejunum were cut at 7 pm and sections incubated with anti-BrdU 
primary antibody (Sigma), biotinylated secondary antibody, and 
visualized using the avidin-biotin-peroxidase complex method 
with diaminobenzidine tetrahydrochloride as the chromogen. 
Sections were counterstained with haematoxylin and eosin to 
facilitate counting of BrdU-negative nuclei.
Laser capture microdissection
Sections of jejunum from rats killed at HALO 6 and HALO 18, the 
respective circadian peak and trough of mir-16 expression, were 
embedded in OCT compound over dry ice and isopentane. Sections 
(9 pm) were cut from the fresh frozen specimens and stained with 
Histogene staining solution (Molecular Devices. Sunnyvale, CA). 
Crypts (all cells in the lower half), villi (all cells in the top half), or 
smooth muscle was isolated by laser capture microdissection 
(Veritas Microdissection System, Molecular Devices). Total RNA 
was extracted from each section (RNAqueous RNA extraction kit, 
Ambion, Austin, TX) and subjected to microRNA reverse tran­
scription and real-time PCR as described above for quantification 
of mir-16 expression in each fraction.
Statistical analysis
Data are presented as means ±SE. Graphical analysis was 
performed using GraphPad Prism (San Diego, CA). microRNAs 
exhibiting a 2-fold or greater difference between any two time- 
points were selected for further analysis, and a false discovery rate 
(q-value) of <0.05 was considered significant. Circadian rhyth­
micity of microRNAs, gene and protein expression and morpho­
logical changes in rat tissue was determined by cross-sectional 
analysis and assuming a 24-h period as described previously, using 
the cosinor procedure which is freely available online [25-27]. The 
acrophase (time of peak expression), mesor (rhythm-adjusted 
mean), amplitude of rhythmicity, and significance of fit to a 24- 
h period (as indicated by p<0.05) for each gene were abstracted 
from the program. ANOVA (analysis of variance) with post-hoc 
Tukey's multiple comparisons test was used to identify significant 
differences across the 3 intestinal fractions at each timepoint. T- 
tests were used to compare the effects of mir-16 overexpression 
with control cells in the in vitro experiments.
Results
microRNAs exhibit diurnal rhythmicity in rat intestine
Of 238 microRNAs tested on in situ hybridization arrays, 13 
microRNAs exhibited > 2-fold difference between peak and trough 
values (range 2.0- to 3.4-fold; q<0.05), 8 of which are conserved 
among human, mouse and rat and were therefore selected for 
further evaluation. Real-time PCR (qPCR) confirmed circadian 
rhythmicity for mir-16, mir-20a and mir-141 as determined by the 
cosinor procedure, with a 24-hour periodicity. Peak expression of 
these three microRNAs occurred between HALO 4 and 6, 
corresponding to the lights-on fasting period (Supplementary 
Table 3, Figs. 1A-C). Two of these are reportedly involved in 
proliferation: mir-20a is pro-proliferative and mir-16 is anti­
proliferative [28-34]. Intestinal villus height and cell number 
have been shown to peak in anticipation of maximal nutrient 
intake in previous studies [35]. Because anti-proliferative mir-16 
began to wane late in the light phase, when intestinal proliferation 
has been shown to increase, we selected this microRNA for further 
study and designed experiments to ascertain its role in the rhythm 
of intestinal proliferation.
To compare mir-16 expression levels in crypt, villus and smooth 
muscle, these cell types were isolated by laser capture microdis­
section at HALO 6 and 18, the respective mir-16 peak and nadir. At 
HALO 18, expression was not significantly different across all three 
cell types (Fig. ID; p = 0.97). However, mir-16expression was 3.2- 
fold higher in crypts at HALO 6 vs. HALO 18 (Fig. ID; p = 0.003) 
while it was not detectably different in villi or smooth muscle. 
Thus, mir-16 rhythmicity appears restricted to crypts, the 
proliferative compartment of the intestinal mucosa.
mir-16 suppresses proliferation in enterocytes by inducing G1 arrest
To determine the effect of mir-16 on enterocyte proliferation, mir- 
16 was overexpressed in rat IEC-6 cells, a cell line derived from 
intestinal crypts. Stable transfection of IEC-6 cells with the mir-16 
expression vector led to a 2.1-fold increase in mir-16 expression vs. 
the control (p = 0.03, Fig. 2A). This modest difference, comparable 
to the peak/trough difference observed in mir-16 expression on a 
diurnal basis, had a profound effect on cell proliferation. At 48 h 
after plating, the proliferation rate was decreased 76% vs. control 
cells as measured by the MTS assay (4.2-fold difference; p = 0.006, 
Fig. 2B) and by 80% as measured by cell counts (5.2-fold difference; 
p = 0.02, Fig. 2C). Overexpression of mir-16 also led a significantly 
larger fraction of cells in G1 compared to control as revealed by 
flow cytometry (65% vs. 24%, p<0.001, Fig. 2D). This result
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Fig. 1 - Temporal pattern of microRNAs showing a 2-fold or greater change between any two timepoints (A-C). Total RNA was 
extracted from the intestinal mucosa of rats harvested at the indicated times, run on microRNA microarrays and microRNAs 
showing a 2-fold or greater change between any two timepoints validated by real-time PCR. mir-16 expression in enterocyte 
fractions (D). Laser capture microdissection and real-time PCR were used to determine mir-16 expression in fractions of crypt, villus 
and smooth muscle in cryofixed sections of jejunum.
indicates that proliferation was curbed by arresting enterocytes in 
G1 rather than the reported effect of mir-16 on apoptosis [31,36]. 
The lack of increase in apoptosis in IEC-6 cells overexpressing mir- 
16 (p = 0.63, Fig. 2E) substantiates this conclusion. These results 
point to an effect of mir-16 on the cell cycle in enterocytes, 
specifically regulators of the Gl/S transition.
mir-16 suppresses key Gl/S regulators in enterocytes
To identify specific mir-16 targets involved in reducing prolifer­
ation in enterocytes, the microRNA target prediction algorithm 
Targetscan was interrogated for the presence of mir-16 binding 
sequences in the 3'UTRs of Gl/S regulatory genes [37]. Potential 
mir-16 targets in both rat and human included cyclin D1 (Ccndl), 
cyclin D2 (Ccnd2), cyclin D3 (Ccnd3), cyclin E (Ccnel) and cyclin- 
dependent kinase 6 (Cdk6). These are all known to regulate the Cl/ 
S transition and were therefore examined for responsiveness to 
mir-16. Cyclin-dependent kinase 4 (Cdk4), a G1 regulator lacking a 
mir-16 target site in its mRNA 3'UTR, was included as a negative 
control.
Overexpression of mir-16 significantly decreased protein levels of 
Ccndl, Ccnd2, Ccnd3, Ccnel and Cdk6 in IEC-6 cells compared to the 
non-silencing control (levels 0.3-0.5 that of controls, p<0.05. 
Table 1, Supplementary Fig. 1). mir-16 appeared to affect translation 
of Ccndl, Ccnd3 and Ccnel rather than mRNA cleavage because 
mRNA levels did not change detectably (p = 0.660, 0.151 and 0.181 
respectively, Table 1). In contrast, reduction of Ccnd2 and Cdk6
mRNAs by 75% (p = 0.002) and 58% (p = 0.001), respectively 
(Table 1) indicated that mir-16 overexpression primarily affected 
transcription and/or mRNA stability of these regulators. Our data 
point to one or more of these Gl/S proteins as mir-16-regulated 
mediators on cell cycle progression. As expected, neither Cdk4 
mRNA (p = 0.591) or protein (p = 0.223) levels were altered 
detectably by mir-16 overexpression (Table 1). These results confirm 
that Cdk4 is not a mir-16 target and indicate that mir-16 over­
expression does not exert non-specific effects on cell cycle proteins.
Gl/S regulatory proteins targeted by mir-16 peak in antiphase to 
mir-16 expression in jejunum
Diurnal rhythmicity in intestinal proliferation is likely to be mediated 
by an underlying diurnal rhythmicity in cell cycle proteins [21,38]. 
Moreover, involvement of mir-16 in the jejunal mucosa cell cycle via 
suppression of these proteins as suggested by the IEC-6 studies 
would likely be evidenced by a corresponding displacement of their 
rhythms from mir-16. To these ends, we examined the temporal 
protein expression patterns for the 5 mir-16 targets as well as Cdk4 in 
jejunum. All six proteins exhibited diurnal rhythmicity with a 24- 
hour period, with acrophases (expression peaks) falling between 
HALO 11 and HALO 17 (p<0.05, Figs. 3A-E; Table 2, Supplementary 
Fig. 2) and nadirs between HALO 3 and 6. These temporal patterns 
would be expected for targets suppressed by mir-16 with its peak 
expression at HALO 6. Ccnd2, Ccnd3 and Cdk4 displayed rhythmicity 
at the transcriptional level (p = 0.011, 0.00018, and 0.00015,
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Fig. 2 - Effects of mir-16 on enterocyte phenotype in vitro, mir-16 (or a scrambled control) was stably overexpressed in IEC-6 cells as 
described in Methods. All assays were performed 48 h after plating, mir-16 expression was quantifled by real-time PCR following 
RNA extraction and reverse transcription (A). Proliferation and cell viability were determined using the MTS assay and cell counting 
respectively (B and C). For analysis of cell cycle, cells were fixed in 70% ethanol and stained with propidium iodide and subjected to 
flow cytometry as described in Methods (D). For determination of apoptosis, cells were stained with Annexin V-FITC and Sytox Blue 
and analyzed by flow cytometry (E).
respectively; Figs. 4B-C,Table 2). Ccndl andCcneJ mRNAs exhibited 
temporal changes but these did not qualify as significant circadian 
rhythms, in keeping with the lack of response at an mRNA level with
Table 1 - Expression of mir-16 target protein and mRNA 
following overexpression of mir-16 in IEC-6 cells. Levels have 
been normalized to that in control cells. Our data 
demonstrate regulation of targets C'cndZ and Cdk6 at the 
transcriptional level in vitro, and Ccndl, Ccnd2 and Ccnel at 
the post-transcriptional level. Cdl<4 is not a predicted target of 
mir- 16and correspondingly did not demonstrate alteration in 
expression following mir-16 overexpression. All predicted 
mir-16 targets were suppressed at the protein level.
Protein expression of Gl/S mRNA expression of Gl/S 
regulators regulators
Target Fold-change p-value Target Fold-change p-value 
vs. control vs. control
Ccndl 0.4 0.030 Ccndl 0.9 0.660
Ccnd2 0.4 0.037 Ccnd2 02 0.002
Ccnd3 0.3 0.030 Ccnd3 12 0.151
Ccnel 0.5 0.030 Ccnel 0.8 0.181
Cdk6 0.4 0.039 Cdk6 0.4 0.001
Cdk4 1.2 0.223 Cdk4 1.0 0.591
mir-16 overexpression in vitro. In contrast, Cdk6 did not display 
diurnal rhythmicity of transcription in vivo (p = 0.77, Fig. 4F) despite 
its transcriptional responsiveness to mir-16 overexpression in IEC-6 
cells.
Diurnal rhythmicity in DNA synthesis and morphology in rat 
jejunum
To define the relationship of proliferation to the cyclin expression 
rhythm, we assessed the temporal patterns of DNA synthesis (S- 
phase) and crypt-villus morphology. The number of cells in S-phase, 
as measured by BrdU labeling, peaked at HALO 5 (p<0.001, 
Supplementary Fig. 3A). Crypt cell number peaked several hours 
later at HALO 12 (p = 0.001, Supplementary Fig. 3B), followed by crypt 
depth and villus height at HALO 13 and HALO 14, respectively 
(p = 0.005 and 0.043, Supplementary Figs. 3C and D). Enterocyte 
number per 100 pm of villus increased modestly in anticipation of 
nutrient arrival but significant rhythmicity was not achieved 
(p = 0.099, Supplementary Fig. 3E). Cell width exhibited circadian 
rhythmicity in crypts with a peak at HALO 15 (p = 0.033, Supplemen­
tary Fig. 3F) but not in villi (p = 0.217). Overall these data demonstrate 
that a combination of cell proliferation and hypertrophy produced the 
observed changes in crypt and villus morphology (Table 3).
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Fig. 3 - Temporal pattern of cell cycle protein expression in rat intestine. Whole-cell protein lysates of rat intestinal mucosa, 
harvested at the indicated times, were analyzed by immunoblotting. Diurnal amplitudes and p-values are summarised in Table 2.
Discussion
This study is the first to profile microRNA expression in rat 
jejunum as well as to establish rhythmic expression of specific 
microRNAs. In particular, our data supports a role for the anti­
proliferative microRNA mir-16 in the intestinal proliferation 
rhythm. In support of this, we have shown that mir-16 expression
peaks at HALO 6, coincident with the troughs in villus height and in 
crypt depth and cell number, mir-16 rhythmicity was also 
restricted to intestinal crypts, the primary site of proliferation. 
The anti-proliferative effect of mirl6 was confirmed in vitro, where 
mir-J 6 inhibited proliferation of IEC-6 enterocytes, and suppressed 
expression of 5 key Gl/S regulators—Ccndl, Ccnd2, Ccnd3, Ccnel 
and Cdk6. Finally, protein abundances of all five Gl/S regulators 
presumably targeted by mir-16 as well as the non-target Cdk4
Table 2 - Expression of cell cycle Gl/S regulator protein and mRNA expression at diurnal timepoints in rat jejunum. The cosinor 
procedure was used to determine the fit of the data to a cosinor curve with 24-hour periodicity. Our data demonstrate circadian 
rhythmicity of Ccnd2, Caul3and Cdl<4at the transcriptional level in vivo, and Ccndl, Ccnel and CdkGat the post-transcriptional level.
Rhythmicity of protein expression Rhythmicity of mRNA expression
Target p-value Acrophase (HALO, h) Fold-change peak/trough Target p-value Acrophase (F1ALO, h) Fold-change peak/trough
Ccndl 0.009 12 2.3 Ccndl 0.120
Ccnd2 0.001 14 4.4 Ccnd2 0.011 0 2.7
Ccnd3 0.004 17 2.8 Ccnd3 0.000 0 2.8
Ccnel 0.013 ll 2.8 Ccnel 0.330
Cdk4 0.000 15 2.8 Cdk4 0.005 2 2.3
Cdk6 0.004 16 2.5 Cdk6 0.770
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Fig. 4 - Temporal pattern of mRNA levels for cell cycle genes in rat intestine. Total RNA was extracted from rat intestinal mucosa, 
harvested at the indicated times and was analyzed by real-time PCR. Diurnal amplitudes and p-values are summarised in Table 2.
exhibit diurnal rhythmicity in rat jejunum in antiphase to mir-16. 
These coordinated responses point to mir-16 as an important 
regulator of proliferation in jejunal crypts. This function may be
Table 3 - Diurnal rhythmicity in morphological parameters 
and BrdU labeling in rat jejunum. The cosinor procedure 
was used to determine the fit of the data to a cosinor curve 
with 24-hour periodicity. BrdU labeling, indicative of cell 
cycle S-phase, peaks at HALO 5, followed by peaks in crypt 
depth and villus height after 8 to 9 h. Rhythmicity in 
numbers of enterocytes per crypt suggests that increases in 
cell numbers contribute to this rhythmicity in crypt-villus
morphology.
Parameter p-value Acrophase Fold-change
(HALO, h) (peak/trough)
BrdU 0.005 5 1.6
Crypt depth 0.005 13 1.3
Villus height 0.043 14 i.i
Enterocytes per crypt 0.001 12 1.2
Villus width 0.610
Crypt width 0.080
essential to coordinate intestinal circadian rhythms, serving to 
optimally match proliferation and absorptive capacity with 
nutrient availability.
Circadian rhythmicity of microRNA expression has been shown 
to regulate cell behavior and gene expression. In the suprachias- 
matic nucleus, rhythmic expression of mir-219 and mir-132 
mediate photic entrainment of circadian clock activity [16]. 
Similarly, depletion of mir-122 in liver disrupted the circadian 
rhythmicity of numerous transcripts regulating metabolism 
[18,39]. In the retina, 12 microRNAs display circadian rhythmicity 
of which two - mir-96 and mir-182 - were shown to mediate 
rhythmic expression of the Adcy6 (adenylate cyclase type 6) gene 
[17], Here we highlight another potential role for microRNAs as 
regulators of intestinal circadian rhythms. Interestingly, the 1.8- to 
3.2-fold amplitude changes we observed in intestinal microRNAs 
are consistent with the 1.25- to 3-fold-changes observed in the 
retina [15-17]. Three microRNAs, mir-16, mir-20a and mir-141 
were shown to exhibit circadian rhythmicity in this study, 
however the limited amount of tissue obtained from laser capture 
microdissection restricted us to the examination of only mir-16 
expression at HALO 6 and 18. Further studies are necessary to
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determine the rhythmicity of the remaining microRNAs in the 
individual intestinal fractions at circadian timepoints, particularly 
for mir-20a which is known to have a pro-proliferative function 
and may therefore contribute to the regulation of rhythmicity of 
intestinal proliferation.
Several observations from our studies merit further discussion. 
First, a modest increase of mir-16 in IEC-6 cells, similar to the 
diurnal change in jejunum, almost completely arrested growth in 
these cells, mir-16 has been suggested to act as a tumour 
suppressor gene in prostate: mir16 is frequently downregulated 
in advanced prostate cancer and rnirW knockdown in prostate 
cancer cells promotes proliferation and invasiveness [40], Similar­
ly, mir-16 expression is reduced in squamous cell carcinomas and 
adenocarcinomas of the lung, and mir-16 overexpression in lung 
cancer cell lines induces cell cycle arrest [34]. Our findings reveal 
that the anti-proliferative function of mir-16 serves an important 
physiological role in normal tissues. We note that, in contrast to its 
lack of effect on IEC-6 cell apoptosis, mir-16 was shown to increase 
apoptosis in leukaemic cell lines, gastric cancer cells and prostate 
cancer via downregulation of pro-survival protein BCL2 (B-cell 
lymphoma 2) [31,36,40,41], This apparent discrepancy in our 
observations, may in fact be due to different properties of BCL2 
pathways in the small intestine; while Bcl2 is expressed in 
enterocytes, it may perform different functions in this tissue. 
Indeed, ablation of Bcl2 in mice increases the apoptosis rate in the 
colon but not the small intestine [42,43].
Second, in IEC-6 enterocytes mir-16 suppressed levels of 
several cell cycle proteins involved in the Gl/S transition 
concomitantly with Cl arrest. In normal cell cycle progression, 
D-type cyclins (Ccndl, Ccnd2 and Ccnd3) complex with cyclin- 
dependent kinases (Cdk4 and Cdk6) during G1 to phosphorylate 
and thereby inactivate the retinoblastoma protein pRb, in turn 
activating cell cycle proteins (including Ccnel and its complex 
Cdk2) vital for entering S-phase [44,45]. Upregulation of mir-16 
expression suppressed expression of Ccndl, Ccnd2, Ccnd3, Ccnel 
and Cdk6 in vitro, thereby corroborating existing evidence that 
small changes in microRNA expression alter cellular phenotypes 
by downregulating multiple components of single pathways 
[13,46,47). In vivo, we found that G1 proteins Ccndl and Ccnd2 
peaked at HALO 12, while the remaining D-type cyclin family 
member Ccnd3 peaked later at HALO 17. These findings are 
consistent with reported differences in the relative timing of D 
cyclins in various cell types, as well as differential regulation and a 
degree of functional redundancy [48,49]. We were unable to 
definitively corroborate rhythms of mir-16 in the crypt with 
rhythms of cell cycle proteins in the crypt due to the small amount 
of tissue obtained from laser capture microdissection, however 
previous studies have demonstrated that in the intestine the D- 
type cyclins and cyclin-dependent kinases are most strongly 
expressed in intestinal crypts [50]. Our study showed peak S-phase 
at HALO 5, indicating a Gl/S duration of approximately 12 to 17 h, 
in agreement with previous studies showing a long Gl/S and short 
G2/M period in the small intestine [51-53]. The 63% change in cell 
labeling we observed at HALO 6 vs. HALO 15 is also similar to the 
30-60% increase at HALO 3 in murine jejunum reported by 
Scheving et al. [38,54]. The rhythmicity in proliferation translated 
to rhythmicity in morphological parameters in the jejunum. The 
large number of crypts and villi across the length of the intestine 
suggests that these small changes are likely to result in a large 
change in absorptive surface area over the diurnal period.
Examination of these morphological parameters in the terminal 
ileum and corroboration of these measurements with mir-16 
expression in the ileum may reveal new insights into the 
regulation of mir-16.
Our data show that mir-16 is able to affect translation of Ccnd 1, 
Ccnd3 and Ccnel without affecting mRNA expression, corroborat­
ing previous data showing microRNAs are able to suppress protein 
levels independent of mRNA expression [46]. This was also 
demonstrated by our data in vivo; Ccndl and Ccnel showed 
rhythmicity only at the protein level. This is in keeping with 
previous data showing that almost half of the proteins demon­
strating circadian rhythmicity in the mouse liver lack a 
corresponding cycling transcript [5]. Together with our findings 
this suggests the possibility that the rhythmic protein expression 
in jejunum in our study may be produced solely by miRNAs, 
whether by mir-16 alone or in combination with others. Cell-type 
specificity of mir-16 rhythmicity, such as seen in the intestinal 
crypts in our study, would then lead to consequent rhythmicity of 
target proteins. Cell cycle proteins are known to have a relatively 
short half-life [55], which is likely to facilitate regulation of these 
proteins by rhythmicity in microRNA expression and allow 
increased responsiveness to other stimuli that may accelerate or 
arrest the cell cycle.
Regulation of gene expression by microRNAs is a complex 
process, with the potential for each to target many related or 
unrelated genes and for responsive genes to be regulated by 
multiple microRNAs. In the case of the cell cycle, microRNAs let-7a, 
mir-34a, mir-192 and mir-215 have been shown, like mir-16, to 
arrest cells in Gl, while mir-106b and mir-221 accelerate Gl/S 
progression by suppressing the cyclin-dependent kinase inhibitors 
p21 and p27, respectively [56-61]. Factors other than microRNAs 
are also clearly important in cuing the intestinal proliferation 
rhythm. For instance, clock gene Period 2 (Per2) regulates 
proliferation in peripheral tissues via cell cycle genes c-Myc, Cyclin 
A, Mdm-2 and Gadd45a, as well as the mir-16 target Ccndl [62]. 
Ultimately, proliferation rhythms likely result from combined 
inputs of circadian clock components, other transcription factors 
and rhythmic microRNAs. The ability of non-microRNA transcrip­
tional regulators such as clock genes to regulate rhythmicity of 
proliferation may explain rhythmicity in Cdk4, a cell cycle gene not 
regulated by mir-16, and the lack of transcriptional rhythmicity in 
Cdk6 in vivo despite responsiveness to mir-16 overexpression in 
vitro. Generation of knockout mice lacking mir-16 will be 
invaluable in defining its functions and dissecting these regulatory 
pathways.
Finally, a broader implication can be drawn from our study. The 
behavior of mir-16 reveals another potential route for linking 
proliferation to nutrient availability, which cues the intestinal 
rhythms. Rhythmic mir-16 expression in crypt cells could be initiated 
by luminal nutrients directly or via neuro-hormonal pathways. In 
either case, proliferation may be a key early component to expand the 
mucosal surface area in the anticipatory diurnal increases in 
absorptive capacities for glucose, peptides, and other nutrients [ 19,63 ].
In summary, we show for the first time rhythmicity of 
microRNA expression in the intestine, and anti-proliferative effects 
of the diurnally expressed mir-16 in untransformed enterocytes in 
vitro. We hypothesize that rhythmicity of mir-16 in jejunum may 
act to mediate the rhythmicity in intestinal proliferation and 
coordinate the proliferative response with nutrient availability to 
optimize intestinal absorption and function.
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